"companyid","keydevid","transcriptid","headline","mostimportantdateutc","keydeveventtypename","companyname","speakertypename","componenttextpreview","word_count","componenttext"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Good morning, and welcome to the UnitedHealth Group's Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. There are some important introductory information. This call contains f",186,"Good morning, and welcome to the UnitedHealth Group's Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. 
There are some important introductory information. This call contains forward-looking statements under U.S. Federal Securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings. 
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the financial and earnings reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated January 20, 2021, which may be accessed from the Investor Relations page of the company's website. 
I will now turn the conference over to the Chief Executive Officer of UnitedHealth Group, David Wichmann."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us today. We remain in a time of unprecedented challenges for individuals, employers and the health system broadly, particularly frontline clinicians, including our own. Health systems across the world have been and",1452,"Good morning, and thank you for joining us today. We remain in a time of unprecedented challenges for individuals, employers and the health system broadly, particularly frontline clinicians, including our own. Health systems across the world have been and continue to be stressed. 
Amidst these challenges, we are grateful for the daily displays of human spirit to serve others and the resolve to make things better. We remain optimistic because we are also living at a time of unprecedented collaboration, knowledge sharing and innovation. The health system has come together in ways previously not seen, a powerful multidimensional response to support patients, physicians and communities. I couldn't be prouder of or more grateful to the more than 325,000 women and men of this enterprise. They work each day under difficult conditions with clinicians comprising well more than 1/3 of the total to advance a high-performing health care system, one built on personal human connections, enabled through information and technology and supported by strong alignment of physician-led, value-based delivery of care. They are another profound reason for our optimism. 
With all that's transpired in 2020, we finished the year responsibly and strongly. We delivered meaningful advances in NPS and employee engagement and financial results well above the upper end of our expectations, all while navigating the uncertain environment and achieving our commitment to address financial imbalances resulting from the COVID-19 pandemic. 
As we move into 2021, we believe we are well positioned to continue to serve more people even more deeply and more effectively while continuing to build this enterprise and grow strongly in the decades to come. Just 7 weeks ago, we were privileged to spend a full day with you at our investor conference. Over the course of that day, we tried to convey how we seek to lead in the development of the next-generation health care system. We shared the distinctive capabilities we apply to make health care more connected, more informed, more human and more deeply personal. We finished 2020 encouraged by the performance across the businesses of Optum and UnitedHealthcare. Let me provide just a few broad highlights. 
The UnitedHealthcare Medicare Advantage offerings are off to an excellent start. 2021 will be one of our strongest years of growth, now expected to approach 900,000 more people served across individual and group Medicare Advantage and dual special needs plans. UnitedHealthcare will have grown to serve 3.5 million more seniors over 5 years. Seniors choose our offerings because of the value they receive, better health outcomes and experiences at lower costs. 
We've also been enhancing our offerings to better meet expectations about how people want to live their lives, focusing on more digital and physical care resources in the home, expanding our one-on-one concierge navigation services and enabling the home as the safest and more effective setting of care. UnitedHealthcare's Medicaid offerings continue to grow strongly as well, including entry into 3 new states in 2021. New business opportunities are substantial, with momentum towards Managed Care adoption by states and RFP activity accelerating this year and next. 
And while the economic effects of COVID-19 impacted UnitedHealthcare's employer sponsor growth in 2020, we're encouraged by the positive market response to the new highly consumer-centric offerings we've been discussing with you in recent months. Among these are digital-first, on-demand and physician-led products each provide deeply aligned, modern, personal and coordinated care experiences and save people up to 20% compared to traditional offerings. These innovative products are generating significant responses because they are designed to better meet the unique needs and financial means of more people. All in, we expect UnitedHealthcare will grow in 2021 to serve upwards of 1.5 million more people across its senior community, employer-sponsored and individual offerings. 
We continue to make important advancements and strategic investments to lay the foundation for the next-generation health system. Over the last many years, you've heard us discuss our ambition to build high-performing systems of care, including an aim to reinvent health care delivery, which is the first of our 5 strategic growth platforms. The foundations for those efforts are in our primary and multispecialty care practices. OptumCare entered 2021 with over 50,000 physicians and 1,400 clinics. Over the course of this year, we expect to grow our employed and affiliated physicians by at least 10,000. This work of building local physician-led systems of care continues to be central to our mission and is accelerating, with notable progress in the Northeast, Pacific Northwest and Southern California in 2020. 
Two weeks ago, we announced the combination of Change Healthcare and Optum Insight. We expect this combination will greatly advance the foundational connectivity and collaboration needed for the next-generation health system, establishing a new, more modern information and technology-enabled health care platform. It will help accelerate the development and use of digital and advanced technologies, another of our 5 key growth platforms and critical to connecting the -- all elements of our business strategy. This advanced platform will help clinicians make the most informed and clinically advanced patient care decisions more quickly and easily. Change Healthcare brings widely adopted technology for integrating evidence-based clinical criteria directly into the clinician's workflow. While Optum's clinical analytics expertise and individual health record can strengthen the evidence base needed to deliver effective clinical decision support at the point of care. This can ensure appropriate clinical pathways are offered in the most appropriate sites of care leading to consistent achievement of the best possible outcomes experiences and value for the patients we serve. 
Another key opportunity will be to enhance administrative processes by combining Optum's advanced data analytics with Change Healthcare's intelligent healthcare network to support simpler, more informed and accurate services and processing at considerably lower cost. 
Finally, combining Change Healthcare's payment capacities with Optum's highly automated payment networks will simplify financial interactions among care providers, payers and consumers and accelerate the movement to a more modern, realtime and transparent payment system. This will help physicians get paid more quickly, accurately and reliably and provide consumers with more options and convenience in managing their health care finances. The Change Healthcare team has been doing outstanding work, and we're looking forward to working alongside them. 
We continue to execute on the core initiatives we laid out for you in December. One example, as the pandemic disrupted care patterns, we all saw the increased need to enhance in-home and alternative settings of care, offering patients to receive safe, effective and efficient care outside of traditional venues. However, the need for in-home care will continue to grow well beyond the current environment. We know that more than 80% of what impacts a person's health happens outside of traditional health care settings. There's a significant opportunity in offering consistent, cost-effective care for seniors, people with complex medical conditions and geographically isolated individuals through in-home and alternative settings. Offering a foundational ability to care for people in their homes is essential to developing a health system that is more consumer-centric, higher quality and lower cost. We already have well-established, trusted capacities to bring skilled care resources into the home, including through Optum's HouseCall program. We expect our advanced practice clinicians will conduct over 2 million in-home visits this year. 
And we are building upon this established home capacity in many ways. We have introduced Viva 5 remote patient monitoring capabilities to improve connectivity and information sharing with physicians. This has been received positively by patients with a Net Promoter Score over 80. Optum at Home provides in-person and telephonic touch points across an interdisciplinary team, including physical, social and behavioral aspects. The program increases preventative care, achieved exceptional NPS in the mid-80s, lowers medical expense and demonstrates high quality with over 90% of our members in a 4-star or higher plan. 
Similarly, Optum's Pharmacy Care Services enables patients to receive the care and medications they need, with capacities to deliver outside of traditional settings. OptumRx's Infusion Services now addresses the needs of about 25,000 patients per month and is growing double digits, which means more patients can obtain the care they need outside of the acute settings. That makes it safer, simpler and more affordable for people. We remain encouraged as well by the traditional Pharmacy Services provided by OptumRx with an over 98% customer retention rate entering 2021. We are off to a good start for the 2022 selling season as we were recently awarded the honor to serve more than 2.5 million members of Blue Cross Blue Shield of Michigan. 
In sum, we entered 2021 with momentum, confident in our capacity to navigate through and begin to emerge from these challenging times as an even more capable, diverse and growing enterprise. Now I'll turn it over to Chief Financial Officer, John Rex."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank.You, Dave. The full year 2020 and fourth quarter results were favorable to the outlook we provided at our December 1 investor conference while continuing to be impacted by the unprecedented environment, which has existed most of the year. To beg",946,"Thank.
You, Dave. The full year 2020 and fourth quarter results were favorable to the outlook we provided at our December 1 investor conference while continuing to be impacted by the unprecedented environment, which has existed most of the year. 
To begin, as we know it is a great interest to you. I'd like to share what we're seeing in current care patterns. Starting at the highest level within the broad member categories we serve. People with commercial benefits continue to exhibit overall higher levels of care activity with less deferral than those served in public sector programs such as Medicare and Medicaid. Our top priority remains getting people the care they need. During the fourth quarter, we saw overall average care activity return to seasonal baselines compared to the just over 95% we cited for the third quarter. The pacing over the course of the quarter, perhaps not too surprisingly, moved from just below baseline as we began to modestly exceeding baseline in the latter half. This measure includes increased direct COVID-19-related care, which, in total, comprised about 11% of all care activity during the fourth quarter compared to about 6% in the third quarter. 
Looking deeper within specific care categories. Outpatient activity began the quarter at baseline, and we were gratified people were able to obtain needed care previously deferred. By the latter part of the quarter however, some outpatient activity moderated as COVID-19 incidents elevated. 
Total inpatient activity increased modestly over the course of the quarter as the direct COVID-19-related care components rose as a percentage of the total in the latter half. For example, of the 65,000 COVID-19-related inpatient admissions during the quarter, about 20% occurred in October and about 50% in December. 
Moving to our specific businesses. OptumHealth's fourth quarter earnings increased 16% year-over-year as care activity at our fee-for-service practices and ambulatory surgery centers continue to recover, with these businesses now operating near baseline. Revenue per consumer served grew 29% over the year ago quarter. The growth in this measure reflects continued development of the value-based care arrangements, the depth of our offerings and the increasing acuity of the types of care we can deliver to the people we serve. You should expect this measure to continue to grow at a strong double-digit pace for many years to come. 
One example which highlights this potential. Of the 20 million patients OptumCare serves today, under 20% are currently in value-based arrangements. We expect both the number of patients served and the depth and number of value-based arrangements to continue to accelerate. 
OptumInsight's earnings were ahead of the outlook we offered at the beginning of December with overall 2020 performance impacted by lower levels of care with revenues dependent upon care activity volumes for many of these businesses and the generally subdued overall business environment. We continue to expect 10% to 15% growth in 2021 as care activity returns to normalized levels and we continue to advance strategic relationships and broaden services with existing customers. This outlook excludes any impact from OptumInsight's combination with Change Healthcare, which we expect will close in the second half of the year. 
OptumRx's earnings were also ahead of this outlook. During 2020, revenues in our pharmacy care services and specialty businesses continue to grow at double digits and now comprise nearly half of total OptumRx revenue. 
Turning to UnitedHealthcare. Fourth quarter operating results were above our December view. They reflect continued customer and provider assistance measures to help people obtain the care they need and comparatively lower levels of care deferral and higher COVID-19 care costs versus the third quarter. Results in the fourth quarter were further impacted by additional reserves for rebates and related activity as plans with such arrangements moved into these positions as a result of the cumulative care deferral impacts throughout 2020 and calendar year-end assessments were concluded. 
As Dave noted, sales activity in the Medicare Advantage open enrollment period was robust. Within the 900,000 new members we expect to serve for full year 2021, about 775,000 will be in individual and group Medicare Advantage and the remainder in dual special needs plans, which are included in the Community & State Medicaid membership tables. 
Strong growth in Medicaid membership continued in the fourth quarter. Recall, our full year 2021 outlook to serve an additional 200,000 to 300,000 people assumes state redetermination activities are reinitiated during the year. We concluded 2020 with commercial membership about 100,000 people ahead of the outlook we provided at our investor conference. Early January results are well supportive of positive commercial growth in 2021, this even considering the challenging economic environment. 
Our liquidity, capital positions and capacities remain strong. Full year 2020 cash flows from operations were $22.2 billion or 1.4x net income, with the fourth quarter result exceeding the outlook we provided due in part to early customer receipts. Our debt-to-total-capital ratio of 38.9% compares to 40.2% last year. 
As we look enthusiastically toward the combination with Change Healthcare, we intend to maintain our long-standing capital policies, including our approach to returning capital to shareholders via share repurchase and an advancing dividend with ample capacity to continue building upon our strategic growth platforms and ongoing priority on expanding our local care delivery capabilities. 
Our full year 2021 outlook remains consistent with the early December commentary with total revenue approaching $280 billion and adjusted earnings per share in the range of $17.75 and to $18.25, inclusive of the negative COVID-19-related effects we described. Given the still highly dynamic circumstances, we will likely hold this broader-than-typical range of expectations as we, much like everyone else, continue to learn more about the environment. 
Now I'll turn it back to Dave."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, John. As you can tell, the businesses of this diversified and growing enterprise remains strong and well positioned for sustained, balanced growth as we continue to add new capabilities and market positions. We remain committed to our mission a",80,"Thank you, John. As you can tell, the businesses of this diversified and growing enterprise remains strong and well positioned for sustained, balanced growth as we continue to add new capabilities and market positions. We remain committed to our mission and an intense focus on serving one person at a time at increasing levels of value, more affordable, better outcomes and improved experiences while generating strong returns for you, our shareholders. 
Operator, let's open it up for questions. [Operator Instructions]"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] And our first question comes from Ralph Giacobbe from Citi.",12,"[Operator Instructions] And our first question comes from Ralph Giacobbe from Citi."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Great. John, I just wanted to go back to some of the commentary. You said trends are near baseline. Just want to be clear, you're talking about just utilization or spending there. And then the commentary that COVID was 11% of activity, I guess, in the f",53,"Great. John, I just wanted to go back to some of the commentary. You said trends are near baseline. Just want to be clear, you're talking about just utilization or spending there. 
And then the commentary that COVID was 11% of activity, I guess, in the fourth quarter, just want to clarify that."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Thanks, Ralph. John, do you want to start?",9,"Great. Thanks, Ralph. John, do you want to start?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ralph, yes. So we're talking about spending when we talk about near baseline levels anticipated and again, inclusive of the COVID-19 care cost. So that's why I was trying to give you some sense of kind of what component -- what those comprise in there ove",68,"Ralph, yes. So we're talking about spending when we talk about near baseline levels anticipated and again, inclusive of the COVID-19 care cost. So that's why I was trying to give you some sense of kind of what component -- what those comprise in there overall. 
And your second question, Ralph, I lost just the last part of it. I just want to make sure I heard that."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","I'm afraid even he got cut out.",8,"I'm afraid even he got cut out."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Just -- I didn't hear quite the very end of it. But when we're talking about kind of the 11% zone, I think maybe what you were looking for is probably how that relates. Think of that 11% zone in terms of medical costs. If you're looking at our medica",132,"Yes. Just -- I didn't hear quite the very end of it. But when we're talking about kind of the 11% zone, I think maybe what you were looking for is probably how that relates. Think of that 11% zone in terms of medical costs. If you're looking at our medical costs on our income statement, use about maybe 3/4 of that level as a measure. What I would exclude from that, because we're thinking about really kind of components, fee-for-service medical costs that we incur on that, so I would include UnitedHealthcare's payments to capitated providers. It would exclude -- sorry, it would also exclude things like pharmacy costs and such. So I'd probably use about 3/4 of that. And I think that's where you're going with that question. Thank you."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Hey, Ralph, we didn't get that. Just circle back with Brett and the team, and we'll be happy to answer your question on the side.",25,"Hey, Ralph, we didn't get that. Just circle back with Brett and the team, and we'll be happy to answer your question on the side."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Ricky Goldwasser from Morgan Stanley.",10,"Our next question comes from Ricky Goldwasser from Morgan Stanley."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","You recently updated your Telehealth policies. I wanted to dig a little bit deeper into this. What do you think is sort of the right balance between in-person medical care versus Telehealth when activity normalizes in there? When do you think -- where do",64,"You recently updated your Telehealth policies. I wanted to dig a little bit deeper into this. What do you think is sort of the right balance between in-person medical care versus Telehealth when activity normalizes in there? When do you think -- where do you think reimbursement will settle? It seems that you are continuing sort of the reimbursement. But as you think about..."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ricky, you cut out, well, at the same time Ralph did. So we'll take a shot at answering your question around Telehealth policies and how we think this will normalize out. I actually ask Dirk to do that. And then maybe ask Dr. Decker to talk about the plus",69,"Ricky, you cut out, well, at the same time Ralph did. So we'll take a shot at answering your question around Telehealth policies and how we think this will normalize out. I actually ask Dirk to do that. And then maybe ask Dr. Decker to talk about the pluses and minuses of in-person, not plus and minuses, but just maybe when more inpatient care should be administered versus digital."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So thanks, Dave. So what I would say is the good news is that Telehealth is a great vehicle for people to access care. So number one, let's just start with that as a premise. We, at UnitedHealthcare, from a policy standpoint, we work with Optum. We w",162,"Yes. So thanks, Dave. So what I would say is the good news is that Telehealth is a great vehicle for people to access care. So number one, let's just start with that as a premise. We, at UnitedHealthcare, from a policy standpoint, we work with Optum. We work a lot of Telehealth providers on different products and capabilities. And I would say, how it's ultimately going to shake out is going to be related to who provides the best outcome using Telehealth, the lowest cost and ultimately, the best patient experience. Those are sort of truisms which are going to exist no matter what. 
We saw a huge spike at the beginning of real high Telehealth access back in April. It sort of metered out throughout the course of the year. I'm not sure where it's going to ultimately end. But clearly, it's here to stay, and it's going to be an important part of health care going forward. Dr. Decker?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Dave. And Ricky, thanks for the question. What's fascinating is not all Telehealth offerings are created equal. And we have found that, not surprisingly, patients really appreciate being connected to their own personal providers, and provider",171,"Yes. Thanks, Dave. And Ricky, thanks for the question. What's fascinating is not all Telehealth offerings are created equal. And we have found that, not surprisingly, patients really appreciate being connected to their own personal providers, and providers very much need the realtime clinical data to provide good advice and care for that patient in a virtual setting. So that's key point 1. 
Point 2 is certain services like ambulatory or outpatient behavioral health care lend themselves to a Telehealth solution. And so we have seen approximately 50% of our our behavioral health care being delivered in a Telehealth setting, and that has been sustained throughout the year even as the pandemic had subsided. And as it returns, it empowers those populations to get excellent care virtually. 
Finally, I'll just add that it's critical, and we're very excited about the ability at OptumHealth to connect physical care, virtual care and home-based care in a comprehensive model that really differentiates itself by providing personal realtime care in the right setting. Thank you."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Thank you, Dr. Decker and Dirk. Thank you for your question, Ricky.",13,"Great. Thank you, Dr. Decker and Dirk. Thank you for your question, Ricky."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Steven Valiquette from Barclays.",9,"Our next question comes from Steven Valiquette from Barclays."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Great. So I guess as you now assess the commercial membership trends exiting 2020 and any early trends so far in 2021, is there any further color just on your conviction around the commercial enrollment projections for 2021? You would now need a small inc",72,"Great. So I guess as you now assess the commercial membership trends exiting 2020 and any early trends so far in 2021, is there any further color just on your conviction around the commercial enrollment projections for 2021? You would now need a small increase in commercial risk membership to hit the target this year and then whereas fee-based or as would remain essentially flat. Just looking for more color around that."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Steve, good question. And I just like to throw in a plug for our commercial team who has worked very hard to get cost structures in line and to be very innovative around new product offerings, bring greater value to people. And I think it's startin",68,"Great. Steve, good question. And I just like to throw in a plug for our commercial team who has worked very hard to get cost structures in line and to be very innovative around new product offerings, bring greater value to people. And I think it's starting to show through in terms of our overall growth performance. Bill, do you want to comment or respond to Steve directly?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question. I'll start with we're really pleased with how our fourth quarter and January 2021 enrollment performance played out. Our enrollment for 1/1 is better than we projected at our investor conference, supported by really strong pe",125,"Yes. Thanks for the question. I'll start with we're really pleased with how our fourth quarter and January 2021 enrollment performance played out. Our enrollment for 1/1 is better than we projected at our investor conference, supported by really strong persistency across really all lines of coverage and then less-than-anticipated attrition. Obviously, in the current economic environment, it's created some challenges. However, we're really well positioned to deliver on our commercial growth strategy that we highlighted at our Investor Day. 
I think we've also benefited from a broad portfolio of products that all of our customers are accessing to renew their business with us. So we feel really nice -- we're feel really strong about our growth prospects for the rest of 2021. Thank you."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes.  I'd just say we have a ways to go. We're kind of turning the corner to growth. And obviously, maintaining that consistently and continuing to accelerate it will be our emphasis as we move forward. Thank you for the question.",41,"Yes.  I'd just say we have a ways to go. We're kind of turning the corner to growth. And obviously, maintaining that consistently and continuing to accelerate it will be our emphasis as we move forward. Thank you for the question."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Lance Wilkes from Bernstein.",9,"Our next question comes from Lance Wilkes from Bernstein."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Could you just talk a little bit in OptumRx about the pace and status for you guys in online pharmacy and in-home delivery and maybe what your long-term strategy and scope is for that?",35,"Could you just talk a little bit in OptumRx about the pace and status for you guys in online pharmacy and in-home delivery and maybe what your long-term strategy and scope is for that?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Happy to. John, please?",5,"Great. Happy to. John, please?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks for the question, Lance. Obviously, we've been very focused on building on our pharmacy care services model for the last several years. So not only have we've been getting into only in pharmacy and home delivery, but we've been creating various pro",195,"Thanks for the question, Lance. Obviously, we've been very focused on building on our pharmacy care services model for the last several years. So not only have we've been getting into only in pharmacy and home delivery, but we've been creating various programs to meet the needs of population, especially in infusion [indiscernible] pharmacies. And why we -- why I frame that is because we're trying to meet the needs of the population in unique ways and create a very differentiated solution. So I think as you look at online pharmacy and home delivery, it's been a big grower for us. We continue to grow share, expand our penetration. But we've also expanded our services within pharmacy care services to serve all consumers so that they don't have to be a member of the PBM. We've been launching over-the-counter Optum store. And so we see a significant growth of selling more products. We also will see in those stores, unique ones like Optum Perks, which is our discount card of bringing them all together in a virtual environment. So we see good prospects, and we see it as a big grower in the long term."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Steve Willoughby from Cleveland Research.",10,"Our next question comes from Steve Willoughby from Cleveland Research."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Just a question regarding one of the lines in the press release this morning related to additional reserves for rebates related to activity as calendar year assessments were concluded. Just wondering if you could provide any more color on that? And any wa",70,"Just a question regarding one of the lines in the press release this morning related to additional reserves for rebates related to activity as calendar year assessments were concluded. Just wondering if you could provide any more color on that? And any way to quantify that as compared to the larger favorable reserve development you experienced during the quarter? Anything else interesting on reserves and movements one way or another?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure, Steve. John Rex here. I would say the additional color I could provide in that is kind of those actions well more than offset the magnitude of favorable reserve development in the quarter. And just as we -- as those moved into those positions, not t",134,"Sure, Steve. John Rex here. I would say the additional color I could provide in that is kind of those actions well more than offset the magnitude of favorable reserve development in the quarter. And just as we -- as those moved into those positions, not too surprisingly, as you can tell, because we were able to -- as we provided an outlook in December for the full year and how things would turn out, given the greater level of volatility in specific pieces of business over this course of this year as utilization moved around over the quarter. So thereby putting more plans into those kind of positions than one would, of course, normally have. Part of what one has to anticipate in this kind of environment, but certainly kind of that move."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Scott Fidel from Stephens.",9,"Our next question comes from Scott Fidel from Stephens."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I had a question just on your latest thinking and expectations just around Medicaid risk corridors and the impact that you're expecting there. Just interested if the impact of corridor is so completed in the fourth quarter in line with the expectations th",98,"I had a question just on your latest thinking and expectations just around Medicaid risk corridors and the impact that you're expecting there. Just interested if the impact of corridor is so completed in the fourth quarter in line with the expectations that you have provided at Investor Day and whether there's been any incremental changes there since then in terms of expansion of of corridor programs and how you think about that on Medicaid margins. One of your competitors have recently cited a larger-than-expected impact in 4Q, so I wanted to get your feedback on that."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure.  We'll send that to Tim Spilker. Tim?",8,"Sure.  We'll send that to Tim Spilker. Tim?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you for the question. Yes, states have continued to leverage risk corridors and MLR structures, and many of these were implemented in the back half of '20. We anticipated those based on discussions with our customers. Now one thing that should be no",137,"Thank you for the question. Yes, states have continued to leverage risk corridors and MLR structures, and many of these were implemented in the back half of '20. We anticipated those based on discussions with our customers. Now one thing that should be noted is that looking ahead, CMS has implemented rules requiring corridors to be implemented proactively versus retrospectively. So that will improve some predictability and visibility. 
And then overall, just in terms of what we're seeing at this point, while most of our  1/1 base rate renewals are in line with expectations, we're really respectful of the financial pressure that many of our states are under as well as the uncertainty surrounding the pandemic. So we'll continue to work with our customers and advocate for sustainable funding in that regard. Thanks for the question. Great."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Justin Lake from Wolfe Research.",10,"Our next question comes from Justin Lake from Wolfe Research."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Just a couple of quickies on post the Investor Day, it sounds like you're saying that cost trend picked up through the quarter a bit. Can you talk about it relative to what you're expecting for the full year 2021 that are you -- is it ahead of where you'r",98,"Just a couple of quickies on post the Investor Day, it sounds like you're saying that cost trend picked up through the quarter a bit. Can you talk about it relative to what you're expecting for the full year 2021 that are you -- is it ahead of where you're expecting or in line? 
And then Medicare position rates went up a bit post the stimulus bill. I'm estimated at about $0.15 of a headwind for the company. Just curious on your estimate there? And are there any offsets that you see as you're going through the year?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Well, we heard the first part, John Rex. And then Tim will handle the second.",15,"Well, we heard the first part, John Rex. And then Tim will handle the second."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, I think the outlook for 2021 in terms of COVID impact, though, even with what you've cited there in terms of as things were trending in the quarter, still consistent with where we were at an investor conference. And our expectation is that total d",107,"Justin, I think the outlook for 2021 in terms of COVID impact, though, even with what you've cited there in terms of as things were trending in the quarter, still consistent with where we were at an investor conference. And our expectation is that total direct COVID-19 care cost in 2021 will be similar to what we experienced in -- for full year 2020. So there isn't anything that would take us off that view right now. I think the other element we cited, though, total COVID-19 care costs higher and then the headwind being that care deferral likely being meaningfully lower than we saw in 2020."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","And Tim, second part?",4,"And Tim, second part?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Justin, for the question. So the fee schedule increase you talked about was, of course, part of the relief deal that was passed on December '20. And the physician fee schedule increase that was included there was partially offset by removing",136,"Yes. Thanks, Justin, for the question. So the fee schedule increase you talked about was, of course, part of the relief deal that was passed on December '20. And the physician fee schedule increase that was included there was partially offset by removing sequester for the first quarter of 2021. As we look at this environment, it's obviously still quite fluid. The PHC has been extended again and obviously, also another relief package that's being worked on. At this time, the sequester relief has only been extended a quarter. It does not match the PHE as it has throughout the pandemic. And if a sequester was extended one more quarter that would offset the small headwind that we're seeing as a result of all of this. So something we're still watching, but that's where it stands."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good observation on puts and takes. That's going to probably happen as we navigate our way through 2021. That's why we have a wider range. And we have a $2 billion estimate on net COVID impacts as well.",38,"Good observation on puts and takes. That's going to probably happen as we navigate our way through 2021. That's why we have a wider range. And we have a $2 billion estimate on net COVID impacts as well."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Robert Jones from Goldman Sachs.",10,"Our next question comes from Robert Jones from Goldman Sachs."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Maybe just to shift over to OptumHealth. I noticed you announced a fairly sizable physician group acquisition in Massachusetts. If I heard you correctly, I believe you said you expect employed and affiliated physicians to increase around 10,000 this year.",79,"Maybe just to shift over to OptumHealth. I noticed you announced a fairly sizable physician group acquisition in Massachusetts. If I heard you correctly, I believe you said you expect employed and affiliated physicians to increase around 10,000 this year. I just wanted to get your latest thoughts on the acquisition environment for doc groups. Are you finding a greater willingness in this kind of post-COVID world for a willingness to consider acquisition for some of these larger groups?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Just before we get started, we have not announced any acquisition as you described, so that's a market rumor and speculation. As it relates to M&A broadly in this space, we've -- Dr. Decker and team have done a terrific job continuing to build in t",251,"Yes. Just before we get started, we have not announced any acquisition as you described, so that's a market rumor and speculation. 
As it relates to M&A broadly in this space, we've -- Dr. Decker and team have done a terrific job continuing to build in the Northeast. I'd say in the fourth quarter, the CareMount transaction was completed. That is a strong addition to our I 95 corridor Tri-state expectation. We also finished a acquisition in the Southwest and Southern California,  in particular, with -- the in the Inland Empire region. And we've also done some work up in the Pacific Northwest this past year as well and some in the center part of the United States. 
I'd say, generally speaking, the the market seems to continue to gravitate towards an OptumCare-type model where there's a great sense of stability as well as a very strong quadrupling model, which seems to resonate very well with physicians, but also with our patients where they get better experiences, outcomes and overall lower cost is demonstrated by the value that's being brought every day and the growth in that overall in that area. 
So I think as we turn into 2021, this will be an area of continued focus for us, and I think you'll continue to see that occur over the next half to full decade or so as we continue to build out this broad health system health system that's much more effective across the 4 aims that I just described."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Whit Mayo from UBS.",9,"Our next question comes from Whit Mayo from UBS."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","You guys have really emphasized some of the new innovative solutions in commercial, the consumer-centric focus, et cetera. Can you talk maybe more about the on-demand solutions that you've been referencing and the partnership with buying, just the recepti",65,"You guys have really emphasized some of the new innovative solutions in commercial, the consumer-centric focus, et cetera. Can you talk maybe more about the on-demand solutions that you've been referencing and the partnership with buying, just the receptivity among plan sponsors, just curious if there's been any sort of surprises in the market as you've kind of brought that capability to your customer base?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Bill, do you want to take that one?",8,"Bill, do you want to take that one?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, sure. I'll start with, we benefit from a broad portfolio of products and plan designs across our business. And depending on the type of buyer, we've seen great interest in all different types of products for us. So we have seen a big uptick in our Mo",148,"Yes, sure. I'll start with, we benefit from a broad portfolio of products and plan designs across our business. And depending on the type of buyer, we've seen great interest in all different types of products for us. So we have seen a big uptick in our Motion product, people looking for digital solutions, looking for activity trackers. There's been a huge amount of emphasis and discussion with employers regarding access to better wellness, obviously, because of the pandemic. And so we've seen a lot of receptivity to that. We've seen a lot of receptivity to our All Savers product. As far as buying, yes, for particular type of buyers, it's really been a very interesting, innovative solution. We continue to bring that to market, and we're excited about the opportunities that will deliver in our fully insured market as well as in our ASO business for Bind."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you. And if I can, I'm just going to have Dan Schumacher, who's on the Bind Board, also comment on what he's seeing with the overall progression there.",29,"Thank you. And if I can, I'm just going to have Dan Schumacher, who's on the Bind Board, also comment on what he's seeing with the overall progression there."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. Thank you. We appreciate the interest. We have seen broad market interest in Bind. I'd say that as you look at what happened over the course of 2020, more people were inclined to stay. So there was less switching going on. You saw that in the broade",119,"Sure. Thank you. We appreciate the interest. We have seen broad market interest in Bind. I'd say that as you look at what happened over the course of 2020, more people were inclined to stay. So there was less switching going on. You saw that in the broader UnitedHealthcare performance in terms of retention. So on the new sales side, we saw probably lower interest than we would have hoped, just given the the tendency towards incumbency. But where we had an existing footprint, we continue to see employees choose Bind inside those offerings. So we're excited about the prospects forward and expect to build on it, especially as we've returned to more normal buying patterns in the future."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So this is a progressive model that will continue to evolve and adapt over time. Like the initial price points and the impact, I also like the receptivity broadly by consumers, which I would say has probably been the greatest surprise for me personally, t",70,"So this is a progressive model that will continue to evolve and adapt over time. Like the initial price points and the impact, I also like the receptivity broadly by consumers, which I would say has probably been the greatest surprise for me personally, that consumers get it as well as they do. So I think that's part of the reason why you've seen strong receptivity in the market overall."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Josh Raskin from Nephron Research.",10,"Our next question comes from Josh Raskin from Nephron Research."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","This well. A question relates to OptumHealth. And you show the 98 million consumers served in 2020 and the average revenue per consumer at $34. I think, John, you mentioned that was up close to 30%. But that's still a fraction of the opportunity of how we",112,"This well. A question relates to OptumHealth. And you show the 98 million consumers served in 2020 and the average revenue per consumer at $34. I think, John, you mentioned that was up close to 30%. But that's still a fraction of the opportunity of how we think about a traditional risk there and capitation rates. So the question really is what percentage of the OptumHealth revenues are sort of pure fee-for-service? What about -- what's the percentage on the other end of the spectrum, sort of global capitation? And how do we think about what's in the middle, really just trying to see where that number can get to over time."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","John Rex will answer. And then I want Dr. Decker to maybe talk a little bit about the evolution from fee-for-service to risk.",23,"John Rex will answer. And then I want Dr. Decker to maybe talk a little bit about the evolution from fee-for-service to risk."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","It's John rex here. So at looking at that membership, so you're right in terms of where it is risk based. Let me frame it from a very top level first. About 2/3 of overall OptumHealth revenue is in is risk-bearing revenue. And we've sized before that you",309,"It's John rex here. So at looking at that membership, so you're right in terms of where it is risk based. Let me frame it from a very top level first. About 2/3 of overall OptumHealth revenue is in is risk-bearing revenue. And we've sized before that you think of that as 2/3 of OptumCare also on risk-bearing relationships. 
If you want to get down to kind of the levels within OptumCare, there are 20 million members that are served by OptumCare, of that 94 million that you're referring to. And then within that 20 million, 3.4 million are in some kind of risk-bearing relationship. And then a smaller percentage than that in a true global cap relationship. I put a well below half of that 3.4 million in a global cap relationship. So you're right. And one of the reasons we were -- I was speaking to that in my prepared comments is because of that opportunity, there's a comparatively small amount of the total membership potential that is currently in a global cap relationship. That's really what's driving the growth of OptumHealth and OptumCare. It comes down to is it primarily an organic revenue growth story because when we affiliate with physician groups, typically, those come in and many of them come in and largely fee-for-service arrangements. And then we seek to convert those to risk arrangements or with more accountability, more value-based care over several years. And so when you look at kind of the overall revenue growth story of that company, it is a predominantly organic revenue growth story just because of that. And that's really -- and I was talking about kind of why do we think there's double-digit revenue growth potential there for years to come. It's because of the still very, I'd say, kind of early stage of where that stands."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Dr. Decker?",2,"Dr. Decker?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you. Thanks, Josh. So I think Rex covered it nicely. So I would just underscore a couple of points. One is this is a major growth engine for Optum as we go forward as we convert fee-for-service practices to value-based care models. Second is, as w",155,"Thank you. Thanks, Josh. So I think Rex covered it nicely. So I would just underscore a couple of points. One is this is a major growth engine for Optum as we go forward as we convert fee-for-service practices to value-based care models. 
Second is, as we touched on earlier, this is very compelling for our physician colleagues. It's quite attractive. It actually allows us to decrease the administrative burden and allow our doctors to practice medicine, which is what they want to do. 
And the third is that we have a deep expertise in this space because we've been practicing fully capitated, fully delegated risk models for over 12 years. And we're able to bring that expertise to our new practices throughout the country. Dave, you touched on the Pacific Northwest and the Northeast. Those are areas where you can expect to see significant growth in our risk-bearing capacities and care delivery. Thank you."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So this is a critical anchor strategy, both for Optum as well as free UnitedHealth Group. It's a very important part of how we will continue to advance outsized growth for this enterprise going forward with an aim towards serving, obviously, more people a",92,"So this is a critical anchor strategy, both for Optum as well as free UnitedHealth Group. It's a very important part of how we will continue to advance outsized growth for this enterprise going forward with an aim towards serving, obviously, more people and doing so with better experiences, outcomes at lower cost. This was designed by the Optum team through their strategic process led by Andrew Witty. And they've done a really nice job deploying this capability, not only behalf Optum, but of course, on behalf of all the UnitedHealth Group."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from A.J. Rice from Crdit Suisse.",11,"Our next question comes from A.J. Rice from Crdit Suisse."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I just wanted to ask about MA a little more. You've got, obviously, a nice step-up in growth expected this year. Any thoughts about what you're assuming relative to your ability to do normal risk assessments and get appropriately reimbursed for the patien",97,"I just wanted to ask about MA a little more. You've got, obviously, a nice step-up in growth expected this year. Any thoughts about what you're assuming relative to your ability to do normal risk assessments and get appropriately reimbursed for the patient population if you've taken a more conservative view given the COVID backdrop? Or do you think you can get back to normal there? And just any quick comment on the 2022 rate notice, a final rate notice that they've just released and that -- how you view that? Sure. Tim Noel, Head of M&R."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, AJ, for the questions. So first, on 2022 revenue that you're getting at there with diagnosis capture for 2021, a little bit early to talk about that at depth. But a couple of things I'll offer is, one, we're really focused in M&R about gettin",263,"Yes. Thanks, AJ, for the questions. So first, on 2022 revenue that you're getting at there with diagnosis capture for 2021, a little bit early to talk about that at depth. But a couple of things I'll offer is, one, we're really focused in M&R about getting our members vaccinated as soon as possible. And across the enterprise, there's also a focus on doing the same for the frontline health care workers. And as both of these things happen, I think seniors will become increasingly more comfortable accessing care, and that will have obviously an impact on diagnosis capture in 2021 that impacts revenue for 2022. Remains to be seen exactly how that timing plays out, and we obviously have a bit of time remaining as we think about the 2022 bid to inform what does play out at the time of the bid and when that's submitted. 
With respect to the final notice that was published by CMS on January 15. As you know, number one, earlier than that's normally published. And the all-in rates that were included in that final notice of just north of 4% was a little bit of an increase over the advance notice. Beyond that, nothing really surprising with respect to rules or policy changes contained in the final notice this year. I'm really too early to comment on what that means for rates and benefits, a lot of moving parts that remain as we think about the 2022 bid filing. Certainly, COVID is one of those things that we're watching as well with respect to that."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks for the question. Just if I can add on a little bit. First, one of the key things for us, and the reason why Tim started with vaccine is because it's important for us to get our a substantial health workforce vaccinated. And in part, our Nurse Hous",107,"Thanks for the question. Just if I can add on a little bit. First, one of the key things for us, and the reason why Tim started with vaccine is because it's important for us to get our a substantial health workforce vaccinated. And in part, our Nurse HouseCalls workforce so that they can safely pass into the home more broadly than what -- maybe what we've seen in, including more volatile circumstances. 
And the other thing just to recognize is the extent that there was impacts on risk adjustment for 2021, we did take those into consideration and providing you with our estimates back in December."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Kevin Fischbeck from Bank of America.",11,"Our next question comes from Kevin Fischbeck from Bank of America."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","All right. Great. Just wanted to maybe dig back into the [$1.80] COVID headwind. Is there any way for you to kind of give us more dimensioning around kind of how that, at least from a relative size perspective, flows across the 3 Optum businesses and the",88,"All right. Great. Just wanted to maybe dig back into the [$1.80] COVID headwind. Is there any way for you to kind of give us more dimensioning around kind of how that, at least from a relative size perspective, flows across the 3 Optum businesses and the 3 health plan businesses? And it sounds like commercial is coming in better than you thought. Is there anything that maybe is different than what you thought a couple of months ago when you first provided that anything better anything worse?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","John Rex?",2,"John Rex?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, John Rex. So the broad view on that is about 2/3 of that relates to the UnitedHealthcare businesses when we think about just over $2 billion, an impact, a negative impact on COVID-19 in 2021, and about 1/3 relates to the Optum businesses. That's ki",267,"Kevin, John Rex. So the broad view on that is about 2/3 of that relates to the UnitedHealthcare businesses when we think about just over $2 billion, an impact, a negative impact on COVID-19 in 2021, and about 1/3 relates to the Optum businesses. That's kind of the general view. It doesn't -- as we break down to different businesses and think about impacts on those, some of the commentary I'd offer. So within OptumInsight, it is most sensitive to just kind of broadly claims volumes and business activity, general business activity. Those are kind of the factors that have been a component within that. The risk-bearing businesses of OptumHealth are impacted similarly to the UnitedHealthcare businesses, as you would expect, also in terms of activity there. 
Within the different categories across OptumHealth or across UnitedHealthcare in general, I would just tell you kind of as we look at that. So David just cited that as it relates to how we anticipated and incorporated thoughts about ability for seniors to access care and get proper risk adjustment done. So that's an impact that's mostly felt within Medicare & Retirement in terms of that component of it as you'd expect also. And to some extent, to a lesser extent in community and states where you'd have some of the dual special needs plan membership also. 
Within OptumRx, that is mostly also a volume-driven component has to do largely just with physician visit activity often in terms of scripts being written and as those flow through the system. So those are kind of the broad overall impacts I'd offer."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","And Dirk, any other comments?",5,"And Dirk, any other comments?"
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. I think one of the things you mentioned was on commercial. I think what's resulted in sort of a little stronger outlook than what we expected from a membership standpoint is persistency was better. There was a lot of group's that decided to stick. I",162,"Yes. I think one of the things you mentioned was on commercial. I think what's resulted in sort of a little stronger outlook than what we expected from a membership standpoint is persistency was better. There was a lot of group's that decided to stick. I would also say the various government stimulus packages helped. And I would also say one product stood out for us. It's our All Savers level funded product, which has done extremely well, which is kind of -- you give back -- if the group performs better than expected, they get a refund. If it's worse than they expected, then you ultimately get a I better than expected, then they have -- they get their refund, that's better than expected. So that's a good thing. It's worse than stop-loss policy kicks in. 
But long story short, I think some good products, as we talked about plus, I would say, good persistency was a big benefit to commercial."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Kevin. That's all we have time for it today. So apologies to Ralph and Ricky. Both those questions got cut off somehow, so please -- I'm glad we were able to fix that, but please give our team a call, and we'll be happy to answer any other ques",209,"Thank you, Kevin. That's all we have time for it today. So apologies to Ralph and Ricky. Both those questions got cut off somehow, so please -- I'm glad we were able to fix that, but please give our team a call, and we'll be happy to answer any other questions that you have. 
I'd like to thank you all for joining us again today. I hope this morning's call provided you with useful context and importantly, clarity and help you better understand our ambitions for the year ahead. As I said in my opening remarks, we are starting 2021 with an optimistic view. Despite these extraordinary circumstances, our team continues to manage the challenges at hand with unprecedented resiliency and ingenuity. At the same time, we continue to pursue our long-term growth strategy with an even greater sense of urgency and intensity, building upon the agility, insights and considerable new capabilities developed this past year to deliver a high-performing health care system built on personal human connections enabled through information and technology and supported by strong alignment of physician-led, value-based delivery of care, serving millions of people 1 person at a time while delivering distinguished returns for our shareholders. 
Thanks again for joining us. We'll see you soon."
104673,699215256,2176499,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Ladies and gentlemen, this concludes today's conference call. Thank you for your participation, and you may now disconnect. Everyone, have a wonderful day.",23,"Ladies and gentlemen, this concludes today's conference call. Thank you for your participation, and you may now disconnect. Everyone, have a wonderful day."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Good morning, and welcome to the UnitedHealth Group's Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.  Here is some important introductory information. This call contains fo",187,"Good morning, and welcome to the UnitedHealth Group's Fourth Quarter and Full Year 2020 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.  
Here is some important introductory information. This call contains forward-looking statements under the U.S. Federal Securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings.  
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the financial and earnings reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated January 20, 2021, which may be accessed from the Investor Relations page of the company's website.  
I will now turn the conference over to the Chief Executive Officer of UnitedHealth Group, David Wichmann."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us today. We remain in a time of unprecedented challenges for individuals, employers and the health system broadly, particularly frontline clinicians, including our own. Health systems across the world have been and",1447,"Good morning, and thank you for joining us today. We remain in a time of unprecedented challenges for individuals, employers and the health system broadly, particularly frontline clinicians, including our own. Health systems across the world have been and continue to be stressed. Amidst these challenges, we are grateful for the daily displays of human spirit to serve others and the resolve to make things better. We remain optimistic because we are also living at a time of unprecedented collaboration, knowledge-sharing and innovation. The health system has come together in ways previously not seen, a powerful multidimensional response to support patients, physicians and communities. 
I couldn't be prouder of or more grateful to the more than 325,000 women and men of this enterprise. They work each day under difficult conditions, with clinicians comprising well more than 1/3 of the total, to advance a high-performing health care system, one built on personal human connections; enabled through information and technology; and supported by strong alignment of physician-led, value-based delivery of care. They are another profound reason for our optimism.  
With all that's transpired in 2020, we finished the year responsibly and strongly. We delivered meaningful advances in NPS and employee engagement and financial results well above the upper end of our expectations, all while navigating the uncertain environment and achieving our commitment to address financial imbalances resulting from the COVID-19 pandemic. As we move into 2021, we believe we are well positioned to continue to serve more people even more deeply and more effectively while continuing to build this enterprise and grow strongly in the decades to come. 
Just 7 weeks ago, we were privileged to spend a full day with you at our investor conference. Over the course of that day, we tried to convey how we seek to lead in the development of the next-generation health care system. We shared the distinctive capabilities we apply to make health care more connected, more informed, more human and more deeply personal.  
We finished 2020 encouraged by the performance across the businesses of Optum and UnitedHealthcare. Let me provide just a few broad highlights.  
The UnitedHealthcare Medicare Advantage offerings are off to an excellent start. 2021 will be one of our strongest years of growth, now expected to approach 900,000 more people served across individual and group Medicare Advantage and Dual Special Needs Plans. UnitedHealthcare will have grown to serve 3.5 million more seniors over 5 years. Seniors choose our offerings because of the value they receive, better health outcomes and experiences at lower costs.  
We've also been enhancing our offerings to better meet expectations about how people want to live their lives, focusing on more digital and physical care resources in the home, expanding our one-on-one concierge navigation services and enabling the home as the safest and more effective setting of care. 
UnitedHealthcare's Medicaid offerings continue to grow strongly as well, including entry into 3 new states in 2021. New business opportunities are substantial, with momentum towards Managed Care adoption by states and RFP activity accelerating this year and next.  
And while the economic effects of COVID-19 impacted UnitedHealthcare's employer-sponsored growth in 2020, we're encouraged by the positive market response to the new, highly consumer-centric offerings we've been discussing with you in recent months. Among these are digital-first, on-demand and physician-led products each provide deeply aligned, modern, personal and coordinated care experiences and save people up to 20% compared to traditional offerings. These innovative products are generating significant responses because they are designed to better meet the unique needs and financial means of more people. 
All in, we expect UnitedHealthcare will grow in 2021 to serve upwards of 1.5 million more people across its senior, community, employer-sponsored and individual offerings.  
We continue to make important advancements and strategic investments to lay the foundation for the next-generation health system. Over the last many years, you've heard us discuss our ambition to build high-performing systems of care, including an aim to reinvent health care delivery, which is the first of our 5 strategic growth platforms. The foundations for those efforts are in our primary and multispecialty care practices. OptumCare entered 2021 with over 50,000 physicians and 1,400 clinics. Over the course of this year, we expect to grow our employed and affiliated physicians by at least 10,000. This work of building local physician-led systems of care continues to be central to our mission and is accelerating, with notable progress in the Northeast, Pacific Northwest and Southern California in 2020.  
2 weeks ago, we announced the combination of Change Healthcare and OptumInsight. We expect this combination will greatly advance the foundational connectivity and collaboration needed for the next-generation health system, establishing a new, more modern information and technology-enabled health care platform. It will help accelerate the development and use of digital and advanced technologies, another of our 5 key growth platforms, and critical to connecting the -- all elements of our business strategy. 
This advanced platform will help clinicians make the most informed and clinically advanced patient care decisions more quickly and easily. Change Healthcare brings widely adopted technology for integrating evidence-based clinical criteria directly into the clinician's workflow, while Optum's clinical analytics expertise and individual health record can strengthen the evidence base needed to deliver effective clinical decision support at the point of care. This can ensure appropriate clinical pathways are offered in the most appropriate sites of care, leading to consistent achievement of the best possible outcomes, experiences and value for the patients we serve. 
Another key opportunity will be to enhance administrative processes by combining Optum's advanced data analytics with Change Healthcare's Intelligent Healthcare Network to support simpler, more informed and accurate services and processing at considerably lower cost. 
Finally, combining Change Healthcare's payment capacities with Optum's highly automated payment networks will simplify financial interactions among care providers, payers and consumers and accelerate the movement to a more modern, realtime and transparent payment system. This will help physicians get paid more quickly, accurately and reliably and provide consumers with more options and convenience in managing their health care finances. 
The Change Healthcare team has been doing outstanding work, and we're looking forward to working alongside them. 
We continue to execute on the core initiatives we laid out for you in December. One example. As the pandemic disrupted care patterns, we all saw the increased need to enhance in-home and alternative settings of care, offering patients to receive safe, effective and efficient care outside of traditional venues. However, the need for in-home care will continue to grow well beyond the current environment. We know that more than 80% of what impacts a person's health happens outside of traditional health care settings. There's a significant opportunity in offering consistent, cost-effective care for seniors, people with complex medical conditions and geographically isolated individuals through in-home and alternative settings. 
Offering a foundational ability to care for people in their homes is essential to developing a health system that is more consumer-centric, higher quality and lower cost. We already have well-established, trusted capacities to bring skilled care resources into the home, including through Optum's HouseCall program. We expect our advanced practice clinicians will conduct over 2 million in-home visits this year. 
And we are building upon this established home capacity in many ways. We have introduced Vivify remote patient monitoring capabilities to improve connectivity and information-sharing with physicians. This has been received positively by patients with a Net Promoter Score over 80. Optum at home provides in-person and telephonic touch points across an interdisciplinary team, including physical, social and behavioral aspects. The program increases preventative care, achieves exceptional NPS in the mid-80s, lowers medical expense and demonstrates high quality, with over 90% of our members in a 4-star or higher plan. 
Similarly, Optum's pharmacy care services enables patients to receive the care and medications they need, with capacities to deliver outside of traditional settings. OptumRx's Infusion Services now addresses the needs of about 25,000 patients per month and is growing double digits, which means more patients can obtain the care they need outside of the acute settings. That makes it safer, simpler and more affordable for people.  
We remain encouraged as well by the traditional pharmacy services provided by OptumRx with an over 98% customer retention rate entering 2021. We are off to a good start for the 2022 selling season as we were recently awarded the honor to serve more than 2.5 million members of Blue Cross Blue Shield of Michigan. 
In sum, we enter 2021 with momentum, confident in our capacity to navigate through and begin to emerge from these challenging times as an even more capable, diverse and growing enterprise. 
Now I'll turn it over to Chief Financial Officer, John Rex."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dave. The full year 2020 and fourth quarter results were favorable to the outlook we provided at our December 1 investor conference while continuing to be impacted by the unprecedented environment which has existed most of the year. To begin,",945,"Thank you, Dave. The full year 2020 and fourth quarter results were favorable to the outlook we provided at our December 1 investor conference while continuing to be impacted by the unprecedented environment which has existed most of the year. 
To begin, as we know it is of great interest to you, I'd like to share what we're seeing in current care patterns. Starting at the highest level, within the broad member categories we serve. People with commercial benefits continue to exhibit overall higher levels of care activity with less deferral than those served in public sector programs such as Medicare and Medicaid. Our top priority remains getting people the care they need. 
During the fourth quarter, we saw overall average care activity return to seasonal baselines compared to the just over 95% we cited for the third quarter. The pacing over the course of the quarter, perhaps not too surprisingly, moved from just below baseline as we began to modestly exceeding baseline in the latter half. This measure includes increased direct COVID-19-related care, which, in total, comprised about 11% of all care activity during the fourth quarter compared to about 6% in the third quarter.  
Looking deeper within specific care categories. Outpatient activity began the quarter at baseline, and we were gratified people were able to obtain needed care previously deferred. By the latter part of the quarter however, some outpatient activity moderated as COVID-19 incidents elevated. Total inpatient activity increased modestly over the course of the quarter as the direct COVID-19-related care component rose as a percentage of the total in the latter half. For example, of the 65,000 COVID-19-related inpatient admissions during the quarter, about 20% occurred in October and about 50% in December. 
Moving to our specific businesses. OptumHealth's fourth quarter earnings increased 16% year-over-year as care activity at our fee-for-service practices and ambulatory surgery centers continue to recover, with these businesses now operating near baseline. Revenue per consumer served grew 29% over the year-ago quarter. The growth in this measure reflects continued development of the value-based care arrangements, the depth of our offerings and the increasing acuity of the types of care we can deliver to the people we serve. You should expect this measure to continue to grow at a strong double-digit pace for many years to come. 
One example which highlights this potential. Of the 20 million patients OptumCare serves today, under 20% are currently in value-based arrangements. We expect both the number of patients served and the depth and number of value-based arrangements to continue to accelerate. 
OptumInsight's earnings were ahead of the outlook we offered at the beginning of December with overall 2020 performance impacted by lower levels of care with revenues dependent upon care activity volumes for many of these businesses and the generally subdued overall business environment. We continue to expect 10% to 15% growth in 2021 as care activity returns to normalized levels and we continue to advance strategic relationships and broaden services with existing customers. This outlook excludes any impact from OptumInsight's combination with Change Healthcare, which we expect will close in the second half of the year. 
OptumRx's earnings were also ahead of this outlook. During 2020, revenues in our pharmacy care services and specialty businesses continued to grow at double digits and now comprise nearly half of total OptumRx revenue. 
Turning to UnitedHealthcare. Fourth quarter operating results were above our December view. They reflect continued customer and provider assistance measures to help people obtain the care they need and comparatively lower levels of care deferrals and higher COVID-19 care costs versus the third quarter. Results in the fourth quarter were further impacted by additional reserves for rebates and related activity as plans with such arrangements moved into these positions as a result of the cumulative care deferral impacts throughout 2020 and calendar year-end assessments were concluded. 
As Dave noted, sales activity in the Medicare Advantage open enrollment period was robust. Within the 900,000 new members we expect to serve for full year 2021, about 775,000 will be in individual and group Medicare Advantage and the remainder in Dual Special Needs Plans which are included in the Community & State Medicaid membership tables. 
Strong growth in Medicaid membership continued in the fourth quarter. Recall, our full year 2021 outlook to serve an additional 200,000 to 300,000 people assumes state redetermination activities are reinitiated during the year. 
We concluded 2020 with commercial membership about 100,000 people ahead of the outlook we provided at our investor conference. Early January results are well supportive of positive commercial growth in 2021, this, even considering the challenging economic environment. 
Our liquidity, capital positions and capacities remain strong. Full year 2020 cash flows from operations were $22.2 billion or 1.4x net income, with the fourth quarter result exceeding the outlook we provided due in part to early customer receipts. Our debt-to-total-capital ratio of 38.9% compares to 40.2% last year. As we look enthusiastically toward the combination with Change Healthcare, we intend to maintain our long-standing capital policy, including our approach to returning capital to shareholders via share repurchase and an advancing dividend with ample capacity to continue building upon our strategic growth platforms and ongoing priority on expanding our local care delivery capabilities. 
Our full year 2021 outlook remains consistent with the early December commentary with total revenue approaching $280 billion and adjusted earnings per share in the range of $17.75 and to $18.25, inclusive of the negative COVID-19-related effects we described. Given the still highly dynamic circumstances, we will likely hold this broader-than-typical range of expectations as we, much like everyone else, continue to learn more about the environment. 
Now I'll turn it back to Dave."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, John. As you can tell, the businesses of this diversified and growing enterprise remained strong and well positioned for sustained, balanced growth as we continue to add new capabilities and market positions. We remain committed to our mission",80,"Thank you, John. As you can tell, the businesses of this diversified and growing enterprise remained strong and well positioned for sustained, balanced growth as we continue to add new capabilities and market positions. We remain committed to our mission in an intense focus on serving one person at a time at increasing levels of value, more affordable, better outcomes and improved experiences while generating strong returns for you, our shareholders. 
Operator, let's open it up for questions. [Operator Instructions]"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] And our first question comes from Ralph Giacobbe from Citi.",12,"[Operator Instructions] And our first question comes from Ralph Giacobbe from Citi."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Great. John, I just wanted to go back to some of the commentary. You said trends are near baseline. Just want to be clear. You're talking about just utilization or spending there? And then the commentary that COVID was 11% of activity, I guess, in the f",55,"Great. John, I just wanted to go back to some of the commentary. You said trends are near baseline. Just want to be clear. You're talking about just utilization or spending there? 
And then the commentary that COVID was 11% of activity, I guess, in the fourth quarter. Just want to clarify that [Audio Gap]"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Thanks, Ralph. John, do you want to start?",9,"Great. Thanks, Ralph. John, do you want to start?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ralph, yes. So we're talking about spending when we talk about near baseline levels anticipated, and again, inclusive of the COVID-19 care cost. So that's why I was trying to give you some sense of kind of what component those -- what those comprise in th",69,"Ralph, yes. So we're talking about spending when we talk about near baseline levels anticipated, and again, inclusive of the COVID-19 care cost. So that's why I was trying to give you some sense of kind of what component those -- what those comprise in there overall. 
And your second question, Ralph, I lost just the last part of it. I just want to make sure I heard that."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","I'm afraid he may have cut out.",8,"I'm afraid he may have cut out."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Just -- I didn't hear quite the very end of it. But when we're talking about kind of the 11% zone, I think maybe what you were looking for is probably how that relates. Think of that 11% zone in terms of medical cost. If you're looking at our medic",132,"Yes. Just -- I didn't hear quite the very end of it. But when we're talking about kind of the 11% zone, I think maybe what you were looking for is probably how that relates. 
Think of that 11% zone in terms of medical cost. If you're looking at our medical costs on our income statement, use about maybe 3/4 of that level as a measure. What I would exclude from that, because we're thinking about really kind of components, fee-for-service medical costs that we incur on that, so would include UnitedHealthcare's payments to capitated providers -- it would exclude, sorry. It would also exclude things like pharmacy costs and such. So I'd probably use about 3/4 of that, and I think that's where you were going with that question. Thank you."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Okay. Ralph, well, we didn't get that. Just circle back with Brett and the team, and we'll be happy to answer your question on the side.",26,"Okay. Ralph, well, we didn't get that. Just circle back with Brett and the team, and we'll be happy to answer your question on the side."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Ricky Goldwasser from Morgan Stanley.",10,"Our next question comes from Ricky Goldwasser from Morgan Stanley."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","You recently updated your Telehealth policies. Wanted to dig a little bit deeper into this. What do you think is sort of the right balance between in-person medical care versus Telehealth when activity normalizes in there? When do you think -- where do",67,"You recently updated your Telehealth policies. Wanted to dig a little bit deeper into this. What do you think is sort of the right balance between in-person medical care versus Telehealth when activity normalizes in there? 
When do you think -- where do you think reimbursement will settle? It seems that you are continuing sort of the in parity reimbursement. But as you think about [Audio Gap]"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ricky, you cut out, well, at the same time Ralph did. So we'll take a shot at answering your question around Telehealth policies and how we think this will normalize out. I'll actually ask Dirk to do that. And then maybe ask Dr. Decker to talk about the p",70,"Ricky, you cut out, well, at the same time Ralph did. So we'll take a shot at answering your question around Telehealth policies and how we think this will normalize out. I'll actually ask Dirk to do that. And then maybe ask Dr. Decker to talk about the pluses and minuses of in-person -- not plus and minuses, but just maybe when more inpatient care should be administered versus digital."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So thanks, Dave. So what I would say is the good news is, is that Telehealth is a great vehicle for people to access care. So number one, let's just start with that as a premise. We at UnitedHealthcare, from a policy standpoint, we work with Optum, w",163,"Yes. So thanks, Dave. So what I would say is the good news is, is that Telehealth is a great vehicle for people to access care. So number one, let's just start with that as a premise. We at UnitedHealthcare, from a policy standpoint, we work with Optum, we work a lot of Telehealth providers on different products and capabilities. And I would say, how it's ultimately going to shake out is going to be related to who provides the best outcome using Telehealth, the lowest cost and ultimately the best patient experience. Those are sort of truisms which are going to exist no matter what. 
We saw a huge spike at the beginning of real high Telehealth access back in April. It sort of metered out throughout the course of the year. I'm not sure where it's going to ultimately end. But clearly, it's here to stay, and it's going to be an important part of health care going forward. 
Dr. Decker?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Dave and Dirk. Ricky, thanks for the question. What's fascinating is not all Telehealth offerings are created equal. And we have found that, not surprisingly, patients really appreciate being connected to their own personal providers, and pro",171,"Yes. Thanks, Dave and Dirk. Ricky, thanks for the question. What's fascinating is not all Telehealth offerings are created equal. And we have found that, not surprisingly, patients really appreciate being connected to their own personal providers, and providers very much need the real-time clinical data to provide good advice and care for that patient in a virtual setting. So that's key point one. 
Point two is certain services, like ambulatory or outpatient behavioral health care, lend themselves to a Telehealth solution. And so we have seen approximately 50% of our behavioral health care being delivered in a Telehealth setting, and that has been sustained throughout the year even as the pandemic had subsided. And as it returns, it empowers those populations to get excellent care virtually. 
Finally, I'll just add that it's critical, and we're very excited about the ability at OptumHealth to connect physical care, virtual care and home-based care in a comprehensive model that really differentiates itself by providing personal, real-time care in the right setting. Thank you."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Steven Valiquette from Barclays.",9,"Our next question comes from Steven Valiquette from Barclays."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Great. So I guess as you now assess the commercial membership trends exiting 2020 and any early trends so far in 2021, is there any further color just on your conviction around the commercial enrollment projections for 2021? As you would now need a small",73,"Great. So I guess as you now assess the commercial membership trends exiting 2020 and any early trends so far in 2021, is there any further color just on your conviction around the commercial enrollment projections for 2021? As you would now need a small increase in commercial risk membership to hit the target this year, and then whereas fee-based or ASO would remain essentially flat. Just looking for more color around that."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Steven, great -- a good question. And I just like to throw in a plug for our commercial team who's worked very hard to get cost structures in line and to be very innovative around new product offerings, bring greater value to people. And I think it",70,"Great. Steven, great -- a good question. And I just like to throw in a plug for our commercial team who's worked very hard to get cost structures in line and to be very innovative around new product offerings, bring greater value to people. And I think it's starting to show through in terms of our overall growth performance. 
Bill, do you want to comment or respond to Steven directly?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question. I'll start with we're really pleased with how our fourth quarter and January 2021 enrollment performance played out. Our enrollment for 1/1 is better than we projected at our investor conference, supported by really strong pe",124,"Yes. Thanks for the question. I'll start with we're really pleased with how our fourth quarter and January 2021 enrollment performance played out. Our enrollment for 1/1 is better than we projected at our investor conference, supported by really strong persistency across really all lines of coverage and then less-than-anticipated attrition. Obviously, in the current economic environment, it's created some challenges. 
However, we're really well positioned to deliver on our commercial growth strategy that we highlighted at our Investor Day. I think we've also benefited from a broad portfolio of products that all of our customers are accessing to renew their business with us. So we feel really nice, we're feeling really strong about our growth prospects for the rest of 2021. Thank you."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. I'd just say we have a ways to go. We're kind of turning the corner to growth. And obviously, maintaining that consistently and continuing to accelerate it will be our emphasis as we move forward. Thank you for the question, Steven.",42,"Yes. I'd just say we have a ways to go. We're kind of turning the corner to growth. And obviously, maintaining that consistently and continuing to accelerate it will be our emphasis as we move forward. Thank you for the question, Steven."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Lance Wilkes from Bernstein.",9,"Our next question comes from Lance Wilkes from Bernstein."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Could you just talk a little bit in OptumRx about the pace and status for you guys in online pharmacy and in home delivery? And maybe what your long-term strategy and scope is for that?",35,"Could you just talk a little bit in OptumRx about the pace and status for you guys in online pharmacy and in home delivery? And maybe what your long-term strategy and scope is for that?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great, happy to. John Prince?",5,"Great, happy to. John Prince?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks for the question, Lance. Obviously, we've been very focused on building on our pharmacy care services model for the last several years. So not only have we been getting into only in pharmacy and home delivery, but we've been creating various progra",201,"Thanks for the question, Lance. Obviously, we've been very focused on building on our pharmacy care services model for the last several years. So not only have we been getting into only in pharmacy and home delivery, but we've been creating various programs to meet the needs of populations, especially in infusion [ join our ] pharmacies. And why we -- why I frame that is because we're trying to meet the needs of the population in unique ways and differ -- and create a very differentiated solution. 
So I think as you look at online pharmacy and home delivery, it's been a big grower for us. We've continued to grow share, expand our penetration. But we've also expanded our services within pharmacy care services to serve all consumers so that they don't have to be a member of the PBM. 
We've been launching over-the-counter, Optum Store. And so we see a significant growth of selling more products. We also will see, in those stores, unique ones like Optum Perks, which is our discount card, of bringing them all together in a virtual environment. So we see good prospects, and we see it as a big grower in the long term."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Steve Willoughby from Cleveland Research.",10,"Our next question comes from Steve Willoughby from Cleveland Research."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Just a question regarding one of the lines in the press release this morning related to additional reserves for rebates related to activity as calendar year assessments were concluded. Just wondering if you could provide any more color on that. And any wa",70,"Just a question regarding one of the lines in the press release this morning related to additional reserves for rebates related to activity as calendar year assessments were concluded. Just wondering if you could provide any more color on that. And any way to quantify that as compared to the larger favorable reserve development you experienced during the quarter? Anything else interesting on reserves and movements one way or another?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure, Steve. John Rex here. I would say the additional color I could provide in that is kind of those actions well more than offset the magnitude of favorable reserve development in the quarter. And just as we -- as those moved into those positions, not t",138,"Sure, Steve. John Rex here. I would say the additional color I could provide in that is kind of those actions well more than offset the magnitude of favorable reserve development in the quarter. And just as we -- as those moved into those positions, not too surprisingly, as you can tell, because we were able to -- as we provided an outlook in December for the full year and how things would turn out, given the greater level of volatility in specific pieces of business over this course of this year as utilization moved around over the quarter, so thereby putting more plans into those kind of positions than one would of course normally have. Part of what one has to anticipate in this kind of environment, and -- but certainly kind of that move. Thank you."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Scott Fidel from Stephens.",9,"Our next question comes from Scott Fidel from Stephens."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I had a question just on your latest thinking and expectations just around Medicaid risk corridors and the impact that you're expecting there. Just interested if the impact of corridors completed in the fourth quarter in line with the expectations that yo",95,"I had a question just on your latest thinking and expectations just around Medicaid risk corridors and the impact that you're expecting there. Just interested if the impact of corridors completed in the fourth quarter in line with the expectations that you have provided at Investor Day, and whether there's been any incremental changes there since then in terms of expansion of corridor programs and how you think about that on Medicaid margins. One of your competitors have recently cited a larger-than-expected impact in 4Q, so I wanted to get your feedback on that."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. We'll send that to Tim Spilker. Tim?",8,"Sure. We'll send that to Tim Spilker. Tim?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you for the question. Yes, states have continued to leverage risk corridors and MLR structures, and many of these were implemented in the back half of '20. We anticipated those based on discussions with our customers. Now one thing that should",138,"Yes. Thank you for the question. Yes, states have continued to leverage risk corridors and MLR structures, and many of these were implemented in the back half of '20. We anticipated those based on discussions with our customers. Now one thing that should be noted is that looking ahead, CMS has implemented rules requiring corridors to be implemented proactively versus retrospectively. So that will improve some predictability and visibility. 
And then overall, just in terms of what we're seeing at this point, while most of our 1/1 base rate renewals are in line with expectations, we're really respectful of the financial pressure that many of our states are under, as well as the uncertainty surrounding the pandemic. So we'll continue to work with our customers and advocate for sustainable funding in that regard. So thanks for the question."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Justin Lake from Wolfe Research.",10,"Our next question comes from Justin Lake from Wolfe Research."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Just a couple of quickies on -- post the Investor Day, it sounds like you're saying that cost trend picked up through the quarter a bit. Can you talk about it relative to what you're expecting for the full year 2021 that are you -- is it ahead of where yo",102,"Just a couple of quickies on -- post the Investor Day, it sounds like you're saying that cost trend picked up through the quarter a bit. Can you talk about it relative to what you're expecting for the full year 2021 that are you -- is it ahead of where you're expecting or in line? 
And then Medicare physician rates went up a bit post the stimulus bill. I've estimated it at about $0.15 of a headwind you -- for the company. Just curious on your estimate there. And are there any offsets that you see as you're going through the year?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Why don't we hand the first part, John Rex. And then Tim Knoll Noel handle the second.",18,"Why don't we hand the first part, John Rex. And then Tim Knoll Noel handle the second."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, I think the outlook for 2021 in terms of COVID impact, though, even with what you've cited there in terms of as things were trending in the quarter, still consistent with where we were at an investor conference, that our expectation is that total",107,"Justin, I think the outlook for 2021 in terms of COVID impact, though, even with what you've cited there in terms of as things were trending in the quarter, still consistent with where we were at an investor conference, that our expectation is that total direct COVID-19 care costs in 2021 will be similar to what we experienced in -- for full year 2020. So there isn't anything that would take us off that view right now. I think the other element we cited, though, total COVID-19 care costs higher and then the headwind being that care deferral likely being meaningfully lower than we saw in 2020."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","And Tim, second part?",4,"And Tim, second part?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Justin, for the question. So the fee schedule increase you talked about was of course part of the relief deal that was passed on December 20. And the physician fee schedule increase that was included there was partially offset by removing seq",135,"Yes. Thanks, Justin, for the question. So the fee schedule increase you talked about was of course part of the relief deal that was passed on December 20. And the physician fee schedule increase that was included there was partially offset by removing sequester for the first quarter of 2021. 
As we look at this environment, it's obviously still quite fluid. The PHC has been extended again, and obviously, also another relief package that's being worked on. At this time, the sequester relief has only been extended a quarter and does not match the PHC as it has throughout the pandemic. And if sequester was extended one more quarter, that would offset the small headwind that we're seeing as a result of all of this. 
So something we're still watching, but that's where it stands."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good observation on puts and takes. That's going to probably happen as we navigate our way through 2021. That's why we have a wider range. And we have a $2 billion estimate on net COVID impacts as well.",38,"Good observation on puts and takes. That's going to probably happen as we navigate our way through 2021. That's why we have a wider range. And we have a $2 billion estimate on net COVID impacts as well."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Robert Jones from Goldman Sachs.",10,"Our next question comes from Robert Jones from Goldman Sachs."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Maybe just to shift over to OptumHealth. I noticed you announced a fairly sizable physician group acquisition in Massachusetts. And if I heard you correctly, I believe you said you expect employed and affiliated physicians to increase around 10,000 this y",82,"Maybe just to shift over to OptumHealth. I noticed you announced a fairly sizable physician group acquisition in Massachusetts. And if I heard you correctly, I believe you said you expect employed and affiliated physicians to increase around 10,000 this year. I just wanted to just get your latest thoughts on the acquisition environment for doc groups. Are you finding a greater willingness in this kind of COVID/post-COVID world for -- a willingness to consider acquisition for some of these larger groups?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Just before we get started, we have not announced any acquisition as you described, so that's a market rumor and speculation. As it relates to M&A broadly in this space, we've -- Dr. Decker and team have done a terrific job continuing to build in t",254,"Yes. Just before we get started, we have not announced any acquisition as you described, so that's a market rumor and speculation. 
As it relates to M&A broadly in this space, we've -- Dr. Decker and team have done a terrific job continuing to build in the Northeast. I'd say in the fourth quarter, the CareMount transaction was completed. That is a strong addition to our I-95 corridor, tristate expectation. We also finished a acquisition in the Southwest and in Southern California in particular with -- in the Inland Empire region. And we've also done some work up in the Pacific Northwest this past year as well and some in the center part of the United States. 
I'd say, generally speaking, the market seems to continue to gravitate towards an OptumCare-type model where there's a great sense of stability as well as a very strong quadruple-aim model which seems to resonate very well with physicians, but also with our patients, where they get better experiences, outcomes and overall lower cost is demonstrated by the value that's being brought every day and the growth of that -- in that -- overall in that area. 
So I think as we turn into 2021, this will be an area of continued focus for us. And I think you'll continue to see that occur over the next half- to full decade or so as we continue to build out this broad health system, a health system that's much more effective across the 4 aims that I just described."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Whit Mayo from UBS.",9,"Our next question comes from Whit Mayo from UBS."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","You guys have really emphasized some of the new, innovative solutions in commercial, the consumer-centric focus, et cetera. Can you talk maybe more about the on-demand solutions that you've been referencing and the partnership with Bind, just the receptiv",65,"You guys have really emphasized some of the new, innovative solutions in commercial, the consumer-centric focus, et cetera. Can you talk maybe more about the on-demand solutions that you've been referencing and the partnership with Bind, just the receptivity among plan sponsors? Just curious if there's been any sort of surprises in the market as you've kind of brought that capability to your customer base."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Bill, do you want to take that one?",8,"Bill, do you want to take that one?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, sure. I'll start with, we benefit from a broad portfolio of products and plan designs across our business. And depending on the type of buyer, we've seen great interest in all different types of products for us. So we have seen a big uptick in our Mo",150,"Yes, sure. I'll start with, we benefit from a broad portfolio of products and plan designs across our business. And depending on the type of buyer, we've seen great interest in all different types of products for us. So we have seen a big uptick in our Motion product, people looking for digital solutions, looking for activity trackers. There's been a huge amount of emphasis and discussion with employers regarding access to better wellness, obviously, because of the pandemic. And so we've seen a lot of receptivity to that. We've seen a lot of receptivity to our All Savers product. 
As far as Bind, yes, for particular type of buyers, it's really been a very interesting, innovative solution. We continue to bring that to market, and we're excited about the opportunities that will deliver in our fully insured market as well as in our ASO business for Bind. Thank you."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","And if I can, I'm just going to have Dan Schumacher, who's on the Bind Board, also comment on what he's seeing with the overall progression there.",27,"And if I can, I'm just going to have Dan Schumacher, who's on the Bind Board, also comment on what he's seeing with the overall progression there."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. Thank you, Whit. Appreciate the interest. We have seen broad market interest in Bind. I'd say that as you look at what happened over the course of 2020, more people were inclined to stay. So there was less switching going on. You saw that in the bro",118,"Sure. Thank you, Whit. Appreciate the interest. We have seen broad market interest in Bind. I'd say that as you look at what happened over the course of 2020, more people were inclined to stay. So there was less switching going on. You saw that in the broader UnitedHealthcare performance in terms of retention. So on the new sales side, we saw probably lower interest than we would have hoped, just given the tendency towards incumbency. But where we had an existing footprint, we continue to see employees choose Bind inside those offerings. 
So we're excited about the prospects forward and expect to build on it, especially as we return to more normal buying patterns in the future."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","[ So it's ] a progressive model that will continue to evolve and adapt over time, like the initial price points and the impact. I also like the receptivity broadly by consumers, which I would say has probably been the greatest surprise for me personally,",71,"[ So it's ] a progressive model that will continue to evolve and adapt over time, like the initial price points and the impact. I also like the receptivity broadly by consumers, which I would say has probably been the greatest surprise for me personally, is that consumers get it as well as they do. So I think that's part of the reason why you've seen strong receptivity in the market overall."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Josh Raskin from Nephron Research.",10,"Our next question comes from Josh Raskin from Nephron Research."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Here with Eric as well. A question relates to OptumHealth. And you show the 98 million consumers served in 2020 and the average revenue per consumer at $34. I think, John, you mentioned that was up close to 30%. But that's still a fraction of the opportun",113,"Here with Eric as well. A question relates to OptumHealth. And you show the 98 million consumers served in 2020 and the average revenue per consumer at $34. I think, John, you mentioned that was up close to 30%. But that's still a fraction of the opportunity of how we think about a traditional risk-bearing capitation rates. 
So the question really is what percentage of the OptumHealth revenues are sort of pure fee-for-service? What about -- what's the percentage, on the other end of the spectrum, sort of global capitation? And how do we think about what's in the middle? Really just trying to see where that number can get to over time."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","John Rex will answer. And then I want Dr. Decker to maybe talk a little bit about the evolution from fee-for-service to risk.",23,"John Rex will answer. And then I want Dr. Decker to maybe talk a little bit about the evolution from fee-for-service to risk."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","John Rex here. So at looking at that membership. So you're right. In terms of where it is risk-based, let me frame it from a very top level first. About 2/3 of overall OptumHealth revenue is in a -- is risk-bearing revenue. And we've cited before that you",310,"John Rex here. So at looking at that membership. So you're right. In terms of where it is risk-based, let me frame it from a very top level first. About 2/3 of overall OptumHealth revenue is in a -- is risk-bearing revenue. And we've cited before that you think of that as 2/3 of OptumCare also on risk-bearing relationships. 
If you want to get down to kind of the level, within OptumCare, there are 20 million members that are served by OptumCare of that 94 million that you're referring to. And then within that 20 million, 3.4 million are in some kind of risk-bearing relationship. And then a smaller percentage than that in a true global cap relationship, I'd put it below half -- well below half of that 3.4 million in a global cap relationship. 
So you're right. And one of the reasons we were -- I was speaking to that in my prepared comments is, because of that opportunity, there's a comparatively small amount of the total membership potential that is currently in a global cap relationship. That's really what's driving the growth of OptumHealth and OptumCare. It comes down to is, it's primarily an organic revenue growth story because when we affiliate with physician groups, typically, those come in, and many of them come in largely fee-for-service arrangements. And then we seek to convert those to risk arrangements or with more accountability, more value-based care over several years. And so when you look at kind of the overall revenue growth story of that company, it is a predominantly organic revenue growth story just because of that. 
And that's really going -- I was talking about kind of why do we think there's double-digit revenue growth potential there for years to come? It's because of the still very, I'd say, kind of early stage of where that stands."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Dr. Decker?",2,"Dr. Decker?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you. Thanks, Josh. So I think Rex covered it nicely. So I would just underscore a couple of points. One is this is a major growth engine for Optum as we go forward, as we convert fee-for-service practices to value-based care models. Second is, as",155,"Thank you. Thanks, Josh. So I think Rex covered it nicely. So I would just underscore a couple of points. One is this is a major growth engine for Optum as we go forward, as we convert fee-for-service practices to value-based care models. 
Second is, as we touched on earlier, this is very compelling for our physician colleagues. It's quite attractive. It actually allows us to decrease the administrative burden and allow our doctors to practice medicine, which is what they want to do. 
And the third is that we have a deep expertise in this space because we've been practicing fully capitated, fully delegated risk models for over 12 years. And we're able to bring that expertise to our new practices throughout the country. Dave, you touched on the Pacific Northwest and the Northeast. Those are areas where you can expect to see significant growth in our risk-bearing capacities in care delivery. Thank you."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So this is a critical anchor strategy both for Optum as well as for UnitedHealth Group. It's a very important part of how we will continue to advance outsized growth for this enterprise going forward, with an aim towards serving, obviously, more peop",97,"Yes. So this is a critical anchor strategy both for Optum as well as for UnitedHealth Group. It's a very important part of how we will continue to advance outsized growth for this enterprise going forward, with an aim towards serving, obviously, more people and doing so at -- with better experiences, outcomes at lower cost. This was designed by the Optum team through their strategic process led by Andrew Witty. And they've done a really nice job deploying this capability, not only in behalf of Optum, but of course, on behalf of all the UnitedHealth Group."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from A.J. Rice from Crdit Suisse.",11,"Our next question comes from A.J. Rice from Crdit Suisse."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Just wanted to ask about MA a little more. You've got, obviously, a nice step-up in growth expected this year. Any thoughts about what you're assuming relative to your ability to do normal risk assessments and get appropriately reimbursed for the patient",89,"Just wanted to ask about MA a little more. You've got, obviously, a nice step-up in growth expected this year. Any thoughts about what you're assuming relative to your ability to do normal risk assessments and get appropriately reimbursed for the patient population. Have you taken a more conservative view given the COVID backdrop? Or do you think you can get back to normal there? 
And just any quick comment on the 2022 rate notice, final rate notice that they've just released, and that -- how you view that."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. Tim Noel, Head of M&R.",6,"Sure. Tim Noel, Head of M&R."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, A.J., for the questions. So first, on 2022 revenue that you're getting at there with kind of diagnosis capture for 2021, a little bit early to talk about that at depth. But a couple of things I'll offer is, one, we're really focused in M&R ab",264,"Yes. Thanks, A.J., for the questions. So first, on 2022 revenue that you're getting at there with kind of diagnosis capture for 2021, a little bit early to talk about that at depth. But a couple of things I'll offer is, one, we're really focused in M&R about getting our members vaccinated as soon as possible. And across the enterprise, there's also a focus on doing the same for the frontline health care workers. And as both of these things happen, I think seniors will become increasingly more comfortable accessing care, and that will have obviously an impact on diagnosis capture in 2021 that impacts revenue for 2022. Remains to be seen exactly how that timing plays out. And we obviously have a bit of time remaining as we think about the 2022 bid to inform what does play out at the time of the bid and when that's submitted. 
With respect to the final notice that was published by CMS on January 15. As you know, number one, earlier than that's normally published. And the all-in rates that were included in that final notice of just north of 4% was a little bit of an increase over the advanced notice. Beyond that, nothing really surprising with respect to rules or policy changes contained in the final notice this year. Really too early to comment on what that means for rates and benefits, a lot of moving parts that remain as we think about the 2022 bid filing. Certainly, COVID is one of those things that we're watching as well with respect to that."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks for the question. Just if I can add on a little bit. First, one of the key things for us, and the reason why Tim started with the vaccine is because it's important for us to get our a substantial health workforce vaccinated, and in part, our Nurse",108,"Thanks for the question. Just if I can add on a little bit. First, one of the key things for us, and the reason why Tim started with the vaccine is because it's important for us to get our a substantial health workforce vaccinated, and in part, our Nurse HouseCalls workforce so that they can safely pass into the home more broadly than what -- maybe what we've seen, including more volatile circumstances. 
And then the other thing, just to recognize, is the extent that there was impacts on risk adjustment for 2021, we did take those into consideration in providing you with our estimates back in December."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from Kevin Fischbeck from Bank of America.",11,"Our next question comes from Kevin Fischbeck from Bank of America."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","All right. Great. Just wanted to maybe dig back into the $1.80 COVID headwind. Is there any way for you to kind of give us more dimensioning around kind of how that, at least from a relative size perspective, flows across the 3 Optum businesses and the 3",88,"All right. Great. Just wanted to maybe dig back into the $1.80 COVID headwind. Is there any way for you to kind of give us more dimensioning around kind of how that, at least from a relative size perspective, flows across the 3 Optum businesses and the 3 health plan businesses? 
And it sounds like commercial is coming in better than you thought. Is there anything that maybe is different than what you thought a couple of months ago when you first provided that? Anything better, anything worse?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","John Rex?",2,"John Rex?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, John Rex. So the broad view on that is about 2/3 of that relates to the UnitedHealthcare businesses when we think about just over $2 billion in impact, negative impact, from COVID-19 in 2021; and about 1/3 relates to the Optum businesses. And that'",275,"Kevin, John Rex. So the broad view on that is about 2/3 of that relates to the UnitedHealthcare businesses when we think about just over $2 billion in impact, negative impact, from COVID-19 in 2021; and about 1/3 relates to the Optum businesses. And that's kind of the general view. It doesn't -- as we break down to different businesses and think about impacts on those, some of the commentary I'd offer. 
So within OptumInsight, it is most sensitive to just kind of broadly claims volumes and business activity, general business activity. Those are kind of the factors that have been a component within that. The risk-bearing businesses of OptumHealth are impacted similarly to the UnitedHealthcare businesses, as you would expect, also in terms of activity there. 
Within the different categories across OptumHealth or across UnitedHealthcare. In general, I would just tell you kind of as we look at that. So David just cited that as it relates to how we anticipated and incorporated thoughts about ability for seniors to access care and get proper risk adjustment done. So that's an impact that's mostly felt within Medicare & Retirement in terms of that component of it, as you'd expect also. And to some extent and to a lesser extent in community and states where you'd have some of the Dual Special Needs Plans membership also. 
Within OptumRx, that is mostly also a volume-driven component. Has to do largely just with physician visit activity oftenly -- often in terms of scripts being written and as those flow through the system. 
So those are kind of the broad overall impacts I'd offer. And Dirk, any other comments?"
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. I think one of the things you mentioned was on commercial. I think what's resulted in sort of a little stronger outlook than what we expected from a membership standpoint is persistency was better. There was a lot of groups that decided to stick. I w",165,"Yes. I think one of the things you mentioned was on commercial. I think what's resulted in sort of a little stronger outlook than what we expected from a membership standpoint is persistency was better. There was a lot of groups that decided to stick. I would also say the various government stimulus packages helped. 
And I would also say one product stood out for us, it's our All Savers level-funded product which has done extremely well, which is kind of -- you give back -- if the group performs better than expected, they get a refund. If it's worse than they expected, then you ultimately get a -- if you're better than expected, then they have -- they get their refund if it's better than expected. So that's a good thing. It's worse, then a stop-loss policy kicks in. 
But long story short, I think some good products, as we talked about. Plus I would say good persistency was a big benefit to commercial."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Kevin. That's all we have time for it today. So apologies to Ralph and Ricky, both whose questions got cut off somehow. So please -- I'm glad we were able to fix that, but please give our team a call, and we'll be happy to answer any other ques",209,"Thank you, Kevin. That's all we have time for it today. So apologies to Ralph and Ricky, both whose questions got cut off somehow. So please -- I'm glad we were able to fix that, but please give our team a call, and we'll be happy to answer any other questions that you have. 
I'd like to thank you all for joining us, again, today. I hope this morning's call provided you with useful context, and importantly, clarity and helped you better understand our ambitions for the year ahead. 
As I said in my opening remarks, we are starting 2021 with an optimistic view. Despite these extraordinary circumstances, our team continues to manage the challenges at hand with unprecedented resiliency and ingenuity. At the same time, we continue to pursue our long-term growth strategy with an even greater sense of urgency and intensity, building upon the agility, insights and considerable new capabilities developed this past year to deliver a high-performing health care system built on personal human connections; enabled through information and technology; and supported by strong alignment of physician-led, value-based delivery of care, serving millions of people 1 person at a time while delivering distinguished returns for our shareholders. 
Thanks again for joining us. We'll see you soon."
104673,699215256,2176588,"UnitedHealth Group Incorporated, Q4 2020 Earnings Call, Jan 20, 2021",2021-01-20,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Ladies and gentlemen, this concludes today's conference call. Thank you for your participation, and you may now disconnect. Everyone, have a wonderful day.",23,"Ladies and gentlemen, this concludes today's conference call. Thank you for your participation, and you may now disconnect. Everyone, have a wonderful day."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the UnitedHealth Group First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded. And now I'd like to introduce your host for tod",47,"Ladies and gentlemen, thank you for standing by, and welcome to the UnitedHealth Group First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded. 
And now I'd like to introduce your host for today's program, Andrew Witty. Please go ahead, sir."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us to discuss our first quarter results and positive outlook as we continue to execute on UnitedHealth Group's long-standing mission and strategies.The exceptional dedication of the people of Optum and UnitedHealt",951,"Good morning, and thank you for joining us to discuss our first quarter results and positive outlook as we continue to execute on UnitedHealth Group's long-standing mission and strategies.
The exceptional dedication of the people of Optum and UnitedHealthcare, again defined this period. They've adapted swiftly and creatively to demanding and rapidly changing circumstances, implemented new ideas and importantly, remain focused on serving people exceptionally well, as a result, adjusted earnings per share were $5.31, reflecting strong execution at both UnitedHealthcare and Optum.
In light of our strong start to the year, balanced with continued respect for the potential pandemic-related effects we have previously described, we are increasing our full year adjusted earnings outlook to a range of $18.10 to $18.60 per share.
I'll touch briefly on 2 highlights, among many, in the quarter that illustrate the increased momentum our colleagues at UnitedHealth Group are driving. People served with our employer and individual offerings grew nearly 100,000 in the quarter, even within the context of a challenged U.S. employment environment, and this underscores the growing consumer orientation, affordability and breadth of our products.
OptumInsight revenues increased 14% and operating income increased 45% compared to the year-ago period as more normal activity levels among health care system customers returned, leading to expansion in how we help them advance clinical and operational excellence. Significant innovation and automation in the OptumInsight businesses drove strong productivity gains.
We have the right capabilities, assets and strategies in place, and we remain restless to innovate, evolve and further integrate our offerings to serve more people more effectively, both directly and with our many external partners throughout the health care environment.
To achieve this, we've been sharpening our focus in 3 key areas: First, delivering even greater value to those we serve throughout the health care system by better harnessing the collaborative capabilities of Optum and UnitedHealthcare. We believe we can develop new products and services, which support people more effectively by bringing to bear greater application and adoption of the combined offerings of these 2 distinct and complementary organizations. OptumCare's work supporting Medicare Advantage patients illustrates this well, and I'll speak more to this shortly.
The second area of focus, increasing the application of our technology and related resources to improve care for people and the operational health systems. There are benefits for everyone in helping to make the health care system work more like an actual system, improving the natural flow accessibility and use of information is essential to that goal. all within a secure and protected framework. We can help care providers and payers better serve patients by more effectively simplifying key administrative processes and by providing timely access to relevant information.
The third focus is making health care work better for consumers. We're ambitious to meet the rising expectations of health care consumers, and we will continue to improve our offerings, including in such critical zones as greatly simplified intuitive and satisfying consumer digital experiences and advanced health care banking and payment services that enable people to find, price and pay for care digitally. You'll hear more from us about these approaches in the months ahead.
But today, I'd like to focus on the first, unlocking greater value for customers at the intersection of Optum and UnitedHealthcare, including through our ability to develop new useful service offerings.
One of the most effective ways of doing so is through stronger alignment of the high-quality clinical services of OptumCare to address the needs of patients we serve for our nearly 90 health plan customers. A key foundation is increasing the clinical outcome accountability of our OptumCare practices. Of the 4 million patients who OptumCare serves in some form of accountable arrangement today, 2 million are being served under fully capitated arrangement, and this demonstrates the strong growth and progress. But OptumCare serves 20 million patients in total, which is one reason why we view the potential of OptumCare is only beginning to be harnessed.
These accountable arrangements drive measurably better patient outcomes and experiences, all at lower costs. For example, seniors served by op care physicians, under such arrangements, spend on average, 1/3 fewer days in the hospital and have 40% fewer days in skilled nursing facilities than seniors in traditional Medicare. We expect the growth in the number of OptumCare patients served under accountable arrangements to accelerate.
A further example of using our combined expertise to advance more beneficial service offerings is the recent opening of a first-of-its-kind Optum Integrated Care facility in Riverside County, California. While we have long offered and continue to actively develop our senior-focused clinics, this new clinic and community center offers a comprehensive range of primary care-led services, including a pharmacy, all under a single roof. And importantly, it is especially orientated around supporting Medicaid, Medicare, commercial and individual members of all ages. This comprehensive health center provides improved care access with modern on-site services, including annual wellness visits, chronic disease management support, coordinated care with trusted specialists, and laboratory, imaging and pharmacy services. The adjacent community center includes a full-service gym and meeting rooms for health education. We see Optum and our payer partners as uniquely positioned to be able to offer these types of impactful venues and look forward to learning from the community and expanding these services.
To sum up, We continue to organize and apply the unique capabilities of this organization in ways that enable to execute on the goals we established for 2021 and beyond, and to continue to deliver on our 13% to 16% long-term earnings growth objective.
Now I'll turn it over to President and Chief Operating Officer, Dirk McMahon, to give more color on initiatives to drive greater performance across the organization."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Andrew. As Andrew noted, we continue to drive growth by supporting more affordable, simpler quality care across Optum and UnitedHealthcare. These are themes you've heard us cover before, and we continue to see the benefits of this approach for peo",543,"Thanks, Andrew. As Andrew noted, we continue to drive growth by supporting more affordable, simpler quality care across Optum and UnitedHealthcare. These are themes you've heard us cover before, and we continue to see the benefits of this approach for people -- for the people we serve. 
Let me turn those themes into some specific examples across Optum and UnitedHealthcare, that illustrate how our approach is working. First is how we've been simplifying the consumer experience over the past year. We've driven greater engagement with seniors by increasing adoption of digital tools. Monthly active users of our digital offerings have risen double digits, with similar increases in online transactions. This has led to greater adoption of our digital therapeutic offerings.
In the first quarter, high-risk chronic disease patients in our home monitoring program logged over 1.5 million biometric measurements, such as glucose level, enabling 99% medication compliance and an NPS of 84. We've also made it easier for people to get and maintain behavioral health support by expanding traditional and virtual provider network and combine them with modern digital therapeutic services.
Behavioral health needs have increased significantly during the pandemic, and as a result, we have seen substantial adoption in our digital behavioral platform that provide on-demand emotional support, logging a rise of over 100% in utilization. Always accompanying our work to simplify health care is Optum and UnitedHealthcare's sharp focus on delivering high-quality care.
We've talked to you before about the advances we are making to integrate patient-specific health data and plan information directly into the physician's workflow. Clinicians can see gaps in care and act to close them during the patient's visit, in addition to other steps that facilitate more efficient care and better outcome.
We now support over 8 million of these in-site-enabled digital interactions each month with rapidly expanding physician adoption. Delivering high-quality care has been central in our response to the COVID pandemic. Our most recent effort to help members access vaccines is a prime example.
We launched a vaccine locator tool, helping people find and sign up for a vaccination. And we've made millions of outbound contacts to engage members and help them get the information they need. 
Lastly, making care more affordable remains central for the people we serve and the health system overall and is essential for increasing access. For instance, through our medication sourcing program, high-cost providers now source drugs at a network specialty pharmacy, including OptumRx or charge market rates only for the drug. Early work on this has generated substantial savings for our customers.
Our work to make health care simpler, higher quality and more affordable drive strong growth for our business. At the end of January, for example, UnitedHealthcare was awarded an Oklahoma SoonerCare Medicaid contract to serve nearly 200,000 people. Oklahoma previously operated under a fee-for-service program. The award affirms the value we bring to state partners and consumers and reflects our commitment to expand access to care for all Americans. We look forward to working with our new partners in Oklahoma and sharing with you, on future calls, new examples as our work on simplicity, quality and affordability continues to create improvements and new growth opportunities.
With that, now I'll turn it over to Chief Financial Officer, John Rex."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dirk. Before I review the performance of our businesses, as in recent quarters, I'd like to provide an update on the care patterns we're seeing as the pandemic continues to evolve.Over the course of the first quarter, total care activity, inc",636,"Thank you, Dirk. Before I review the performance of our businesses, as in recent quarters, I'd like to provide an update on the care patterns we're seeing as the pandemic continues to evolve.
Over the course of the first quarter, total care activity, including COVID-19-related care, ran marginally below seasonal baseline. Pacing of elective care activity through the quarter generally trapped and in opposite directions with the rise in decline of COVID incidence rates, which were much higher in the early part of the quarter than in the latter part.
To put this in perspective, February and March showed COVID-related care at about half the level experienced in January. Since the quarter's end, we have again begun to see a rise in COVID-related care, while at this time, not approaching the January level.
Outpatient care activity was moderately below seasonal baseline for the full quarter, running in counterpoint to the COVID incidence patterns over the 3 months and reflecting a well-below average influenza and respiratory illness season. And total inpatient activity was modestly above seasonal baseline, with over 55,000 COVID-19-related emissions during the quarter compared to 65,000 in the fourth quarter 2020.
Moving to business unit performance. OptumHealth's first quarter revenue and earnings increased 35% year-over-year. Revenue per consumer served grew 31% over the year-ago quarter. The growth in this metric continues to reflect the expanding number of people served under value-based care arrangements and the increasing acuity of the care services we offer.
OptimumInsight's revenue grew 14% in the quarter and earnings 45%, due to growth in our services and technology offerings and improved productivity. The revenue backlog at $20.8 billion grew $1.6 billion over the first quarter 2020, as more normalized business activity started to return among our provider and payer customers.
OptumRx' revenue and earnings were relatively consistent year-over-year and in line with our expectations. Adjusted scripts declined modestly from the year-ago quarter, a period during which we provided advanced medications to the people we serve as the pandemic began. Pharmacy Care and Specialty Services continue to grow strongly, in particular, home infusion and our community behavioral health pharmacies.
Turning to UnitedHealthcare. First quarter operating results reflected strong execution and continued membership growth. In addition to the growth in commercial and Medicare Advantage offerings noted earlier, people served in managed Medicaid programs grew by nearly 1.1 million over the year-ago quarter. Of the 900,000 new seniors we expect to serve within Medicare Advantage this year, about 775,000 are in individual and group and 125,000 in dual special needs offering.
Of importance to the senior customers we serve, our house calls clinicians have been considerably more able compared to this time last year to provide their vital services. We conducted nearly 600,000 home visits in the quarter as more seniors and caregivers were vaccinated and comfortable having in-person visit. That's up by a 1/3 compared to first quarter 2020 and about 4x higher than what was achieved in the second quarter 2020.
Our liquidity and capital positions remain strong, with first quarter cash flows from operations at $6 billion or 1.2x net income. As we look forward toward the combination with Change Healthcare, we intend to maintain our long-standing capital policy. These include our approach to returning capital to shareholders via share repurchase and an advancing dividend, with ample capacity to continue building upon our strategic growth platform.
We now expect adjusted earnings per share in the range of $18.10 to $18.60, an increase of $0.35 from the outlook we offered at our investor conference. This outlook continues to include an estimated $1.80 per share of unfavorable COVID-19-related effects. The substantial majority of which we still expect to occur in the latter part of the year, largely as carriers more freely able to be delivered to people.
Now I'll turn it back to Andrew."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John. The story you heard about this quarter is the story you've heard for many years, and will continue to do so about UnitedHealth Group, a focus on better serving people and organizations in health care, using the combined capabilities of Optum",74,"Thanks, John. The story you heard about this quarter is the story you've heard for many years, and will continue to do so about UnitedHealth Group, a focus on better serving people and organizations in health care, using the combined capabilities of Optum and UnitedHealthcare to improve care, cost and experience and an unwavering attention to executional excellence in all that we do. 
Operator, let's open it up for questions. One per caller, please."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our first question comes from the line of Matt Borsch from BMO Capital Markets.",14,"Our first question comes from the line of Matt Borsch from BMO Capital Markets."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Congratulations on the quarter. I have a question for you on the prior year reserve development, which is obviously a very large number. Can you just talk to where that emanated from in terms of components, whether by program or by quarter in 2020? And ho",55,"Congratulations on the quarter. I have a question for you on the prior year reserve development, which is obviously a very large number. Can you just talk to where that emanated from in terms of components, whether by program or by quarter in 2020? And how that may be influencing your posture on forward reserving?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. I'm glad you asked that. I know a lot of people probably have that in mind. John, you should answer that, I think.",24,"Great. I'm glad you asked that. I know a lot of people probably have that in mind. John, you should answer that, I think."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. Matt, it's John Rex. Let me give a little color on that. So yes, the prior year development, $1 billion favorable versus $850 million in the 4Q. As I'm sure you expect, that emanates heavily from the second half of 2020 and a lot from the fourth qua",147,"Sure. Matt, it's John Rex. Let me give a little color on that. So yes, the prior year development, $1 billion favorable versus $850 million in the 4Q. As I'm sure you expect, that emanates heavily from the second half of 2020 and a lot from the fourth quarter. It was favorable really across the businesses. The elements there that would be driving that would be largely along care deferral activity that would have occurred in the quarter.
I think when you think about kind of impact to the company and P&L impact, certainly, there are significant mitigating factors that I know you're well aware, MLR rebates, risk order arrangements, reserve reestablishment that occurs. When I look at it and take it all together with those mitigating factors, P&L impact would have been in a similar zone to last year's first quarter with those elements coming in."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Kevin Fischbeck from Bank of America.I'm sorry -- our next question comes from the line of Robert Jones from Goldman Sachs.",30,"Our next question comes from the line of Kevin Fischbeck from Bank of America.
I'm sorry -- our next question comes from the line of Robert Jones from Goldman Sachs."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Congrats to Andrew and Brian on the new roles. I actually just wanted to ask one on OptumHealth. I think you said 35% of the growth there was driven by global cap. You also shared 2 million risk patients in OptumCare are now in global cap.Just curious i",110,"Congrats to Andrew and Brian on the new roles. I actually just wanted to ask one on OptumHealth. I think you said 35% of the growth there was driven by global cap. You also shared 2 million risk patients in OptumCare are now in global cap.
Just curious if you could give a little bit more on kind of where you think this number could get to, the number of patients in global cap arrangements within Optum Care this year and then maybe over time? And then it'd be helpful to understand a little bit just how many of the 20 million patients you highlighted are actually in MA today?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Listen, Robert, thanks so much for the question. Before I ask why it's Decker to add, you put your finger on a really key part of the growth strategy going forward. Clearly, you're going to see, over this year and next year, an accelerating move to",162,"Great. Listen, Robert, thanks so much for the question. Before I ask why it's Decker to add, you put your finger on a really key part of the growth strategy going forward. Clearly, you're going to see, over this year and next year, an accelerating move towards more capitated patients within the OptumCare universe. As I mentioned in my prepared comments, there's tremendous opportunity as we look at those 20 million and growing number of patients who we look after migrating towards what we believe to be a better mechanism to help them manage both their care outcome and also the cost implications. So you'll see that continue to accelerate. 
As we expand our OptumCare networks, we are rapidly transitioning our capabilities clinic by clinic to be able to do this. And it's one of the areas I think we feel extremely optimistic about future momentum.
But to give you a little bit more detail, Dr. Decker, who leads Optum Health, please."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you, Robert, for the question. And Andrew, I think you set it up nicely.OptumCare has become the nation's preeminent ambulatory delivery of value-based care. It is position-led. And increasingly, you'll see us bringing comprehensive services",111,"Yes. Thank you, Robert, for the question. And Andrew, I think you set it up nicely.
OptumCare has become the nation's preeminent ambulatory delivery of value-based care. It is position-led. And increasingly, you'll see us bringing comprehensive services there to meet the needs of all of our patients, but a particular focus on value base and in particular focus on the fully capitated individual.
We will continue to grow over 250,000 lives this year, and you can expect that to accelerate in the years to come as we continue to attract individuals through organic growth as well as through our partnership with UHC, and as Andrew mentioned, nearly 90 other providers."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] Our next question comes from the line of Lisa Gill from JPMorgan.",14,"[Operator Instructions] Our next question comes from the line of Lisa Gill from JPMorgan."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Hi, Lisa, go ahead.",4,"Hi, Lisa, go ahead."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I'm just curious how we think about digital and Telehealth impacting medical costs? What you've seen thus far? And what's the future role post the pandemic when we think about helping to control costs from a Telehealth perspective?",39,"I'm just curious how we think about digital and Telehealth impacting medical costs? What you've seen thus far? And what's the future role post the pandemic when we think about helping to control costs from a Telehealth perspective?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Lisa, that's a great question. I'm going to ask, in a second, Dr. Decker. And also, I think I'll ask Dirk McMahon to make a couple of comments, but let me just preface that.So we've obviously seen Telehealth develop as a set of capabilities over the las",211,"Lisa, that's a great question. I'm going to ask, in a second, Dr. Decker. And also, I think I'll ask Dirk McMahon to make a couple of comments, but let me just preface that.
So we've obviously seen Telehealth develop as a set of capabilities over the last several years. We've been a very extensive user of those capabilities. But I think one of the things we've seen from 2020 and the pandemic is really a kind of shift in terms of people's thinking and willingness to utilize Telehealth. We also think that the way in which they're being utilized are -- is evolving.
And so what you're going to see from us, and it's one of the examples I might cite in terms of the opportunity for new product development between Optimum and United Healthcare, is you're going to see UnitedHealth Group lean forward into much more integrated Telehealth capabilities. We've got a number of new initiatives in deployment as we speak, operating between the 2 companies.
And with that introduction, let me pass it over to Wyatt to maybe give you a little bit more detail on that. And then I think it would be good to hear from Dirk the perspective he has on this. So Wyatt first."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Well, thanks for the question. And as you've heard us mention before, we were very proud of how quickly we stood up over 17,000 providers during the pandemic on Telehealth solutions, but that really just is the beginning. And of course, across the co",260,"Yes. Well, thanks for the question. And as you've heard us mention before, we were very proud of how quickly we stood up over 17,000 providers during the pandemic on Telehealth solutions, but that really just is the beginning. And of course, across the country, we've seen a massive shift in consumer adoption and willingness to engage in virtual health solutions as well as with our providers more broadly.
So our philosophy is that not all Telehealth is created equally. And as we continue to develop our new products, you'll see us integrating physical care, virtual care, home care and behavioral care in a way that is innovative and differentiated. And in fact, we've already launched a product we call Optum Virtual Care, that is live in all 50 states and is doing just that. And what will really differentiate our product to those that we serve is the ability to offer virtual solutions, but then if necessary, immediately connect them to a live bricks-and-mortar solution for more complex or thorough care as well as identifying and triaging both physical and behavioral health care needs and offering comprehensive behavioral health care.
We're seeing continued sustainability of virtual care solutions, which, as you may know, peaked during the height of the pandemic, have declined some, but are still probably 10x where they were pre-pandemic and certain conditions or behavior -- or areas like behavioral health care are now seeing about 50% utilization through virtual services. So we're very excited about where we can take this. I'll turn it over to Dirk."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Wyatt. I think Andrew and Wyatt pretty both drained it. But let me just add a couple of things. First, we know that people want to meet with their doctor, and we've been focused on facilitating that with OptumCare. And with people -- basicall",136,"Yes. Thanks, Wyatt. I think Andrew and Wyatt pretty both drained it. But let me just add a couple of things. First, we know that people want to meet with their doctor, and we've been focused on facilitating that with OptumCare. And with people -- basically, as you look at how things evolve, the brick-and-mortar physicians have the vast majority of the [indiscernible] today.
I would also say that I do see a tremendous opportunity for new models and new product strategies with OptumCare and others, where we lean towards those providers who have, again, the best outcomes and provide the most efficient care. So like any other doctors in our network, we, at UnitedHealthcare, are going to be looking for that strongly. And we think OptumCare can provide that very well. That's it. Thanks, Lisa."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Dirk. Thanks, Wyatt. I got to say, Lisa, I've been keeping an eye on the patient verbatims as we've been deploying the Optum virtual platform that Wyatt referred to. And really, the feedback is really extraordinary in terms of how patients are see",140,"Thanks, Dirk. Thanks, Wyatt. I got to say, Lisa, I've been keeping an eye on the patient verbatims as we've been deploying the Optum virtual platform that Wyatt referred to. And really, the feedback is really extraordinary in terms of how patients are seeing this, the benefit they feel from it and the ease with which they're able to engage with it. 
So this is exactly the kind of thing you're going to see going forward. I think Optum is in an extremely advantaged position, being able to bring together this notion of integrated Telehealth with physical and behavioral health, and that's going to be the path we go. And I think we're on the verge of kind of next generation of what this looks like versus what we've seen previously. So Lisa, thanks so much for raising the question."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Kevin Fischbeck from Bank of America.",14,"Our next question comes from the line of Kevin Fischbeck from Bank of America."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I guess one clarification. First, I guess, does your guidance assume anything for sequestration delay? But then I guess the real question is, is the $1.80 that you guys are still including in your guidance, it sounds like things are starting off the year",103,"I guess one clarification. First, I guess, does your guidance assume anything for sequestration delay? But then I guess the real question is, is the $1.80 that you guys are still including in your guidance, it sounds like things are starting off the year relatively well with overall utilization coming in better and membership growing and some of the OptumInsight things kind of normalizing. 
I guess how do you think about that $1.80? How is that progressing? And what kind of signpost do you need to kind of see before you feel like that number might come in and be lower than that?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, listen, Kevin, thanks for the question. I'll let -- I'm going to ask John in a second to refer to the $1.80 -- the math, I guess, behind that and the underlying trends.As far as sequestration is concerned, obviously, we're keeping a close eye o",91,"Yes. No, listen, Kevin, thanks for the question. I'll let -- I'm going to ask John in a second to refer to the $1.80 -- the math, I guess, behind that and the underlying trends.
As far as sequestration is concerned, obviously, we're keeping a close eye on the guidance from the administration. We've clearly seen the extensions, but the guidance raise we've given to date not caveated by that in any way. So we have our assumptions on that, but the guidance stands notwithstanding any outcome there. John, on $1.80."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Kevin, it's John Rex. Let me talk a little bit about that and how we think about that progressing throughout the course of the year.So just some impacts here. I think the first important impact, I suggested that if a significant majority, I'd call",269,"Yes, Kevin, it's John Rex. Let me talk a little bit about that and how we think about that progressing throughout the course of the year.
So just some impacts here. I think the first important impact, I suggested that if a significant majority, I'd call it, 70% of our projected COVID impact is -- really occurs in the second half of the year. And just to be frank, we just don't know enough now about what is going to happen later in the year, kind of have a very meaningfully different projection of what our full year results will be in terms of will they be better in terms of better than the original projections, except for what we've experienced thus far, which we would expect -- expected some stronger underlying business performance, growth across a number of businesses. We've executed well on productivity measures, and maybe just very modestly less impact in the 1Q unfavorable impact than we would have anticipated. 
But the important component there being that it is really much more a back half weighted view in terms of COVID-19 impact. That's really premised upon our expectation that as we get later in the year, people are going to be more able to access previously deferred care and higher acuity levels as a result of missed or postponed treatments. And that's what we're -- that's what we built -- that's what we build into that view in terms of an expectation. But that's really an unusual time still, no question. And we therefore, increased our full year estimate, but -- by what we know today."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John, and Kevin, thanks so much for asking the question. I mean, I think John really summarized it super well. We've raised our expectations for the year based on our experience so far this year with -- and we've retained that $1.80 assumption, if",98,"Thanks, John, and Kevin, thanks so much for asking the question. I mean, I think John really summarized it super well. We've raised our expectations for the year based on our experience so far this year with -- and we've retained that $1.80 assumption, if you will, in terms of what could happen. But we just -- we obviously don't have the detailed visibility of that yet, but we feel that's the right balance stands to take in terms of the rest of this year. So I hope that's clear. And thanks so much for the question, Kevin."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Josh Raskin from Nephron Research.",13,"Our next question comes from the line of Josh Raskin from Nephron Research."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Here with Eric Percher as well. So our question this quarter again on OptumHealth. And I appreciate the comments in the prepared remarks and the Q&A. But I want to speak to the ultimate strategy around the accumulation of employed physicians. And if this",123,"Here with Eric Percher as well. So our question this quarter again on OptumHealth. And I appreciate the comments in the prepared remarks and the Q&A. But I want to speak to the ultimate strategy around the accumulation of employed physicians. And if this is all about a move to global capitation? And we're really more interested in the how, right? Is this more center-based like what you're talking about in Riverside, California? Is this more of a technology overlay that enables the physicians to do this? And then I would just ask again, how many of those 20 million, I understand 250,000 will move this year. But how many of those 20 million ultimately end up in global cap in your mind?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Josh, thanks for the question. And before I pass it to Wyatt, again to respond to the specifics, let me just give you a sense of how we see this playing out.And I think the answer to your question is really both. So we absolutely see tremendous opportun",281,"Josh, thanks for the question. And before I pass it to Wyatt, again to respond to the specifics, let me just give you a sense of how we see this playing out.
And I think the answer to your question is really both. So we absolutely see tremendous opportunity to continue to develop a variety of different clinic types. And if you look at the -- I cited one particular example, but we've been opening a wide number different type of clinics depending on the environment that -- or the locality that we're operating in. And you should continue to expect to see that degree of customization according to the need of the geography. It's not a one-size-fits-all model by any means. So you'll continue to see that. 
But at the same time, we strongly believe there is opportunity over the next few years. And this is why I focused in my kind of second area of going deeper around technology. How we can then help those clinics operate more efficiently? How we can ensure they are better connected, both locally with other clinics that we may own or to a higher level of information support? So we see this as being a highly activated network of clinics and centers.
The center -- the network itself will have a high degree of diversity in it because it needs to be responsive to the needs of the locality, the communities that we're operating in. And of course, as sensitive to the previous comments, it will have a very significant Telehealth capability deployed alongside it.
Wyatt, maybe you could talk a little bit to how you see the progression within the $20 million?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you, Andrew. Thanks, Josh. Great question. We will continue to evolve. And one of the pieces that will differentiate us as a comprehensive care provider is just that being comprehensive. And so you'll see us continuing to weave together product",324,"Yes. Thank you, Andrew. Thanks, Josh. Great question. We will continue to evolve. And one of the pieces that will differentiate us as a comprehensive care provider is just that being comprehensive. And so you'll see us continuing to weave together products and services that meet people's needs in new and innovative ways, and Telehealth and digital solutions are a big piece, but not the only piece. 
The other part that I'd call out is we're increasingly leveraging technology to bring advanced decision support to our physicians and providers. And you may have heard previously about optimal care. This is a value-based care delivery set of decision tools that are yielding real results, giving people the best, highest quality care that eliminates what we tend to call low-value care, and is a differentiator. So we'll continue to deploy those technologies.
As you know, we are on track to grow by over 10,000 physicians. We're now at 56,000 doctors, both affiliated, contracted and employed. And we'll leverage all of those models as we go forward. And we continue to evolve and employ doctors who are really actually quite attracted to our model of value-based primary care. We eliminate much of the clerical burden in our physicians and advanced practitioners' practice and let them focus on the work they love. So this is really gaining traction among our physician workforce.
And then to your point around how much of the 20 million lives that we serve today will ultimately be capitated, we anticipate that not only will a significant portion, you heard the number 2 million today and 0.25 million, as we mentioned, growing. So as we continue to grow, we also expect that we'll always offer a host of modalities, including fee-for-service. And that actually is a feeder system as we think about value-based care being kind of the core of what we offer and fully capitated the core of the core, if you will."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Maybe I'll just ask Dan Schumacher to briefly add to the comments and talk a little bit about Optum at home, which is a further dimension of this. So go ahead.",32,"Maybe I'll just ask Dan Schumacher to briefly add to the comments and talk a little bit about Optum at home, which is a further dimension of this. So go ahead."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Andrew, and great question, Josh. To the question around sort of center-based, tech-based, data-enabled and different versions to that, that Wyatt was talking about, Optum at home is a great example of a collaboration between UnitedHealthcare and",209,"Thanks, Andrew, and great question, Josh. To the question around sort of center-based, tech-based, data-enabled and different versions to that, that Wyatt was talking about, Optum at home is a great example of a collaboration between UnitedHealthcare and Optum. It's in relatively early stages. But we focused on Medicare Advantage members that are in dual special need plans initially, and that's a full risk offering. And we're doing it in markets where we don't currently have local OptumCare practices. 
So what we're doing in the program is really both providing care, but also arranging and coordinating care, so trying to address medical, behavioral and social needs. And the results initially have been great. We've improved access for people with more than 80% having an in-home visit, and more than half of them getting connected back into office-based care, social services referrals and so forth as well as great health quality and outcomes.
So today, we've got a little under 100,000 lives across 6 markets. We're looking to expand that across Medicare Advantage Dual SNP but also into the individual MA. We're doing it with UnitedHealthcare and ultimately, to do that with other health plans. So another growth factor for us as we look at building out our value-based orientation."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So Josh, I mean, I know that was a little bit of a long answer from the 3 of us, but you asked a really important question. And this is really one of the core elements of the future of the company. And it's why you've heard us talk so much about OptumHeal",170,"So Josh, I mean, I know that was a little bit of a long answer from the 3 of us, but you asked a really important question. And this is really one of the core elements of the future of the company. And it's why you've heard us talk so much about OptumHealth, OptumCare, and you can see the growth potential. We're at that 2 million life level now. We clearly see the capitation strategy as a highly effective strategy to deliver both quality and cost management for patients. That movement is really significant, and it's really moving strongly.
And with the development of the diverse sets of clinics and skills, the development of the technology support that you've just heard referred to, we believe we're in a very strong position to be able to be the leader in ability to manage those patients in the best possible way and ensure that they get the kind of health care they deserve. So Josh, thanks so much for asking the question."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] Our next question comes from the line of Ricky Goldwasser from Morgan Stanley.",15,"[Operator Instructions] Our next question comes from the line of Ricky Goldwasser from Morgan Stanley."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","If we think about your utilization, I mean, you gave us some data on how utilization is tracking. But can you give us a little bit more details on how it's tracking across the different patient population? And also, we talked about acuity levels, your exp",125,"If we think about your utilization, I mean, you gave us some data on how utilization is tracking. But can you give us a little bit more details on how it's tracking across the different patient population? And also, we talked about acuity levels, your expectations for acuity level to step up second half of the year.
But from the experience to date, as you're starting to see individuals are coming back, what type of acuity you're seeing for those that haven't received care for the last year? And I think the final one there. If you can just remind us, as you think about that guidance for the full year, are you assuming digitalization by year-end, it's going to be above the 2019 baseline?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So great question, Ricky. I'm going to ask Brian Thompson, who has recently been appointed as the Chief Executive Officer of UnitedHealthcare, to respond to that. So BT?",28,"So great question, Ricky. I'm going to ask Brian Thompson, who has recently been appointed as the Chief Executive Officer of UnitedHealthcare, to respond to that. So BT?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question there. When I think about baseline, what I can say right now is what we're seeing is largely tracking to our expectations. And as we had signaled, where we see abatement in services, it's largely offset by the increase in COVI",177,"Yes. Thanks for the question there. When I think about baseline, what I can say right now is what we're seeing is largely tracking to our expectations. And as we had signaled, where we see abatement in services, it's largely offset by the increase in COVID-related costs. And that's tracked as we had expected.
When you back out the impact of some suppressed utilization, the underlying factors associated with medical cost trend largely looked like they did. We aren't seeing significant upticks in services in specific areas out of the norm. So I would say it looks a lot like utilization prior to the COVID implications.
And when I think by line of business, I would say, generally tracking a little below baseline in both our government programs closer to baseline inside our commercial business, but largely in track with what we had expected. And where it's a little out of line again, where perhaps infection rates were higher, and we saw that naturally offset with greater utilization. So first quarter, I would say, largely as expected."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","John, do you want to add?",6,"John, do you want to add?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Ricky, it's John Rex here. So as Brian noted, one of the aspects we look for is this rising acuity from patients that have deferred or care or missed treatments. And at this point, we don't have evidence of that occurring. And it could be just that i",229,"Yes, Ricky, it's John Rex here. So as Brian noted, one of the aspects we look for is this rising acuity from patients that have deferred or care or missed treatments. And at this point, we don't have evidence of that occurring. And it could be just that it's still too early on to have enough evidence to see it, but we have not yet seen that rising acuity in the populations that we serve.
Your point in terms of how we think about as we get later into the year? And why that moves like it does? And you heard my commentary that significant majority of the $1.80 we have layered into the second half of the year. That is largely because of the assumptions around those elements that we see that people are increasingly able to get the care they need. The amount of care deferral declined meaningfully as you get into the latter part of the year. They're accessing the system. And we do get into these elements where we see rising acuity coming at.
So those are the elements that are premised in terms of that expectation at this point. So -- but really -- and the other element that Brian touched on also just in terms of your population, you have commercial, a little more access to the system versus the public program members."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John, and thanks, Ricky, for the question.",8,"Thanks, John, and thanks, Ricky, for the question."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Dave Windley from Jefferies.",12,"Our next question comes from the line of Dave Windley from Jefferies."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to ask a question about integration and longitudinal care and data versus fragmentation. And the question is this, so Andrew, over many years, Optum has really invested a lot of money in kind of aggregating data about the patient status, care and s",110,"I want to ask a question about integration and longitudinal care and data versus fragmentation. And the question is this, so Andrew, over many years, Optum has really invested a lot of money in kind of aggregating data about the patient status, care and services delivered so that touch with United or Optum could have all that information at hand.
I guess what I'm interested in around kind of your build-out, but specifically the comments you made about telemedicine is, how important is it for telemedicine to enhance and augment the longitudinal and integrated nature of care versus fragmenting that by having it kind of siloed as a separate benefit?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Right. That's a great question. So I think our bias is increasingly, and I think rightly towards driving a more and more seamless, simple, easy-to-access care environment, both for the patient and the provider actually.So what that speaks to is trying t",332,"Right. That's a great question. So I think our bias is increasingly, and I think rightly towards driving a more and more seamless, simple, easy-to-access care environment, both for the patient and the provider actually.
So what that speaks to is trying to avoid the fragmentation of the interface and definitely trying to avoid the fragmentation of the information that then sits behind it. So we want to really try and create much more seamless opportunity. And so for example, I'll give you a real example in Optum Virtual, which is -- you've heard a little bit about on the call already today.
So of course, patients are looking for a way to engage with a physician. They actually want to talk to their physicians. So one of the things that we're doing is building that plan. But then there might be situations where the physician wants to bring in a specialist into that conversation.
Now in a multidisciplinary clinic, they might be in a position, in normal times, to go down the hall, get somebody to come down and visit. Now in Optum Virtual, they're able to do that kind of thing. So that's an example of trying to bring that integration even within the virtual space. So it kind of replicates a little bit more what you might expect in a physical environment.
And so we definitely see the need to try and drive toward that, and we definitely want to try and create the fluidity of the information to ensure that physicians have what they need when they're in front of the patient, when they're talking to the patient, they can make the best possible choices. So we want them to be as highly educated as possible in that context. So we're leaning much -- we're leaning very much toward the idea of integrated, seamless, and that's true whether you're in the physical or the virtual space, and we want the 2 to sit together. Thanks for the question."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Justin Lake from Wolfe Research.",13,"Our next question comes from the line of Justin Lake from Wolfe Research."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","A lot of good topics already covered here. So I just have a few quick follow-ups. First, the detail on OptumCare was very helpful. I was hoping I could ask for one more piece of information here, which is the -- so it sounds like you're going to have 18 m",168,"A lot of good topics already covered here. So I just have a few quick follow-ups. First, the detail on OptumCare was very helpful. I was hoping I could ask for one more piece of information here, which is the -- so it sounds like you're going to have 18 million people out of 20 million that are still not capitated. Wondering how many of these are sitting in Medicare Advantage plans that aren't capitated, given this is where most of the capitation happen? Just trying to think about the potential kind of pent-up growth there.
And then on Medicare Advantage, it sounded like your health assessments are going better in 2021. Should we expect that you should get a significant amount of that risk score headwind that everybody saw for 2021 to reverse next year and get those revenues back? And then lastly, could you give us an update on earnings seasonality for the year versus the 50-50 split you talked about on the last update ?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","I'm going to ask, in a second, John, to talk to the earnings seasonality and/or Wyatt to address the degree to -- the population we have within the MA plan.Let me just touch on the health assessment. You heard in the prepared comments the very strong pe",186,"I'm going to ask, in a second, John, to talk to the earnings seasonality and/or Wyatt to address the degree to -- the population we have within the MA plan.
Let me just touch on the health assessment. You heard in the prepared comments the very strong performance of the house calls program, actually higher than last year, record quarter actually in terms of performance of house calls.
And you're quite right, that makes us feel pretty optimistic that, that headwind that we saw is going to dissipate pretty rapidly as we rotate to 2022. And that gives us kind of a rising optimism that much of the -- much of that kind of the negative headwind that characterize the emergence of the pandemic starts to mitigate at least on that dimension.
Obviously, we don't know what's going to happen in the next few months with this disease. But as we sit here today, that would be the right kind of expectation to look at.
Let me go to Wyatt first. And then, John, if you pick up from Wyatt on the seasonality. So Wyatt?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Justin, thanks for the question. And of the individuals that we serve that are not in fully capitated programs, about 1/3 of them are seniors. And so you can think of that as the Medicare population that we serve through a variety of touch points in",145,"Yes, Justin, thanks for the question. And of the individuals that we serve that are not in fully capitated programs, about 1/3 of them are seniors. And so you can think of that as the Medicare population that we serve through a variety of touch points in our care delivery assets. And then you -- as you'd expect, a subset of those are already in MA plan, which is to your question.
And so we see, again, a great potential to continue to capture and enroll and care for MA patients through OptumCare's delivery capabilities. And you'll also see us going deeper in the markets that we're in and bringing risk -- our very mature risk-based platform in established markets to new markets where, today, we are primarily fee-for-service. So expect both geographic growth and increasing depth and penetration in the markets we serve today."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, it's John. In terms of the seasonality, so historically, we've been at, what I'd call, a kind of 48-52 split in terms of first half, second half. I put that probably more in the zone of first half being in the 52, 53 zone this year. That is really",103,"Justin, it's John. In terms of the seasonality, so historically, we've been at, what I'd call, a kind of 48-52 split in terms of first half, second half. I put that probably more in the zone of first half being in the 52, 53 zone this year. That is really due to the -- how we're tracking in the $1.80 per share impact on us. That -- the majority of that is occurring in the second half of the year. So that would be the -- really the reason for the seasonality looking great this year than it has looked in other years."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John. And thanks, Justin, for the questions. Appreciate it.",10,"Thanks, John. And thanks, Justin, for the questions. Appreciate it."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of A.J. Rice from Credit Suisse.",14,"Our next question comes from the line of A.J. Rice from Credit Suisse."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Maybe drill down a little bit on OptumInsight. Obviously, you had a really good margin trend this quarter. I wondered -- because I know there was a discussion last year during the pandemic that some of the John Muir type of deals were somewhat on hold. As",182,"Maybe drill down a little bit on OptumInsight. Obviously, you had a really good margin trend this quarter. I wondered -- because I know there was a discussion last year during the pandemic that some of the John Muir type of deals were somewhat on hold. As it was tough to sell a health system on that given social distancing and so forth.
Does the fact that you don't have investments for those, is that helping you on the margin right now? And are those now basically reopened now, that you can go out and bid? And maybe another aspect of the OptumInsight story, as you think ahead now that Change Health coming on board, do -- should we assume that there's a pause in selling activity of some sort while you integrate that and position the company to be even stronger -- that business to be even stronger? Or I know there's a lot of synergy assumed to be coming online with that one. So how should we think about how Change Health coming online affects the trajectory of that business?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","I'm going to ask Robert Musselwhite to make some comments in a second around the progression of the margin in the quarter, which obviously, we're very, very pleased to see that, and it was due to a ton of hard work on a number of different dimensions that",266,"I'm going to ask Robert Musselwhite to make some comments in a second around the progression of the margin in the quarter, which obviously, we're very, very pleased to see that, and it was due to a ton of hard work on a number of different dimensions that Robert can describe to you.
Just on those large contract agreements like the one we have with John Muir. Yes, there was a bit of disruption last year, but I would say that is absolutely back on stream now in terms of a line of business for us, and we have a very, very exciting pipeline. And that pipeline exists both in the short, medium and longer term. So that's an area you're going to hear more from us on, and is absolutely back in full swing.
In terms of Change, obviously, we're -- we are very keen to continue to work through the regulatory process. We expect this to close in the second half, as we've previously indicated. And you should not expect any disruption from us bringing Change on board to really anything that we're doing, and especially not in terms of our selling activity. So we absolutely continue to operate OptumInsight fully as if we were not in a transaction. And even post-transaction, I would fully expect the ongoing sales energy of the company to be not disrupted. So nothing I really would not lead you to expect anything on that front.
With that, Robert, would you go into a bit more detail, please, around the evolution of the margin during the last quarter?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. A.J, listen, we were pleased with the quarter. It was a really good quarter on the top line, and that, of course, drove profitable growth that contributed to margin.But specifically on margin, we also are really seeing the results of a lot of the",297,"Sure. A.J, listen, we were pleased with the quarter. It was a really good quarter on the top line, and that, of course, drove profitable growth that contributed to margin.
But specifically on margin, we also are really seeing the results of a lot of the modernization work we did across 2020. So last year, we undertook a significant review of the business across the operations and drove -- find some multiple ways to drive stronger and more efficient performance and help find -- ensure that the investments we are making were invested appropriately against our key growth opportunities.
And so if you look at those initiatives, multiple automation initiatives using advanced techniques and AI, and LP, Machine Learning, it really drove a lot of short-term productivity. But it also drives a situation where we feel like we've made sustainable margin improvements for the long term, and that puts us in a position to be more competitive. And that actually rolls over to exactly what you were mentioning, being more competitive on the large engagements.
And as Andrew said, we feel really optimistic about that pipeline and where it's headed. The disruption was more in timing and not really an interest during the pandemic. In fact, during the pandemic, I think there was growing recognition among our health system relationships that this was a very productive way to work with Optum and a really important need for them as they face some disruption even coming out of the pandemic to their finances in ways that we can sustainably support them in a really holistic way. So we feel like that's a great path forward. We're excited about the business and feel like we've made some important changes that put us on a really good track going forward."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Robert. And A.J., thanks for asking the question. Insight, I think, is really on the cusp of a very exciting few years. Thanks to the significant work that was done last year, the increase in rate of opportunity that we see to bring in new signifi",79,"Thanks, Robert. And A.J., thanks for asking the question. Insight, I think, is really on the cusp of a very exciting few years. Thanks to the significant work that was done last year, the increase in rate of opportunity that we see to bring in new significant contracts. And then obviously, the pending change acquisition creates some really exciting momentum for this business. So this is an area I fully anticipate us looking to for material growth going forward."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our final question comes from the line of George Hill from Deutsche.",12,"Our final question comes from the line of George Hill from Deutsche."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Andrew, I'd just be interested to hear your commentary about the outlook for commercial bundles. I know we're all talking a lot about risk sharing, what I call, resyndication in the Medicare Advantage space and the bundling of risk in the Medicare Advanta",71,"Andrew, I'd just be interested to hear your commentary about the outlook for commercial bundles. I know we're all talking a lot about risk sharing, what I call, resyndication in the Medicare Advantage space and the bundling of risk in the Medicare Advantage space. But I'd be interested in the company's outlook for the commercial business? And if you're seeing increased uptake of kind of more risk-sharing tools in that market?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, great. So listen, I think in the commercial -- and I'm going to ask Golden to come in here real quick. But I think in the commercial space, just as  possible for us to start to design innovative products, and we've already begun to do that betwee",67,"Yes. No, great. So listen, I think in the commercial -- and I'm going to ask Golden to come in here real quick. But I think in the commercial space, just as  possible for us to start to design innovative products, and we've already begun to do that between Optum and UHC. Let me ask Bill to dive into that in a little bit more detail. Bill?"
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you, and thanks for the question. Yes, I would say we're in the early stages of provider aligned products, where we're taking advantage of that risk-based.As an example, in our Southern California OptumCare partnership, Harmony really continu",124,"Yes. Thank you, and thanks for the question. Yes, I would say we're in the early stages of provider aligned products, where we're taking advantage of that risk-based.
As an example, in our Southern California OptumCare partnership, Harmony really continues to be a cornerstone over those offerings. We're learning a lot with that product, not only regarding how it's priced and -- but more importantly, the -- actually experience for the members. And so we're using that as a cornerstone and as a program to continue to roll out throughout the country with other areas. So we're very optimistic about the opportunities that, that will show in the future, but still in the very early stages of our global cap with the commercial business."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Bill. And George, thanks so much for the question. That's clearly an area we expect to see more in the future. But as Bill said, it's early days. And we'll see how that progresses.With that, everybody, thank you so much for spending the time wit",153,"Thanks, Bill. And George, thanks so much for the question. That's clearly an area we expect to see more in the future. But as Bill said, it's early days. And we'll see how that progresses.
With that, everybody, thank you so much for spending the time with us this morning. As we move through what we all hope are the latter stages of this pandemic, you can expect us to continue to focus on the areas where UnitedHealth Group can do the most to improve health care, including adding even greater value at the intersection of Optum and UnitedHealthcare, applying our technology and expertise to create a better function and more responsive and cost-efficient health care system and making health care work better for consumers.
We look forward to connecting with you again on these priorities in the weeks and months ahead. And once again, thank you for your attention this morning. Bye-bye."
104673,708988184,2251751,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day.",22,"Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the UnitedHealth Group First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded. And now I'd like to introduce your host for tod",47,"Ladies and gentlemen, thank you for standing by, and welcome to the UnitedHealth Group First Quarter 2021 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded. 
And now I'd like to introduce your host for today's program, Andrew Witty. Please go ahead, sir."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us to discuss our first quarter results and positive outlook as we continue to execute on UnitedHealth Group's long-standing mission and strategies.The exceptional dedication of the people of Optum and UnitedHealt",950,"Good morning, and thank you for joining us to discuss our first quarter results and positive outlook as we continue to execute on UnitedHealth Group's long-standing mission and strategies.
The exceptional dedication of the people of Optum and UnitedHealthcare again defined this period. They've adapted swiftly and creatively to demanding and rapidly changing circumstances, implemented new ideas and importantly, remained focused on serving people exceptionally well. As a result, adjusted earnings per share were $5.31, reflecting strong execution at both UnitedHealthcare and Optum.
In light of our strong start to the year, balanced with continued respect for the potential pandemic-related effects we have previously described, we are increasing our full year adjusted earnings outlook to a range of $18.10 to $18.60 per share.
I'll touch briefly on 2 highlights, among many, in the quarter that illustrate the increased momentum our colleagues at UnitedHealth Group are driving. People served with our employer and individual offerings grew nearly 100,000 in the quarter, even within the context of a challenged U.S. employment environment, and this underscores the growing consumer orientation, affordability and breadth of our products.
OptumInsight revenues increased 14% and operating income increased 45% compared to the year-ago period as more normal activity levels among health care system customers returned, leading to expansion in how we help them advance clinical and operational excellence. Significant innovation and automation in the OptumInsight businesses drove strong productivity gains.
We have the right capabilities, assets and strategies in place, and we remain restless to innovate, evolve and further integrate our offerings to serve more people more effectively, both directly and with our many external partners throughout the health care environment. 
To achieve this, we've been sharpening our focus in 3 key areas: First, delivering even greater value to those we serve throughout the health care system by better harnessing the collaborative capabilities of Optum and UnitedHealthcare. We believe we can develop new products and services which support people more effectively by bringing to bear greater application and adoption of the combined offerings of these 2 distinct and complementary organizations. OptumCare's work supporting Medicare Advantage patients illustrates this well, and I'll speak more to this shortly. 
The second area of focus, increasing the application of our technology and related resources to improve care for people and the operational health systems. There are benefits for everyone in helping to make the health care system work more like an actual system, improving the natural flow accessibility and use of information is essential to that goal, all within a secure and protected framework. We can help care providers and payers better serve patients by more effectively simplifying key administrative processes and by providing timely access to relevant information. 
The third focus is making health care work better for consumers. We're ambitious to meet the rising expectations of health care consumers, and we will continue to improve our offerings, including in such critical zones as greatly simplified intuitive and satisfying consumer digital experiences and advanced health care banking and payment services that enable people to find, price and pay for care digitally. You'll hear more from us about these approaches in the months ahead. 
But today, I'd like to focus on the first, unlocking greater value for customers at the intersection of Optum and UnitedHealthcare, including through our ability to develop new useful service offerings. 
One of the most effective ways of doing so is through stronger alignment of the high-quality clinical services of OptumCare to address the needs of patients we serve for our nearly 90 health plan customers. A key foundation is increasing the clinical outcome accountability of our OptumCare practices. Of the 4 million patients who OptumCare serves in some form of accountable arrangement today, 2 million are being served under fully capitated arrangement, and this demonstrates a strong growth and progress. But OptumCare serves 20 million patients in total, which is one reason why we view the potential of OptumCare is only beginning to be harnessed. 
These accountable arrangements drive measurably better patient outcomes and experiences, all at lower costs. For example, seniors served by OptumCare physicians under such arrangements spend, on average, 1/3 fewer days in the hospital and have 40% fewer days in skilled nursing facilities than seniors in traditional Medicare. We expect the growth in the number of OptumCare patients served under accountable arrangements to accelerate. 
A further example of using our combined expertise to advance more beneficial service offerings is the recent opening of a first-of-its-kind Optum integrated care facility in Riverside County, California. While we have long offered and continue to actively develop our senior-focused clinics, this new clinic and community center offers a comprehensive range of primary care-led services, including a pharmacy, all under a single roof. And importantly, it is especially orientated around supporting Medicaid, Medicare, commercial and individual members of all ages. This comprehensive health center provides improved care access with modern on-site services, including annual wellness visits, chronic disease management support, coordinated care with trusted specialists, and laboratory, imaging and pharmacy services. The adjacent community center includes a full-service gym and meeting rooms for health education. We see Optum and our payer partners as uniquely positioned to be able to offer these types of impactful venues and look forward to learning from the community and expanding these services. 
To sum up, We continue to organize and apply the unique capabilities of this organization in ways that enable to execute on the goals we established for 2021 and beyond, and to continue to deliver on our 13% to 16% long-term earnings growth objective. 
Now I'll turn it over to President and Chief Operating Officer, Dirk McMahon, to give more color on initiatives to drive greater performance across the organization."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Andrew. As Andrew noted, we continue to drive growth by supporting more affordable, simpler quality care across Optum and UnitedHealthcare. These are themes you've heard us cover before, and we continue to see the benefits of this approach for peo",543,"Thanks, Andrew. As Andrew noted, we continue to drive growth by supporting more affordable, simpler quality care across Optum and UnitedHealthcare. These are themes you've heard us cover before, and we continue to see the benefits of this approach for people -- for the people we serve.  
Let me turn those themes into some specific examples across Optum and UnitedHealthcare that illustrate how our approach is working. First is how we've been simplifying the consumer experience over the past year. We've driven greater engagement with seniors by increasing adoption of digital tools. Monthly active users of our digital offering have risen double digits, with similar increases in online transactions. This has led to greater adoption of our digital therapeutic offerings. 
In the first quarter, high-risk chronic disease patients in our home monitoring program logged over 1.5 million biometric measurements, such as glucose level, enabling 99% medication compliance and an NPS of 84. We've also made it easier for people to get and maintain behavioral health support by expanding traditional and virtual provider network and combine them with modern digital therapeutic services. 
Behavioral health needs have increased significantly during the pandemic, and as a result, we have seen substantial adoption in our digital behavioral platform that provide on-demand emotional support, logging a rise of over 100% in utilization. Always accompanying our work to simplify health care is Optum and UnitedHealthcare's sharp focus on delivering high-quality care. 
We've talked to you before about the advances we are making to integrate patient-specific health data and plant information directly into the physician's workflow. Clinicians can see gaps in care and act to close them during the patient's visit, in addition to other steps that facilitate more efficient care and better outcome. 
We now support over 8 million of these in-site-enabled digital interactions each month with rapidly expanding physician adoption. Delivering high-quality care has been central in our response to the COVID pandemic. Our most recent effort to help members access vaccines is a prime example. We launched a vaccine locator tool, helping people find and sign up for a vaccination. And we've made millions of outbound contacts to engage members and help them get the information they need.  
Lastly, making care more affordable remains central for the people we serve and the health system overall and is essential for increasing access. For instance, through our medication sourcing program, high-cost providers now source drugs at a network specialty pharmacy, including OptumRx or charge market rates only for the drug. Early work on this has generated substantial savings for our customers. 
Our work to make health care simpler, higher quality and more affordable drive strong growth for our business. At the end of January, for example, UnitedHealthcare was awarded an Oklahoma SoonerCare Medicaid contract to serve nearly 200,000 people. Oklahoma previously operated under a fee-for-service program. The award affirms the value we bring to state partners and consumers and reflects our commitment to expand access to care for all Americans. We look forward to working with our new partners in Oklahoma and sharing with you on future calls new examples as our work on simplicity, quality and affordability continues to create improvements and new growth opportunities. 
With that, now I'll turn it over to Chief Financial Officer, John Rex."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dirk. Before I review the performance of our businesses, as in recent quarters, I'd like to provide an update on the care patterns we're seeing as the pandemic continues to evolve. Over the course of the first quarter, total care activity, in",636,"Thank you, Dirk. Before I review the performance of our businesses, as in recent quarters, I'd like to provide an update on the care patterns we're seeing as the pandemic continues to evolve. 
Over the course of the first quarter, total care activity, including COVID-19-related care, ran marginally below seasonal baseline. Pacing of elective care activity through the quarter generally trapped and in opposite directions with the rise in decline of COVID incidence rates, which were much higher in the early part of the quarter than in the latter part. 
To put this in perspective, February and March showed COVID-related care at about half the level experienced in January. Since the quarter's end, we have again begun to see a rise in COVID-related care, while at this time, not approaching the January level. 
Outpatient care activity was moderately below seasonal baseline for the full quarter, running in counterpoint to the COVID incidence patterns over the 3 months and reflecting a well-below average influenza and respiratory illness season. And total inpatient activity was modestly above seasonal baseline, with over 55,000 COVID-19-related admissions during the quarter compared to 65,000 in the fourth quarter 2020. 
Moving to business unit performance. OptumHealth's first quarter revenue and earnings increased 35% year-over-year. Revenue per consumer served grew 31% over the year ago quarter. The growth in this metric continues to reflect the expanding number of people served under value-based care arrangements and the increasing acuity of the care services we offer. 
OptumInsight's revenue grew 14% in the quarter and earnings 45%, due to growth in our services and technology offerings and improved productivity. The revenue backlog at $20.8 billion grew $1.6 billion over the first quarter 2020, as more normalized business activity started to return among our provider and payer customers. 
OptumRx revenue and earnings were relatively consistent year-over-year and in line with our expectations. Adjusted scripts declined modestly from the year-ago quarter, a period during which we provided advanced medications to the people we serve as the pandemic began. Pharmacy care and specialty services continue to grow strongly, in particular, home infusion and our community behavioral health pharmacies. 
Turning to UnitedHealthcare. First quarter operating results reflected strong execution and continued membership growth. In addition to the growth in commercial and Medicare Advantage offerings noted earlier, people served in managed Medicaid programs grew by nearly 1.1 million over the year-ago quarter. Of the 900,000 new seniors we expect to serve within Medicare Advantage this year, about 775,000 are in individual and group and 125,000 in dual special needs offering. 
Of importance to the senior customers we serve, our house calls clinicians have been considerably more able compared to this time last year to provide their vital services. We conducted nearly 600,000 home visits in the quarter as more seniors and caregivers were vaccinated and comfortable having in-person visit. That's up by 1/3 compared to first quarter 2020 and about 4x higher than what was achieved in the second quarter 2020. 
Our liquidity and capital positions remain strong, with first quarter cash flows from operations at $6 billion or 1.2x net income. As we look forward toward the combination with Change Healthcare, we intend to maintain our long-standing capital policy. These include our approach to returning capital to shareholders via share repurchase and an advancing dividend, with ample capacity to continue building upon our strategic growth platform. 
We now expect adjusted earnings per share in the range of $18.10 to $18.60, an increase of $0.35 from the outlook we offered at our investor conference. This outlook continues to include an estimated $1.80 per share of unfavorable COVID-19-related effects. The substantial majority of which we still expect to occur in the latter part of the year, largely as carriers more freely able to be delivered to people. 
Now I'll turn it back to Andrew."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John. The story you heard about this quarter is the story you've heard for many years, and will continue to do so about UnitedHealth Group, a focus on better serving people and organizations in health care, using the combined capabilities of Optum",74,"Thanks, John. The story you heard about this quarter is the story you've heard for many years, and will continue to do so about UnitedHealth Group, a focus on better serving people and organizations in health care, using the combined capabilities of Optum and UnitedHealthcare to improve care, cost and experience and an unwavering attention to executional excellence in all that we do.  
Operator, let's open it up for questions. One per caller, please."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our first question comes from the line of Matt Borsch from BMO Capital Markets.",14,"Our first question comes from the line of Matt Borsch from BMO Capital Markets."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Congratulations on the quarter. I have a question for you on the prior year reserve development, which is obviously a very large number. Can you just talk to where that emanated from in terms of components, whether by program or by quarter in 2020? And ho",55,"Congratulations on the quarter. I have a question for you on the prior year reserve development, which is obviously a very large number. Can you just talk to where that emanated from in terms of components, whether by program or by quarter in 2020? And how that may be influencing your posture on forward reserving?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. I'm glad you asked that. I know a lot of people probably have that in mind. John, you should answer that, I think.",24,"Great. I'm glad you asked that. I know a lot of people probably have that in mind. John, you should answer that, I think."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. Matt, it's John Rex. Let me give a little color on that. So yes, the prior year development, $1 billion favorable versus $850 million in the 4Q. As I'm sure you expect, that emanates heavily from the second half of 2020 and a lot from the fourth qua",147,"Sure. Matt, it's John Rex. Let me give a little color on that. So yes, the prior year development, $1 billion favorable versus $850 million in the 4Q. As I'm sure you expect, that emanates heavily from the second half of 2020 and a lot from the fourth quarter. It was favorable really across the businesses. The elements there that would be driving that would be largely along care deferral activity that would have occurred in the quarter. 
I think when you think about kind of impact to the company and P&L impact, certainly, there are significant mitigating factors, as I know you're well aware, MLR rebates, risk order arrangements, reserve reestablishment that occurs. When I look at it and take it all together with those mitigating factors, P&L impact would have been in a similar zone to last year's first quarter with those elements coming in."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Kevin Fischbeck from Bank of America. I'm sorry -- our next question comes from the line of Robert Jones from Goldman Sachs.",30,"Our next question comes from the line of Kevin Fischbeck from Bank of America. 
I'm sorry -- our next question comes from the line of Robert Jones from Goldman Sachs."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Congrats to Andrew and Brian on the new roles. I actually just wanted to ask one on OptumHealth. I think you said 35% of the growth there was driven by global cap. You also shared 2 million risk patients in OptumCare are now in global cap. Just curious",109,"Congrats to Andrew and Brian on the new roles. I actually just wanted to ask one on OptumHealth. I think you said 35% of the growth there was driven by global cap. You also shared 2 million risk patients in OptumCare are now in global cap. 
Just curious if you could give a little bit more on kind of where you think this number could get to, the number of patients in global cap arrangements within OptumCare this year and then maybe over time? And then it'd be helpful to understand a little bit just how many of the 20 million patients you highlighted are actually in MA today?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great. Listen, Robert, thanks so much for the question. Before I ask Wyatt Decker to add, you put your finger on a really key part of the growth strategy going forward. Clearly, you're going to see, over this year and next year, an accelerating move towar",161,"Great. Listen, Robert, thanks so much for the question. Before I ask Wyatt Decker to add, you put your finger on a really key part of the growth strategy going forward. Clearly, you're going to see, over this year and next year, an accelerating move towards more capitated patients within the OptumCare universe. As I mentioned in my prepared comments, there's tremendous opportunity as we look at those 20 million and growing number of patients who we look after migrating towards what we believe to be a better mechanism to help them manage both their care outcome and also the cost implications. So you'll see that continue to accelerate.  
As we expand our OptumCare networks, we are rapidly transitioning our capabilities clinic by clinic to be able to do this. And it's one of the areas I think we feel extremely optimistic about future momentum. 
But to give you a little bit more detail, Dr. Decker, who leads Optum Health, please."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you, Robert, for the question. And Andrew, I think you set it up nicely. OptumCare has become the nation's preeminent ambulatory delivery of value-based care. It is physician-led. And increasingly, you'll see us bringing comprehensive service",113,"Yes. Thank you, Robert, for the question. And Andrew, I think you set it up nicely. 
OptumCare has become the nation's preeminent ambulatory delivery of value-based care. It is physician-led. And increasingly, you'll see us bringing comprehensive services to bear to meet the needs of all of our patients, but a particular focus on value-based and a particular focus on the fully capitated individual. 
We will continue to grow over 250,000 lives this year, and you can expect that to accelerate in the years to come as we continue to attract individuals through organic growth as well as through our partnership with UHC, and as Andrew mentioned, nearly 90 other providers. Thank you."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] Our next question comes from the line of Lisa Gill from JPMorgan.",14,"[Operator Instructions] Our next question comes from the line of Lisa Gill from JPMorgan."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I'm just curious how we think about digital and Telehealth impacting medical costs? What you've seen thus far? And what's the future role post the pandemic when we think about helping to control costs from a Telehealth perspective?",39,"I'm just curious how we think about digital and Telehealth impacting medical costs? What you've seen thus far? And what's the future role post the pandemic when we think about helping to control costs from a Telehealth perspective?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Lisa, that's a great question. I'm going to ask, in a second, Dr. Decker. And also, I think I'll ask Dirk McMahon to make a couple of comments, but let me just preface that.So we've obviously seen Telehealth develop as a set of capabilities over the las",211,"Lisa, that's a great question. I'm going to ask, in a second, Dr. Decker. And also, I think I'll ask Dirk McMahon to make a couple of comments, but let me just preface that.
So we've obviously seen Telehealth develop as a set of capabilities over the last several years. We've been a very extensive user of those capabilities. But I think one of the things we've seen from 2020 and the pandemic is really a kind of shift in terms of people's thinking and willingness to utilize Telehealth. We also think that the way in which they're being utilized are -- is evolving.
And so what you're going to see from us, and it's one of the examples I might cite in terms of the opportunity for new product development between Optum and United Healthcare, is you're going to see UnitedHealth Group lean forward into much more integrated Telehealth capabilities. We've got a number of new initiatives in deployment as we speak, operating between the 2 companies.
And with that introduction, let me pass it over to Wyatt to maybe give you a little bit more detail on that. And then I think it would be good to hear from Dirk the perspective he has on this. So Wyatt first."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Well, thanks for the question. And as you've heard us mention before, we were very proud of how quickly we stood up over 17,000 providers during the pandemic on Telehealth solutions, but that really just is the beginning. And of course, across the co",260,"Yes. Well, thanks for the question. And as you've heard us mention before, we were very proud of how quickly we stood up over 17,000 providers during the pandemic on Telehealth solutions, but that really just is the beginning. And of course, across the country, we've seen a massive shift in consumer adoption and willingness to engage in virtual health solutions as well as with our providers more broadly.
So our philosophy is that not all Telehealth is created equally. And as we continue to develop our new products, you'll see us integrating physical care, virtual care, home care and behavioral care in a way that is innovative and differentiated. And in fact, we've already launched a product we call Optum virtual care, that is live in all 50 states and is doing just that. And what will really differentiate our product to those that we serve is the ability to offer virtual solutions, but then if necessary, immediately connect them to a live bricks-and-mortar solution for more complex or thorough care as well as identifying and triaging both physical and behavioral health care needs and offering comprehensive behavioral health care.
We're seeing continued sustainability of virtual care solutions, which, as you may know, peaked during the height of the pandemic, have declined some, but are still probably 10x where they were pre-pandemic and certain conditions or behavior -- or areas like behavioral health care are now seeing about 50% utilization through virtual services. So we're very excited about where we can take this. I'll turn it over to Dirk."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Wyatt. I think Andrew and Wyatt pretty well drained it. But let me just add a couple of things. First, we know that people want to meet with their doctor, and we've been focused on facilitating that with OptumCare. And with people -- basicall",136,"Yes. Thanks, Wyatt. I think Andrew and Wyatt pretty well drained it. But let me just add a couple of things. First, we know that people want to meet with their doctor, and we've been focused on facilitating that with OptumCare. And with people -- basically, as you look at how things evolve, the brick-and-mortar physicians have the vast majority of the televisits today.
I would also say that I do see a tremendous opportunity for new models and new product strategies with OptumCare and others, where we lean towards those providers who have, again, the best outcomes and provide the most efficient care. So like any other doctors in our network, we, at UnitedHealthcare, are going to be looking for that strongly. And we think OptumCare can provide that very well. That's it. Thanks, Lisa."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Dirk. Thanks, Wyatt. I got to say, Lisa, I've been keeping an eye on the patient verbatims as we've been deploying the Optum virtual platform that Wyatt referred to. And really, the feedback is really extraordinary in terms of how patients are see",140,"Thanks, Dirk. Thanks, Wyatt. I got to say, Lisa, I've been keeping an eye on the patient verbatims as we've been deploying the Optum virtual platform that Wyatt referred to. And really, the feedback is really extraordinary in terms of how patients are seeing this, the benefit they feel from it and the ease with which they're able to engage with it. 
So this is exactly the kind of thing you're going to see going forward. I think Optum is in an extremely advantaged position, being able to bring together this notion of integrated Telehealth with physical and behavioral health, and that's going to be the path we go. And I think we're on the verge of kind of next generation of what this looks like versus what we've seen previously. So Lisa, thanks so much for raising the question."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Kevin Fischbeck from Bank of America.",14,"Our next question comes from the line of Kevin Fischbeck from Bank of America."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I guess one clarification. First, I guess, does your guidance assume anything for sequestration delay? But then I guess the real question is, the $1.80 that you guys are still including in your guidance, it sounds like things are starting off the year rel",102,"I guess one clarification. First, I guess, does your guidance assume anything for sequestration delay? But then I guess the real question is, the $1.80 that you guys are still including in your guidance, it sounds like things are starting off the year relatively well with overall utilization coming in better and membership growing and some of the OptumInsight things kind of normalizing. 
I guess how do you think about that $1.80? How is that progressing? And what kind of signpost do you need to kind of see before you feel like that number might come in and -- lower than that?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, listen, Kevin, thanks for the question. I'll let -- I'm going to ask John in a second to refer to the $1.80 -- the math, I guess, behind that and the underlying trends.As far as sequestration is concerned, obviously, we're keeping a close eye o",91,"Yes. No, listen, Kevin, thanks for the question. I'll let -- I'm going to ask John in a second to refer to the $1.80 -- the math, I guess, behind that and the underlying trends.
As far as sequestration is concerned, obviously, we're keeping a close eye on the guidance from the administration. We've clearly seen the extensions, but the guidance raise we've given today is not caveated by that in any way. So we have our assumptions on that, but the guidance stands notwithstanding any outcome there. John, on $1.80."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Kevin, it's John Rex. Let me talk a little bit about that and how we think about that progressing throughout the course of the year.So just a few impacts here. I think the first important impact, I suggested that if a significant majority, I'd call",271,"Yes, Kevin, it's John Rex. Let me talk a little bit about that and how we think about that progressing throughout the course of the year.
So just a few impacts here. I think the first important impact, I suggested that if a significant majority, I'd call it, 70% of our projected COVID impact is -- really occurs in the second half of the year. And just to be frank, we just don't know enough now about what is going to happen later in the year, kind of have a very meaningfully different projection of what our full year results will be in terms of will they be better in terms of better than the original projections, except for what we've experienced thus far, which we would expect -- expect to see some stronger underlying business performance, growth across a number of businesses. We've executed well on productivity measures, and maybe just very modestly less impact in the 1Q, unfavorable impact than we would have anticipated. 
But the important component there being that it is really much more a back half-weighted view in terms of COVID-19 impact. That's really premised upon our expectation that as we get later in the year, people are going to be more able to access previously deferred care and higher acuity levels as a result of missed or postponed treatments. And that's what we're -- that's what we built -- that's what we build into that view in terms of an expectation. But that's really an unusual time still, no question. And we therefore, increased our full year estimate, but -- by what we know today."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John, and Kevin, thanks so much for asking the question. I mean, I think John really summarized it super well. We've raised our expectations for the year based on our experience so far this year with -- and we've retained that $1.80 assumption, if",98,"Thanks, John, and Kevin, thanks so much for asking the question. I mean, I think John really summarized it super well. We've raised our expectations for the year based on our experience so far this year with -- and we've retained that $1.80 assumption, if you will, in terms of what could happen. But we just -- we obviously don't have the detailed visibility of that yet. But we feel that's the right balanced stance to take in terms of the rest of this year. So I hope that's clear. And thanks so much for the question, Kevin."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Josh Raskin from Nephron Research.",13,"Our next question comes from the line of Josh Raskin from Nephron Research."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Here with Eric Percher as well. So our question this quarter, again on OptumHealth. And I appreciate the comments in the prepared remarks and the Q&A. But I want to speak to the ultimate strategy around the accumulation of employed physicians. And if this",123,"Here with Eric Percher as well. So our question this quarter, again on OptumHealth. And I appreciate the comments in the prepared remarks and the Q&A. But I want to speak to the ultimate strategy around the accumulation of employed physicians. And if this is all about a move to global capitation? And we're really more interested in the how, right? Is this more center-based like what you're talking about in Riverside, California? Is this more of a technology overlay that enables the physicians to do this? And then I would just ask again, how many of those 20 million, I understand 250,000 will move this year. But how many of those 20 million ultimately end up in global cap, in your mind?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Josh, thanks for the question. And before I pass it to Wyatt, again to respond to the specifics, let me just give you a sense of how we see this playing out.And I think the answer to your question is really both. So we absolutely see tremendous opportun",282,"Josh, thanks for the question. And before I pass it to Wyatt, again to respond to the specifics, let me just give you a sense of how we see this playing out.
And I think the answer to your question is really both. So we absolutely see tremendous opportunity to continue to develop a variety of different clinic types. And if you look at the -- I cited one particular example, but we've been opening a wide number of different type of clinics depending on the environment that -- or the locality that we're operating in. And you should continue to expect to see that degree of customization according to the need of the geography. It's not a one-size-fits-all model by any means. So you'll continue to see that. 
But at the same time, we strongly believe there is opportunity over the next few years. And this is why I focused in my kind of second area of going deeper around technology. How we can then help those clinics operate more efficiently? How we can ensure they are better connected, both locally with other clinics that we may own or to a higher level of information support? So we see this has been a highly activated network of clinics and centers.
The center -- the network itself will have a high degree of diversity in it because it needs to be responsive to the needs of the locality, the communities that we're operating in. And of course, as sensitive to the previous comments, it will have a very significant Telehealth capability deployed alongside it.
Wyatt, maybe you could talk a little bit to how you see the progression within the $20 million?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you, Andrew. Thanks, Josh. Great question. We will continue to evolve. And one of the pieces that will differentiate us as a comprehensive care provider is just that, being comprehensive. And so you'll see us continuing to weave together produc",326,"Yes. Thank you, Andrew. Thanks, Josh. Great question. We will continue to evolve. And one of the pieces that will differentiate us as a comprehensive care provider is just that, being comprehensive. And so you'll see us continuing to weave together products and services that meet people's needs in new and innovative ways, and Telehealth and digital solutions are a big piece, but not the only piece. 
The other part that I'd call out is we're increasingly leveraging technology to bring advanced decision support to our physicians and providers. And you may have heard previously about optimal care. This is a value-based care delivery set of decision tools that are yielding real results, giving people the best, highest quality care that eliminates what we tend to call low-value care, and is a differentiator. So we'll continue to deploy those technologies.
As you know, we are on track to grow by over 10,000 physicians. We're now at 56,000 doctors, both affiliated, contracted and employed. And we'll leverage all of those models as we go forward. And we continue to evolve and employ doctors who are really actually quite attracted to our model of value-based primary care. We eliminate much of the clerical burden in our physicians and advanced practitioners' practice and let them focus on the work they love. So this is really gaining traction among our physician workforce.
And then to your point around how much of the 20 million lives that we serve today will ultimately be capitated. We anticipate that not only will a significant portion, you heard the number 2 million today and 0.25 million, as we mentioned, growing. So as we continue to grow, we also expect that we'll always offer a host of modalities, including fee-for-service. And that actually is a feeder system as we think about value-based care being kind of the core of what we offer, and fully capitated the core of the core, if you will. Thank you."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Wyatt. And maybe I'll just ask Dan Schumacher to briefly add to the comments and talk a little bit about Optum at home, which is a further dimension of this. So go ahead.",34,"Thanks, Wyatt. And maybe I'll just ask Dan Schumacher to briefly add to the comments and talk a little bit about Optum at home, which is a further dimension of this. So go ahead."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Andrew, and great question, Josh. To the question around sort of center-based, tech-based, data-enabled and different versions of that, that Wyatt was talking about, Optum at home is a great example of a collaboration between UnitedHealthcare and",210,"Thanks, Andrew, and great question, Josh. To the question around sort of center-based, tech-based, data-enabled and different versions of that, that Wyatt was talking about, Optum at home is a great example of a collaboration between UnitedHealthcare and Optum. It's in relatively early stages. But we focused on Medicare Advantage members that are in dual special need plans initially, and that's a full risk offering. And we're doing it in markets where we don't currently have local OptumCare practices. 
So what we're doing in the program is really both providing care, but also arranging and coordinating care, so trying to address medical, behavioral and social needs. And the results initially have been great. We've improved access for people with more than 80% having an in-home visit, and more than half of them getting connected back into office-based care, social services referrals and so forth as well as great health quality and outcomes.
So today, we've got a little under 100,000 lives across 6 markets. We're looking to expand that across Medicare Advantage Dual SNP but also into the individual MA. We're doing it with UnitedHealthcare and ultimately, look to do that with other health plans. So another growth vector for us as we look at building out our value-based orientation."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So Josh, I mean, I know that was a little bit of a long answer from the 3 of us, but you asked a really important question. And this is really one of the core elements of the future of the company. And it's why you've heard us talk so much about OptumHeal",170,"So Josh, I mean, I know that was a little bit of a long answer from the 3 of us, but you asked a really important question. And this is really one of the core elements of the future of the company. And it's why you've heard us talk so much about OptumHealth, OptumCare, and you can see the growth potential. We're at that 2 million life level now. We clearly see the capitation strategy as a highly effective strategy to deliver both quality and cost management for patients. That movement is really significant, and it's really moving strongly.
And with the development of the diverse sets of clinics and skills, the development of the technology support that you've just heard referred to, we believe we're in a very strong position to be able to be the leader in ability to manage those patients in the best possible way and ensure that they get the kind of health care they deserve. So Josh, thanks so much for asking the question."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] Our next question comes from the line of Ricky Goldwasser from Morgan Stanley.",15,"[Operator Instructions] Our next question comes from the line of Ricky Goldwasser from Morgan Stanley."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","If we think about your utilization, I mean, you gave us some data on how utilization is tracking. But can you give us a little bit more details on how it's tracking across the different patient population? And also, we talked about acuity levels, your exp",126,"If we think about your utilization, I mean, you gave us some data on how utilization is tracking. But can you give us a little bit more details on how it's tracking across the different patient population? And also, we talked about acuity levels, your expectations for acuity level to step up second half of the year.
But from the experience to date, as you're starting to see individuals that are coming back, what type of acuity you're seeing for those that haven't received care for the last year? And I think the final one there. If you can just remind us, as you think about that guidance for the full year, are you assuming digitalization by year-end, it's going to be above the 2019 baseline?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So great question, Ricky. I'm going to ask Brian Thompson, who has recently been appointed as the Chief Executive Officer of UnitedHealthcare, to respond to that. So BT?",28,"So great question, Ricky. I'm going to ask Brian Thompson, who has recently been appointed as the Chief Executive Officer of UnitedHealthcare, to respond to that. So BT?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question there. When I think about baseline, what I can say right now is what we're seeing is largely tracking to our expectations. And as we had signaled, where we see abatement in services, it's largely offset by the increase in COVI",177,"Yes. Thanks for the question there. When I think about baseline, what I can say right now is what we're seeing is largely tracking to our expectations. And as we had signaled, where we see abatement in services, it's largely offset by the increase in COVID-related costs. And that's tracked as we had expected.
When you back out the impact of some suppressed utilization, the underlying factors associated with medical cost trend largely looked like they did. We aren't seeing significant upticks in services in specific areas out of the norm. So I would say it looks a lot like utilization prior to the COVID implications.
And when I think by line of business, I would say, generally tracking a little below baseline in both our government programs, closer to baseline inside our commercial business, but largely in track with what we had expected. And where it's a little out of line, again, where perhaps infection rates were higher, and we saw that naturally offset with greater utilization. So first quarter, I would say, largely as expected."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","John, do you want to add?",6,"John, do you want to add?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Ricky, it's John Rex here. So as Brian noted, one of the aspects we look for is this rising acuity from patients that have deferred or care or missed treatments. And at this point, we don't have evidence of that occurring. And it could be just that i",232,"Yes, Ricky, it's John Rex here. So as Brian noted, one of the aspects we look for is this rising acuity from patients that have deferred or care or missed treatments. And at this point, we don't have evidence of that occurring. And it could be just that it's still too early on to have enough evidence to see it, but we have not yet seen that rising acuity in the populations that we serve.
Your point in terms of how we think about as we get later into the year and why that moves like it does? And you heard my commentary that significant majority of the $1.80 we have layered into the second half of the year, that is largely because of the assumptions around those elements, that we see -- that people are increasingly able to get the care they need. The amount of care deferral declined meaningfully as you get into the latter part of the year. They're accessing the system. And we do get into these elements where we see rising acuity coming in.
So those are the elements that are premised in terms of that expectation at this point. So -- but really -- and the other element that Brian touched on also just in terms of your population, you have commercial, a little more access to the system versus the public program members. Thank you."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John, and thanks, Ricky, for the question.",8,"Thanks, John, and thanks, Ricky, for the question."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Dave Windley from Jefferies.",12,"Our next question comes from the line of Dave Windley from Jefferies."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to ask a question about integration and longitudinal care and data versus fragmentation. And the question is this, so Andrew, over many years, Optum has really invested a lot of money in kind of aggregating data about the patient status, care and s",111,"I want to ask a question about integration and longitudinal care and data versus fragmentation. And the question is this, so Andrew, over many years, Optum has really invested a lot of money in kind of aggregating data about the patient status, care and services delivered so that touch points with United or Optum could have all that information at hand.
I guess what I'm interested in around kind of your build-out, but specifically the comments you made about telemedicine is, how important is it for telemedicine to enhance and augment the longitudinal and integrated nature of care versus fragmenting that by having it kind of siloed as a separate benefit?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Right. That's a great question. So I think our bias is increasingly, and I think rightly, toward driving a more and more seamless, simple, easy-to-access care environment, both for the patient and the provider, actually.So what that speaks to is trying",334,"Right. That's a great question. So I think our bias is increasingly, and I think rightly, toward driving a more and more seamless, simple, easy-to-access care environment, both for the patient and the provider, actually.
So what that speaks to is trying to avoid the fragmentation of the interface and definitely trying to avoid the fragmentation of the information that then sits behind it. So we want to really try and create much more seamless opportunity. And so for example, I'll give you a real example in Optum virtual, which is -- you've heard a little bit about on the call already today.
So of course, patients are looking for a way to engage with a physician. They actually want to talk to their physicians. So one of the things that we're doing is building that platform. But then there might be situations where the physician wants to bring in a specialist into that conversation.
Now in a multidisciplinary clinic, they might be in a position, in normal times, to go down the hall, get somebody to come down and visit. Now in Optum virtual, they're able to do that kind of thing. So that's an example of trying to bring that integration even within the virtual space. So it kind of replicates a little bit more what you might expect in a physical environment.
And so we definitely see the need to try and drive toward that, and we definitely want to try and create the fluidity of the information to ensure that physicians have what they need when they're in front of the patient, when they're talking to the patient, they can make the best possible choices. So we want them to be as highly educated as possible in that context. So we're leaning much -- we're leaning very much toward the idea of integrated, seamless, and that's true whether you're in the physical or the virtual space, and we want the 2 to sit together. Thanks for the question. Thank you."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of Justin Lake from Wolfe Research.",13,"Our next question comes from the line of Justin Lake from Wolfe Research."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","A lot of good topics already covered here. So I just have a few quick follow-ups. First, the detail on OptumCare was very helpful. I was hoping I could ask for one more piece of information here, which is the -- so it sounds like you're going to have 18 m",167,"A lot of good topics already covered here. So I just have a few quick follow-ups. First, the detail on OptumCare was very helpful. I was hoping I could ask for one more piece of information here, which is the -- so it sounds like you're going to have 18 million people out of 20 million that are still not capitated. Wondering how many of these are sitting in Medicare Advantage plans that aren't capitated, given this is where most of the capitation happened? Just trying to think about the potential kind of pent-up growth there.
And then on Medicare Advantage, it sounded like your health assessments are going better in 2021. Should we expect that you should get a significant amount of that risk score headwind that everybody saw for 2021 to reverse next year and get those revenues back? And then lastly, could you give us an update on earnings seasonality for the year versus the 50-50 split you talked about on the last update?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","I'm going to ask, in a second, John, to talk to the earnings seasonality and for Wyatt to address the degree to -- the population we have within the MA plan.Let me just touch on the health assessment. You heard in the prepared comments the very strong p",187,"I'm going to ask, in a second, John, to talk to the earnings seasonality and for Wyatt to address the degree to -- the population we have within the MA plan.
Let me just touch on the health assessment. You heard in the prepared comments the very strong performance of the house calls program, actually higher than last year, record quarter actually in terms of performance of house calls.
And you're quite right, that makes us feel pretty optimistic that, that headwind that we saw is going to dissipate pretty rapidly as we rotate to 2022. And that gives us kind of a rising optimism that much of the -- much of that kind of the negative headwind that characterized the emergence of the pandemic starts to mitigate at least on that dimension.
Obviously, we don't know what's going to happen in the next few months with this disease. But as we sit here today, that would be the right kind of expectation to look at.
Let me go to Wyatt first. And then, John, if you pick up from Wyatt on the seasonality. So Wyatt?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Justin, thanks for the question. And of the individuals that we serve that are not in fully capitated programs, about 1/3 of them are seniors. And so you can think of that as the Medicare population that we serve through a variety of touch points in",147,"Yes, Justin, thanks for the question. And of the individuals that we serve that are not in fully capitated programs, about 1/3 of them are seniors. And so you can think of that as the Medicare population that we serve through a variety of touch points in our care delivery assets. And then you -- as you'd expect, a subset of those are already in MA plan, which is to your question.
And so we see, again, a great potential to continue to capture and enroll and care for MA patients through OptumCare's delivery capabilities. And you'll also see us going deeper in the markets that we're in and bringing risk -- our very mature risk-based platform in established markets to new markets where, today, we are primarily fee-for-service. So expect both geographic growth and increasing depth and penetration in the markets we serve today. Thank you."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, it's John. In terms of the seasonality, so historically, we've been at, what I'd call, a kind of 48-52 split in terms of first half, second half. I put that probably more in the zone of first half being in the [ 52%, 53% ] zone this year. That is",105,"Justin, it's John. In terms of the seasonality, so historically, we've been at, what I'd call, a kind of 48-52 split in terms of first half, second half. I put that probably more in the zone of first half being in the [ 52%, 53% ] zone this year. That is really due to the -- how we're tracking in the $1.80 per share impact on us. That -- the majority of that is occurring in the second half of the year. So that would be the -- really the reason for the seasonality looking different this year than it has looked in other years."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John. And thanks, Justin, for the questions. Appreciate it.",10,"Thanks, John. And thanks, Justin, for the questions. Appreciate it."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our next question comes from the line of A.J. Rice from Credit Suisse.",14,"Our next question comes from the line of A.J. Rice from Credit Suisse."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Maybe drill down a little bit on OptumInsight. Obviously, you had a really good margin trend this quarter. I wondered -- because I know there was a discussion last year during the pandemic that some of the John Muir type of deals were somewhat on hold as",182,"Maybe drill down a little bit on OptumInsight. Obviously, you had a really good margin trend this quarter. I wondered -- because I know there was a discussion last year during the pandemic that some of the John Muir type of deals were somewhat on hold as it was tough to sell a health system on that given social distancing and so forth.
Does the fact that you don't have investments for those, is that helping you on the margin right now? And are those now basically reopened now that you can go out and bid? And maybe another aspect of the OptumInsight story, as you think ahead now with Change Health coming on board, do -- should we assume that there's a pause in selling activity of some sort while you integrate that and position the company to be even stronger -- that business to be even stronger? Or I know there's a lot of synergy assumed to be coming online with that one. So how should we think about how Change Health coming online affects the trajectory of that business?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","I'm going to ask Robert Musslewhite to make some comments in a second around the progression of the margin in the quarter, which obviously, we're very, very pleased to see that, and it was due to a ton of hard work on a number of different dimensions that",269,"I'm going to ask Robert Musslewhite to make some comments in a second around the progression of the margin in the quarter, which obviously, we're very, very pleased to see that, and it was due to a ton of hard work on a number of different dimensions that Robert can describe to you.
Just on those large contract agreements like the one we have with John Muir. Yes, there was a bit of disruption last year, but I would say that is absolutely back on stream now in terms of a line of business for us, and we have some -- a very, very exciting pipeline. And that pipeline exists both in the short, medium and longer term. So that's an area you're going to hear more from us on, and is absolutely back in full swing.
In terms of Change, obviously, we're -- we are very keen to continue to work through the regulatory process. We expect this to close in the second half, as we've previously indicated. And you should not expect any disruption from us bringing Change on board to really anything that we're doing, and especially not in terms of our selling activity. So we absolutely continue to operate OptumInsight fully as if we were not in a transaction. And even post-transaction, I would fully expect the ongoing sales energy of the company to be not disrupted. So nothing -- I really would not lead you to expect anything on that front.
With that, Robert, would you go into a bit more detail, please, around the evolution of the margin during the last quarter?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. A.J, listen, we were pleased with the quarter. It was a really good quarter on the top line, and that, of course, drove profitable growth that contributed to margin.But specifically on margin, we also are really seeing the results of a lot of the",296,"Sure. A.J, listen, we were pleased with the quarter. It was a really good quarter on the top line, and that, of course, drove profitable growth that contributed to margin.
But specifically on margin, we also are really seeing the results of a lot of the modernization work we did across 2020. So last year, we undertook a significant review of the business across the operations and drove -- find some multiple ways to drive stronger and more efficient performance and help find -- ensure that the investments we are making were invested appropriately against our key growth opportunities.
And so if you look at those initiatives, multiple automation initiatives using advanced techniques and AI, NLP, machine learning, it really drove a lot of short-term productivity. But it also drives a situation where we feel like we've made sustainable margin improvements for the long term, and that puts us in a position to be more competitive. And that actually rolls over to exactly what you were mentioning, being more competitive on the large engagements.
And as Andrew said, we feel really optimistic about that pipeline and where it's headed. The disruption was more in timing and not really an interest during the pandemic. In fact, during the pandemic, I think there was growing recognition among our health system relationships that this was a very productive way to work with Optum and a really important need for them as they face some disruption even coming out of the pandemic to their finances in ways that we can sustainably support them in a really holistic way. So we feel like that's a great path forward. We're excited about the business and feel like we've made some important changes that put us on a really good track going forward."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Robert. And A.J., thanks for asking the question. Insight, I think, is really on the cusp of a very exciting few years. Thanks to the significant work that was done last year, the increase in rate of opportunity that we see to bring in new signifi",79,"Thanks, Robert. And A.J., thanks for asking the question. Insight, I think, is really on the cusp of a very exciting few years. Thanks to the significant work that was done last year, the increase in rate of opportunity that we see to bring in new significant contracts. And then obviously, the pending Change acquisition creates some really exciting momentum for this business. So this is an area I fully anticipate us looking to for material growth going forward."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Our final question comes from the line of George Hill from Deutsche.",12,"Our final question comes from the line of George Hill from Deutsche."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Andrew, I'd just be interested to hear your commentary about the outlook for commercial bundles. I know we're all talking a lot about risk sharing, what I call, risk syndication in the Medicare Advantage space and the bundling of risk in the Medicare Adva",72,"Andrew, I'd just be interested to hear your commentary about the outlook for commercial bundles. I know we're all talking a lot about risk sharing, what I call, risk syndication in the Medicare Advantage space and the bundling of risk in the Medicare Advantage space. But I'd be interested in the company's outlook for the commercial business? And if you're seeing increased uptake of kind of more risk-sharing tools in that market?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, great. So listen, I think in the commercial -- and I'm going to ask Bill Golden to come in here real quick. But I think in the commercial space, just as possible for us to start to design innovative products, and we've already begun to do that be",68,"Yes. No, great. So listen, I think in the commercial -- and I'm going to ask Bill Golden to come in here real quick. But I think in the commercial space, just as possible for us to start to design innovative products, and we've already begun to do that between Optum and UHC. Let me ask Bill to dive into that in a little bit more detail. Bill?"
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you, and thanks for the question. Yes, I would say we're in the early stages of provider-aligned products, where we're taking advantage of that risk-based.As an example, in our Southern California OptumCare partnership, Harmony really continu",125,"Yes. Thank you, and thanks for the question. Yes, I would say we're in the early stages of provider-aligned products, where we're taking advantage of that risk-based.
As an example, in our Southern California OptumCare partnership, Harmony really continues to be a cornerstone over those offerings. We're learning a lot with that product, not only regarding how it's priced and -- but more importantly, the -- actually experience for the members. And so we're using that as a cornerstone and as a program to continue to roll out throughout the country with other areas. So we're very optimistic about the opportunities that, that will show in the future, but still in the very early stages of our global cap with the commercial business. Thank you."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Bill. And George, thanks so much for the question. That's clearly an area we expect to see more in the future. But as Bill said, it's early days. And we'll see how that progresses.With that, everybody, thank you so much for spending the time wit",152,"Thanks, Bill. And George, thanks so much for the question. That's clearly an area we expect to see more in the future. But as Bill said, it's early days. And we'll see how that progresses.
With that, everybody, thank you so much for spending the time with us this morning. As we move through what we all hope are the latter stages of this pandemic, you can expect us to continue to focus on the areas where UnitedHealth Group can do the most to improve health care, including adding even greater value at the intersection of Optum and UnitedHealthcare, applying our technology and expertise to create a better functioning, more responsive and cost-efficient health care system and making health care work better for consumers.
We look forward to connecting with you again on these priorities in the weeks and months ahead. And once again, thank you for your attention this morning. Bye-bye."
104673,708988184,2251815,"UnitedHealth Group Incorporated, Q1 2021 Earnings Call, Apr 15, 2021",2021-04-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day.",22,"Thank you, ladies and gentlemen, for your participation in today's conference. This does conclude the program. You may now disconnect. Good day."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Audio Gap] natural and long-standing ESG impact. Our recently published sustainability report captures the full range of efforts we've dedicated ourselves to in areas of crucial concern to our stakeholders, none more so than advancing health and health e",143,"[Audio Gap] natural and long-standing ESG impact. Our recently published sustainability report captures the full range of efforts we've dedicated ourselves to in areas of crucial concern to our stakeholders, none more so than advancing health and health equity. This agenda is an essential part of our way of doing business. I'd like to thank our 330,000 colleagues from across the company for the passion and diligence they show every day in helping to deliver improvements in serving our members, clients and patients. I have great confidence that we're emerging from the last 18 months of disruption with an unprecedented set of opportunities to help improve the health system for all of those we can serve. And now I'll turn it over to President and Chief Operating Officer, Dirk McMahon, to provide more detail on the initiatives to drive performance across the organization"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Andrew. In an enterprise with our breadth of market engagement, we have many ways to assess how we're doing. I'd like to share some of those metrics with you, picking up on Andrew's commentary on our 3 key strategic themes. First, collaborati",613,"Thank you, Andrew. In an enterprise with our breadth of market engagement, we have many ways to assess how we're doing. I'd like to share some of those metrics with you, picking up on Andrew's commentary on our 3 key strategic themes. 
First, collaboration. UnitedHealthcare's value proposition is rooted in lower costs, better outcomes and a better experience. Optum supports this value proposition for UnitedHealthcare and other health plans with ambulatory services, which patients and their doctors value. 
In this quarter, we met the ambulatory surgery needs of over 250,000 patients, delivering exceptional care in convenient and affordable settings with revenue growth approaching 20% over the non-pandemic affected 2019 second quarter. These centers are meeting higher acuity and more complex needs, such as total joint replacement spine and cardiovascular procedures, which are performed at an increasing number of centers. Our ambulatory settings received a consumer NPS of 92, and we deliver better and more consistent quality outcomes at about half the cost of traditional settings. 
OptumCare has over 1,600 clinics and is rapidly expanding virtual offerings to serve patients in settings where they feel the most comfortable and, importantly, with their own physician. Seniors served by OptumCare under our integrated care approach spend considerably more time with their primary care physicians than seniors in traditional Medicare and, as a result, spend 1/3 fewer days in a hospital. 
Second is our strategy to increase the application of technology to improve patient care and help the system run better. We recently announced the partnership with Bassett Healthcare, another strong example of how OptumInsight is helping health systems to expand and scale essential capabilities, including revenue cycle management and digital modernization to improve health outcomes and patients' health care experiences. We expect to continue to add new partnerships like this. 
Also at OptumInsight, we've been tackling the most resource-intensive operations through the deployment of advanced technology and other approaches. For example, we have transformed what were once largely manual chart review processes into highly automated operations. 
Third, we have been hard at work advancing our consumer capabilities. UnitedHealthcare has made significant advances in the management of complex conditions. We're focused on making sure that patients with the highest acute care needs are able to access the most appropriate site of care by assigning them advocates to help navigate the system. Nearly 1 million of these members are matched with a personal navigator to help them manage and improve their health. 
OptumRx continues to improve access and affordability of home delivery for patients, leading to significant improvements in continuity of care and having already reduced the cost to process and dispense prescriptions by nearly 20% in just the past 2 years. Also, along consumer cost savings lines, for those who prefer an in-store retail experience, we now offer tools to find the lowest cost prescriptions near them regardless of the health benefits -- of their health benefits coverage status. These tools can save self-paying consumers up to 80% on their medications. 
Consumer preference is also having an impact in behavioral health. Already this year, the OptumHealth behavioral platform has delivered over 500,000 virtual visits, an option we initiated in just the last year. Many consumers and clinicians prefer these virtual encounters since they offer enhanced accessibility, flexibility and simplicity. Care encounters delivered through our dedicated channel have a patient satisfaction of 98%.  
These are just a few of the many initiatives we are executing on as we apply technology, data and analytics to make our strategic growth agenda come alive. We look forward to updating you on our progress over the quarters to come. With that, now I'll turn it over to Chief Financial Officer, John Rex."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dirk. Our first half performance supports the foundation for strong and expanding growth for the remainder of this year and beyond. Before I review business performance, I'll offer a brief perspective on the pandemic-driven trends we're observi",631,"Thank you, Dirk. Our first half performance supports the foundation for strong and expanding growth for the remainder of this year and beyond. Before I review business performance, I'll offer a brief perspective on the pandemic-driven trends we're observing. The core takeaway is that our outlook for COVID-19 impact is consistent with our past commentary. The second quarter showed overall care activity continuing to trend toward baseline or normalized levels, albeit with variation across lines of business. For example, in commercial markets, care activity was above baseline as members were willing and able to obtain needed care, some of which was deferred from prior periods. Our public sector markets continue to run below baseline, even as we are actively encouraging people to get the care they need. We were gratified to see care activity for these populations begin to progress over the course of the quarter as vaccination rates advanced. We continue to estimate approximately $1.80 per share of unfavorable COVID-19 impacts for full year 2021 and to expect the majority of these effects to occur in the second half. 
Moving to overall business performance. OptumHealth's second quarter revenue and earnings increased 46% and 34%, respectively, year-over-year. Revenue per consumer grew by 43%, reflecting the impact of accountable arrangements and our expanding home and community health platform, combined with the growing complexity of the needs we're serving. Of the 20 million patients we serve through OptumCare, over 2 million are in fully accountable or capitated care arrangements, an increase of 17% from a year ago, and we expect this pacing to accelerate strongly in the years ahead. 
OptumInsight's revenue grew 12% in the quarter and earnings grew 36% with the revenue backlog increasing by $1.9 billion to $21.3 billion. Key growth drivers were managed services, the continued recovery of care activity to more normal levels and further implementations of technology-enabled services. In particular, we are seeing strong sales momentum in the services, software and analytics businesses, which serve care providers. 
OptumRx revenue and earnings increased 5% and 19% year-over-year, and script growth was 8%, with this comparison impacted by last year's pandemic-affected care patterns. Our expanding pharmacy care and specialty services continue to grow strongly now comprising just under half of OptumRx revenues. 
Turning to UnitedHealthcare. We are encouraged by the receptivity to our expanding set of responsive commercial benefits centered around Virtual First, on-demand and physician-led offerings. Year-to-date, we have added about 150,000 members in such innovative commercial offerings, even with the evolving and uneven labor market trends which impacted second quarter membership. Medicare Advantage membership has grown by 675,000 year-to-date, tracking well to our full year outlook. Our HouseCalls clinicians have been able to provide their vital services to seniors conducting over 1.1 million home visits in the first half, more than double the year ago level. 
People served in managed Medicaid programs grew by nearly 920,000 over the year ago quarter in part as state-based redetermination activities remained on hold. Our Medicaid offerings continue to deliver a positive consumer experience and demonstrable cost effectiveness for our state government partners, and we look for this momentum to build heading into next year. 
Our liquidity and capital positions remain strong with second quarter cash flows from operations at $5.5 billion or 1.3x net income. -- and we ended the quarter with a debt-to-capital ratio of 40%. And in early June, our Board of Directors increased the dividend by 16%. 
As noted earlier, given the strength of our business performance, we've updated our full year adjusted earnings per share outlook to a range of $18.30 to $18.80 per share. inclusive of the COVID-19 impact incorporated into our full year view. Within this, we expect the pacing through the second half to be fairly level. Now I'll turn it back to Andrew."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John. what we tried to provide you with this quarter as we do each time is a sense not only of what UnitedHealth Group's results are but how we achieve them. The examples we've referenced and countless others throughout this enterprise, along with",108,"Thanks, John. what we tried to provide you with this quarter as we do each time is a sense not only of what UnitedHealth Group's results are but how we achieve them. The examples we've referenced and countless others throughout this enterprise, along with the consistent execution by our colleagues, are what underpin our confidence in our long-term 13% to 16% EPS growth rate target and in our ability to help people live healthier lives and help the health system work better for everyone over the years to come. With that, operator, let's open up the call for questions. One question per caller, please. Alan, over to you."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] The first person we'll take a question from will be Kevin Fischbeck with Bank of America.",18,"[Operator Instructions] The first person we'll take a question from will be Kevin Fischbeck with Bank of America."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","All right. Great. I guess you guys reported 2 quarters in a row but raised guidance both times by less than the beat. You signaled out the $1.80 headwind included in the guidance. Is there any other kind of major onetime positives or negatives in the guid",86,"All right. Great. I guess you guys reported 2 quarters in a row but raised guidance both times by less than the beat. You signaled out the $1.80 headwind included in the guidance. Is there any other kind of major onetime positives or negatives in the guidance that we should think about when thinking about this year as a base for how to forecast future numbers? And is there anything offsetting the upside in the first half that we should think about in the back half?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, thanks so much for the question. Before I ask John to give a little bit more detail. I mean a couple of things. obviously, still too early to give you kind of real shape in for 2022. So you won't be surprised we won't go there. And I would say the",263,"Kevin, thanks so much for the question. Before I ask John to give a little bit more detail. I mean a couple of things. obviously, still too early to give you kind of real shape in for 2022. So you won't be surprised we won't go there. And I would say the overwhelming story for this year is, of course, the dynamic of COVID in terms of the various puts and takes, which are taking place under the surface. And as we've done for the last several quarters, we've tried to kind of dimension that within the $1.80. But as we've also said repeatedly, the bulk of that $1.80 sits in the rest of the year, the year to go between now and the end of 2021. And so really, really pleased with the momentum and underlying performance of the company in the first 2 quarters of this year but also respectful of uncertainties that remain around the COVID puts and takes. And -- And of course, and that all feeds into how we make the judgment on raising the earnings expectation for the rest of the year. 
I think where I sit, I feel great about that underlying performance. So far, broadly speaking, the COVID dynamic has played the way we would have anticipated more or less. But there's still a ways to go and there are uncertainties within that. And maybe, John, you might go a little further and take that $1.80 apart and maybe reflect a little bit on how you're seeing those different elements of the driver of that."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, good morning. It's John Rex. Yes, just to get a little further into those. So within the $1.80, we still expect about 70% of that to occur within -- in the second half of the year. So the vast majority, a lot to be seen on how that $1.80 really pla",315,"Kevin, good morning. It's John Rex. Yes, just to get a little further into those. So within the $1.80, we still expect about 70% of that to occur within -- in the second half of the year. So the vast majority, a lot to be seen on how that $1.80 really plays out. Keep in mind, kind of the main elements of that comprises. It's the direct treatment and testing costs that we would see offset by elective care deferral that might continue to occur or not in the rest of the year; the potential for higher acuity for those that have missed or deferred care; and at least within 2021, the impact of the care deferrals that occurred last year. So those are all super important components here. Within those elements, the things to play out would be most around the direct treatment and testing costs and the potential for higher acuity and how much care occurs in the back half. 
The other elements within the $1.80, I would say, are more steady throughout the course of the year. So that point being around care deferral in 2020 and the related revenue impacts for 2021, those should be relatively steady and I would say are running in line with the expectations that were set out for you back in December. So I don't think we've had a surprise on that element within our outlook. And I would say the kind of economic impacts, also pretty relatively steady over the course of the year in terms of the quarterly progression. So those are really the elements we continue to look for. 
You're right. Look, we saw good strength in a lot of the business, growth across the platform, really, we could point to every business. But it's a look-out to really understanding how those trends play in the second half of the year. Thank you."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll next go to Josh Raskin with Nephron Research.",10,"We'll next go to Josh Raskin with Nephron Research."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","So our question again this quarter is around OptumCare. And I think the question is really how do you think about the capacity constraints for OptumCare. Is that more on the provider side or gaining consumers in the totality of OptumHealth? And with all o",122,"So our question again this quarter is around OptumCare. And I think the question is really how do you think about the capacity constraints for OptumCare. Is that more on the provider side or gaining consumers in the totality of OptumHealth? And with all of these sort of new options or what appear to be new options available to physicians, how are you convincing docs that Optum is the best solution? 
And lastly, and I know I apologize for the last part here, but -- is there an argument we made that OptumCare and not Optum overall, but just the Optum Care segment would be more valuable to shareholders as a stand-alone company because of the physician independence issue that comes up?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So Josh, thanks so much for the questions. And before I -- I'm going to ask Dr. Decker to make a few comments in a minute or 2 but maybe just make a couple of introductory observations. So first off, I think you're really starting to see OptumHealth bro",467,"So Josh, thanks so much for the questions. And before I -- I'm going to ask Dr. Decker to make a few comments in a minute or 2 but maybe just make a couple of introductory observations. 
So first off, I think you're really starting to see OptumHealth broadly. And within that business, in particular, Optum Care and, of course, home And community really starting to demonstrate their capacity for growth because of the scale of the footprint that they now establish across the country. And I think you're starting to see these businesses move into a kind of critical mass dynamic. That's reflected in its overall growth. It's also reflected in this very rapid expansion of OptumHealth revenue per consumer up over 40% this quarter. That's reflective of the quality of services which are being delivered and the perceived value that they obviously reflect. So we feel very good about that. 
Your question around capacity constraints is a really good question. We continue to extend rapidly the number of physicians and clinicians in our organization either directly or through affiliation. This year, we expect to add about 10,000. We're well over halfway through that journey, so going super well on that front. 
I would say one of the key elements is really making sure that those practices as rapidly as possible start to develop the skills to be able to manage capitated risk, which is really what then drives a tremendous amount of the distinctive behavior and value creation for patients and, of course, for the system. That process, I think, has been continually refined. As you would be well aware, in the marketplace, people have tried different models. They don't always work super well. I'll maybe ask Dr. Decker in a second to dive a little bit more detail into some of the work they're doing there to accelerate that dimension of capacity because it's not simply having the practices and the clinicians. It's having that way of working which really drives the change in what we're able to do. 
As far as your last question is concerned, I actually think that the Optum Care clinics within the broader Optum and UHG organization, that's where some of the magic really sits here in terms of being able to leverage many different aspects. And as you see these elements of OptumHealth and Optum Care, in particular, develop, you're also seeing [Audio Gap] and health, if you will, being provided by other businesses across the organization. Payment integrity, good example, beginning to be adopted by parts of Optum Care. 
So with all of that, I'd like Dr. Decker, maybe just to go a little deeper on how we move or how we help practices develop the capabilities which allow them to deliver the value we're now seeing."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew. Thanks, Josh, for the question. To Andrew's comment, we are increasingly bringing our depth and breadth in value-based care delivery to new markets that have been historically fee-for-service. And you'll see this unfolding right now a",182,"Yes. Thanks, Andrew. Thanks, Josh, for the question. To Andrew's comment, we are increasingly bringing our depth and breadth in value-based care delivery to new markets that have been historically fee-for-service. And you'll see this unfolding right now and over the next year or 2 in markets like the Pacific Northwest and the Northeast, where we have -- we've acquired and grown considerable clinical delivery assets. But we are now bringing the expertise in markets like Texas and Southern California that have been delivering value-based and full risk capitated care for years. And so that really is a differentiator for us. 
And the other piece I'd build on is Andrew's comment around how we are creating a comprehensive set of offerings that address virtually every aspect of an individual's health care journey from a focus on primary care and keeping you healthy and well to post-acute care to end-of-life care and complex care in all environments, virtual, home and in the clinic. And that, to us, as we bring that together and connect the dots, is a differentiator in all markets. Thanks."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ricky Goldwasser with Morgan Stanley.",9,"Next, we'll go to Ricky Goldwasser with Morgan Stanley."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","So many of the initiatives that you are putting in place and the asset that you're putting together are leading to lower utilization, at least the hospital setting, in a move to lower cost setting. So keeping this in mind, and when we see the lower utiliz",66,"So many of the initiatives that you are putting in place and the asset that you're putting together are leading to lower utilization, at least the hospital setting, in a move to lower cost setting. So keeping this in mind, and when we see the lower utilization, at least on the public side, do you still think that 2019 is the right baseline for utilization?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ricky, that's a great question. So you're quite right that a lot of what we're -- we focus on is, well, first and foremost, to try and understand what is the very best care that an individual needs and to make sure that they get access to that. And one of",384,"Ricky, that's a great question. So you're quite right that a lot of what we're -- we focus on is, well, first and foremost, to try and understand what is the very best care that an individual needs and to make sure that they get access to that. And one of the big things we've been doing this year is trying to get people, particularly seniors, back into the system, those who may be held back because of the pandemic. And as you heard earlier, we're glad to see some of that move in, albeit some way to go. 
Now within that, we also recognize there are a whole series of places, where, frankly, there are better, more effective ways to deliver care. I'm going to pick out one very simple example just to build on what you described. So if I think about some of the work that's going on at OptumRx and within our Optum infusion business, you can take drugs where perhaps $10,000, $15,000 per treatment for a hospital outpatient, exactly the same drug being delivered by Optum at-home infusion, $3,500. I mean, just that's the kind of impact that we can deliver through really thoughtful application of location of delivery and the like. And that's just one example. UHC are very much focused on this in much of their guidance, and of course, Optum is building a variety of different capabilities. 
Having said all of that, I think the reality is it's very early days, even for us in terms of change in behavior against the overall trend of the health care system. So I think that baseline in of 2019 probably is the right rational piece. Over time, I think these practices will start to bear down on the overall trend of cost. But of course, that's -- that will happen as we see those capabilities spread more broadly as we see them get more adoption and that starts to change the price point in the marketplace for some of these treatments or therapies, which are frankly overpriced. And what our clients are looking for us to do, both through UnitedHealthcare and doctors who find ways to get great care at lower cost, and that's exactly what we're focused on doing. So Ricky, thanks so much for the question."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to A.J. Rice with Credit Suisse.",9,"Next, we'll go to A.J. Rice with Credit Suisse."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I might just continue to focus on OptumRx. You've got good script growth and a pickup in margin. there. There are 2 things that are sort of impacting script growth. It seems like to me across some of the companies that are reporting it One is how quickly",141,"I might just continue to focus on OptumRx. You've got good script growth and a pickup in margin. there. There are 2 things that are sort of impacting script growth. It seems like to me across some of the companies that are reporting it One is how quickly we're seeing the rebound of sort of the acute scripts as people start going back to the doctor and get new prescriptions. Can you comment on where we're at relative to prepandemic levels on that? And then vaccines and some of the script reporting is having an impact. I'm not sure that, that's relevant for you guys in OptumRx, but can you sort of parse that out in any way? And then I guess, just any comments on the selling season for OptumRx and for this year going into next that you see?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, listen, that's a great question, A.J. And before I hand it over to Heather Cianfrocco, our Head of OptumRx, let me just make a couple of introductory remarks. That 8% script growth, about half of that is we would estimate kind of bounce back fr",161,"Yes. No, listen, that's a great question, A.J. And before I hand it over to Heather Cianfrocco, our Head of OptumRx, let me just make a couple of introductory remarks. 
That 8% script growth, about half of that is we would estimate kind of bounce back from the suppression of this time last year caused by the COVID -- the initial waves of the COVID disruption. But even having said that, the 4% residual growth is great. And we feel very good about the performance of the OptumRx business across its breadth of businesses. So within the kind of core PBM, but also across all of its various other pharmacy services businesses, which the company has been invested in over the last several years. We did about 10 million vaccine prescriptions, I think, year-to-date. 
To give you a little bit more detail on that and a little bit further into selling season observation, maybe hand over to Heather. Heather, go ahead."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Andrew. Thanks, A.J., for the question. So yes, I think as Andrew said, so maybe I'll take script volume quickly and then just to finish that off and then maybe talk a little bit about selling season. So as Andrew said, really, if you look at whet",433,"Thanks, Andrew. Thanks, A.J., for the question. So yes, I think as Andrew said, so maybe I'll take script volume quickly and then just to finish that off and then maybe talk a little bit about selling season. So as Andrew said, really, if you look at whether ours is indicative of other things you've seen, what I'd say is specific to us, what you've seen over the last year is, yes, about half of that is the rebound from compression. And the rest of that is really a little bit of vaccine volume, and Andrew gave you the number there but that really hits volumes for us more than anything else because of the -- just the ratio of revenue to script there. And then in addition to that, there's a continued double-digit growth in the pharmacy services businesses. So that's making up the bulk of the additional growth that you're seeing year-over-year there. 
As far as the split of acute maintenance, et cetera. So I guess I would say we just had this discussion about what baseline is. I guess, again, we're kind of watching this in quarterly progressions. But I'd basically say that we're seeing second quarter look more like '19 than it certainly did from the -- looking like second quarter of 2020. And we basically don't see anything unique there as far as acute versus -- as far as acute ratio kind of back to what we saw prepandemic for this quarter. 
Maybe let me switch quickly to selling season. So we're still in the midst of it this year, and that's for all segments that's for employer. It's for health plan, public sector and coalition. And I'd say, generally, same activity, maybe a little different pacing of decision-making right now, but really in the midst of it. The biggest thing I would say about the selling season is clients are very interested in solutions to address high cost of specialty drugs and getting to medications and therapies that really help on the medical and the pharmacy side. So for us, we're very focused on those solutions, and we're finding that our site of care services for alternative sites and alternative therapies like biosimilars, together with some of our specialty programs that work through OptumHealth and OptumRx and straddle the medical and pharmacy benefit, are really resonating, together with our really intense clinical consulting that we're bringing to the market right now. So we're finding that resonating in the selling season, and we think we've got a lot of value out there. So hopefully, that answers your question."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Heather. Really appreciate it. I might just add, A.J., one other dimension that's under Heather's leadership, which is really pertinent is behavioral health. And as I think we all recognize, that's a huge issue across the U.S. I think many of us a",212,"Thanks, Heather. Really appreciate it. I might just add, A.J., one other dimension that's under Heather's leadership, which is really pertinent is behavioral health. And as I think we all recognize, that's a huge issue across the U.S. I think many of us anticipate the COVID pandemic and various impacts from that may well exacerbate some of the trend there. But I just wanted to call out the progress of Genoa pharmacy within that. It's a business that came into our organization 2 or 3 years ago. We're going to open 60 more of those centers this year. We're already up to 582 of those centers. We're well on the way to close to double what we had when they first became part of the organization. And the impact that, that group has is extraordinary, both from a consumer NPS score 95, provider NPS score 80. The impact they have in terms of helping improve adherence for highly complex patients, particularly those patients who are served through our Medicaid books of business, is super important. So to mention that alongside the other elements of OptumRx, another key part of the growth and a key part where OptumRx is really helping our Medicaid business deliver really high-quality service for folks who need it."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Justin Lake with Wolfe Research.",9,"Next, we'll go to Justin Lake with Wolfe Research."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wanted to follow up on the helpful comments that John gave during the prepared remarks on medical cost trend. So for instance, John, you mentioned that commercial utilization was back above kind of typical. Would love to know how that progressed during",134,"I wanted to follow up on the helpful comments that John gave during the prepared remarks on medical cost trend. So for instance, John, you mentioned that commercial utilization was back above kind of typical. Would love to know how that progressed during the quarter and kind of how far above typical you saw it coming out of the quarter, what you're thinking for the rest of the year. And then any other commentary on Medicare and Medicaid there? And then also, if you could give us your view on this new Biogen Alzheimer's drug in terms of how you think things develop in terms of price -- in terms of pricing and physician take-up or patient take-up rates and how you think you're going to manage this process would be great as well."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Justin, thanks so much. I'll address the Alzheimer's drug issue in a second. But first of all, I'd like John maybe to pick up on your broader MCR questions.",30,"Yes, Justin, thanks so much. I'll address the Alzheimer's drug issue in a second. But first of all, I'd like John maybe to pick up on your broader MCR questions."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, good morning. A little color perhaps on how that progression occurred in the quarter here. So as it relates particularly thinking about the quarterly progression that we saw, perhaps not unsurprisingly, COVID testing and treatment costs were highe",165,"Justin, good morning. A little color perhaps on how that progression occurred in the quarter here. So as it relates particularly thinking about the quarterly progression that we saw, perhaps not unsurprisingly, COVID testing and treatment costs were highest in the month of April, actually trending up a little bit from what we saw in March, and that tracks with the incidence rates and the hospitalization rates that we would have been seeing and then that trending down pretty rapidly in May and June in terms of the number of individuals in hospital beds and the treatment costs. 
In terms of utilization in commercial populations, interestingly, that was also the highest course of the quarter but still just marginally -- very marginally above baseline as we -- in June as we exited June. Just to give you a little color commentary on how that was progressing. So that was really the trending that we saw within that. And Andrew, I'll turn it back to you."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, great. Thanks, John. The other thing I'd say, Justin, is there's plenty of noise within those numbers that John just described, right? So you see inpatient outpatient physician visit trends different by different books of business. It's a more co",171,"Yes. No, great. Thanks, John. The other thing I'd say, Justin, is there's plenty of noise within those numbers that John just described, right? So you see inpatient outpatient physician visit trends different by different books of business. It's a more complex picture than it looks on the surface. 
As far as the Alzheimer's drug is concerned, I'm going to -- in a second, I'm going to ask Dr. Migliori, our Chief Medical Officer, to make a couple of comments on this particular thing. I mean overall bottom line from our perspective is this remains obviously a super important area for patients' families to look for progress in. We all want to see that progress happen I think from where we stand today, there's still a lot of information that we need to be able to make really clear decisions. And I think we're not the only ones in that regard looking for greater clarity in this arena. Maybe Dr. Migliori, you might give a perspective from the medical perspective, please."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew, and you said it well. We are encouraged to see meaningful progress being made against this devastating disease and advances in its treatment. We are continuing to develop our clinical policy as well as our ultimate position on coverag",109,"Yes. Thanks, Andrew, and you said it well. We are encouraged to see meaningful progress being made against this devastating disease and advances in its treatment. We are continuing to develop our clinical policy as well as our ultimate position on coverage. But in doing so, we're looking forward to getting the guidance that we need from Medicare and also, looking at the continually contributing clinical outcomes that are coming from the clinical evidence that comes from the ongoing clinical trials. But most importantly, we're looking for the advice from those expert professional organizations, the physicians who have committed their career to helping people with this devastating disease. Andrew?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks so much, Dr. Migliori in. Justin, I think bottom line is I think this has some way to go before we get to real clarity. So I wouldn't guide you to expect a very rapid decision-making on this piece, not because we don't want to see these good e",167,"Yes. Thanks so much, Dr. Migliori in. Justin, I think bottom line is I think this has some way to go before we get to real clarity. So I wouldn't guide you to expect a very rapid decision-making on this piece, not because we don't want to see these good effective treatments being made available. Of course, we do. But it's really important to have a real clear understanding of really how they should be used, what their value is in utilization and Dr. Migliori already said really well, really understanding where CMS get recognized in the MA population likely to be a very significant fraction of utilizers. We need to understand where all of that is. 
So I think this is potentially good news, but it's still early days, and we have a lot more to learn before we can be more definitive than that. So can't be too much more helpful at this point. I'm afraid, Justin. But thank you so much for the question."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ralph Giacobbe with Citi.",8,"Next, we'll go to Ralph Giacobbe with Citi."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to stick on to that last question. So it sounds like commercial was marginally above baseline for the quarter. Hoping you can give us similar comments on sort of magnitude of how much lower Medicare and Medicaid are. And then also, if you could pro",93,"I want to stick on to that last question. So it sounds like commercial was marginally above baseline for the quarter. Hoping you can give us similar comments on sort of magnitude of how much lower Medicare and Medicaid are. And then also, if you could provide any sense of magnitude of the rising you embed in guidance at this point for the second half of the year, if you could frame that just in terms of what normal growth would be and maybe what you're embedding or how much higher guidance contemplates"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Ralph, thanks so much. I'm going to ask John to reflect on the second part of your question in terms of forward-looking for the second half of the year. Just to nail this first part, though,  the commercial book, as you've heard already now from John",100,"Yes, Ralph, thanks so much. I'm going to ask John to reflect on the second part of your question in terms of forward-looking for the second half of the year. Just to nail this first part, though,  the commercial book, as you've heard already now from John a couple of times, basically right on baseline, maybe a hair above but right there. And then the 2 government books of business, a few percentage points below. So I won't go further than that. But maybe, John, you could give some insight into how you're seeing things within the next 6 months."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, Ralph. Yes. So then you blend a little bit -- just a little bit below overall, right? When you blend the books and you weight our books across in terms of what we are seeing in the second quarter. And then as you might expect, that trends up",353,"Good morning, Ralph. Yes. So then you blend a little bit -- just a little bit below overall, right? When you blend the books and you weight our books across in terms of what we are seeing in the second quarter. And then as you might expect, that trends up progressively every quarter, every quarter, you'd see rising in that overall level utilization and the expectations as we head into the end of the year. 
Embedded in that is also a view in terms of what happens with intensity, acuity levels. One comment that -- a question that we've often received is what are we seeing currently in acuity levels to progress. And part of the impact as we progress in the second half is an expectation that you do see rising acuity levels. I'd tell you, we haven't observed that yet, but it's still probably a little bit early to say. When we -- among the things we look at, we look at new cancer diagnoses, new cardiac diagnoses. Those are still running below baseline levels that we'd expect. But they're -- a view to that could continue to progress as we get into the back half of the year. 
The other element in terms of just thinking about utilization and rising in the back of the year is -- and ultimately, this is one of the calls, what occurs with COVID testing and treatment costs. Clearly, there's been the evidence of the new variants and their impact in other countries and then also moving into the U.S. And even in our own data, we can see that but I would tell you still fairly limited in terms of impact. And as I sit here and look at a number of members of our members that we have in receiving treatment today in hospital beds today as you say here this morning, still well below the levels even we sit here in mid-July, what we were seeing in the April level. but that could be a trend back factor also in the second half of the year as we see that progression."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next we'll go to Scott Fidel with Stephens.",9,"Next we'll go to Scott Fidel with Stephens."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to ask a question around Medicare Advantage. Just interested in terms of what you've been seeing progressing year-to-date around the risk scores and how that's been normalizing relative to the post-pandemic disruption. And then just also interested",65,"I want to ask a question around Medicare Advantage. Just interested in terms of what you've been seeing progressing year-to-date around the risk scores and how that's been normalizing relative to the post-pandemic disruption. And then just also interested if you've received the update yet from CMS on the midyear risk score updates. And if you could share how those came out relative to expectations."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, thanks so much for the question. I'm going to pass that over to our new CEO of UnitedHealthcare BT. BT, you and Tim might like to address those 2 points from Scott. BT?",34,"Scott, thanks so much for the question. I'm going to pass that over to our new CEO of UnitedHealthcare BT. BT, you and Tim might like to address those 2 points from Scott. BT?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. I'll start. I think as a follow-on, perhaps -- this is Brian Thompson. Thanks for the question. To the question around engagement levels, I think the piece that I am most encouraged by is the physician engagement levels. And in particular, in our se",96,"Sure. I'll start. I think as a follow-on, perhaps -- this is Brian Thompson. Thanks for the question. To the question around engagement levels, I think the piece that I am most encouraged by is the physician engagement levels. And in particular, in our senior communities, we're really seeing strong receptivity certainly reflective of the vaccination rates. And I think that's really giving us encouraging signals overall not only to 2022 but just the population and health at large. With that, I'll turn it over to Tim to talk a little bit more specifically about MA."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, thanks for the question. Yes. The revenue for 2021 and the risk scores that support those are totally in line with our expectations, as John indicated in his remarks. And yes, we did receive the midyear payment from CMS, which gives us a more fulso",80,"Scott, thanks for the question. Yes. The revenue for 2021 and the risk scores that support those are totally in line with our expectations, as John indicated in his remarks. And yes, we did receive the midyear payment from CMS, which gives us a more fulsome view into what 2021 revenue is. And again, that aligns to our expectations. And at this point, we consider 2021 revenue to be pretty complete in terms of what we'll know about risk scores."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Dave Windley with Jefferies.",8,"Next, we'll go to Dave Windley with Jefferies."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wondered, relative to your conversations about the relative headwinds. Does your view of your ability to recoup the $1.80 in '22, is that influenced at all by the timing of when these things hit if they do in the second half of '21? So be curious about",52,"I wondered, relative to your conversations about the relative headwinds. Does your view of your ability to recoup the $1.80 in '22, is that influenced at all by the timing of when these things hit if they do in the second half of '21? So be curious about your comments there, please."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. And I'll ask John in a sec to give you more on this. I mean, first off, obviously, again, we're not going to be really shining the light on our expectation for '22 yet. Having said that, we also think the majority of the $1.80 headwind will have been",104,"Yes. And I'll ask John in a sec to give you more on this. I mean, first off, obviously, again, we're not going to be really shining the light on our expectation for '22 yet. Having said that, we also think the majority of the $1.80 headwind will have been utilized this year will essentially be recurring -- Of course, that depends on some assumptions around the pandemic itself remaining under control. I mean, so that is an observation which has to be taken in. John, you may want to go a little deeper on how each of the elements perhaps you think about."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. A few factors on that and how timing might impact, though. So maybe just to refresh a little bit on that. Tim did a nice job describing the impacts in terms of -- the revenue impacts from particularly our Medicare Advantage members being able to be",293,"Sure. A few factors on that and how timing might impact, though. So maybe just to refresh a little bit on that. Tim did a nice job describing the impacts in terms of -- the revenue impacts from particularly our Medicare Advantage members being able to be seen by their physicians. We are encouraged by what's going on in our HouseCalls activity, very strong receptivity to those. BT just mentioned, encouraged by what we're seeing in terms of seniors and their receptivity to even going in and seeing their physicians. That's all super important. 
I don't know if timing is so important on that piece. It just needs to occur during the year in terms of when that activity occurs. So that would be more the more important factor as it relates to 2022. Does it occur in 2021? Do they get in? So that's an important factor. 
Other factors here, I would say. So there's care that didn't occur in 2020 and probably hasn't occurred in '21 yet that was deferred and needs to occur. So that's more about also an element of, does it not occur at all in this year; does it work its way into 2022 and the potential for and kind of the resident impact of whether or not there's an increase in acuity or that -- from those populations. 
That -- those are really kind of the main elements, I would say, in terms of what I would call timing-related. The other elements are more just -- would be around this concept around the occurrence of COVID-19 incidents, direct treatment and testing costs, how that progresses over the back half of the year, too. But those would be the elements that would be sensitive to timing factors."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Lance Wilkes with Bernstein.",8,"Next, we'll go to Lance Wilkes with Bernstein."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Yes. You made a comment about Virtual First offerings helping to drive incremental membership growth this year. Can you talk a little bit about what the digital first and or Virtual First offerings look like? And then is that contribution in '21? Or -- an",66,"Yes. You made a comment about Virtual First offerings helping to drive incremental membership growth this year. Can you talk a little bit about what the digital first and or Virtual First offerings look like? And then is that contribution in '21? Or -- and if it is, could you talk a little bit about in the sales cycle, how it's looking for uptake in '22?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great question, Lance. Thanks. I'm going to ask Dirk in a second to make a couple of comments around the overall shift towards digital first, virtual first and may also ask Dr. Decker to refer to some of further what's going on within OptumHealth, which i",275,"Great question, Lance. Thanks. I'm going to ask Dirk in a second to make a couple of comments around the overall shift towards digital first, virtual first and may also ask Dr. Decker to refer to some of further what's going on within OptumHealth, which is an important around Optum virtual. 
As I've made super clear over the last couple of quarters, really elevating our consumer focus is a top priority for the whole company. And that really speaks to ensuring that we're delivering simpler, more intuitive experiences that we're thinking about the journey of the consumer and the patient in an end-to-end sense, that we're making it easier for them to make all of the various sequential decisions. And we also want to meet the consumer where they want to be met, whether that be outside of a facility in their home, online or in person. 
And we also -- we fully recognize how the premium that patients and consumers in particular put on being able to talk to the physicians they know rather than rather than just any physician. And so how we start to pool all of that together is essentially reflected in many of the different initiatives we have. 
Over the last few quarters, you've seen us build up things like Optum Virtual, Dr. Decker will talk to you in a second. But things like Optum Store just been rolled out under the OptumRx organization really starts to bring together a ton of access for consumers in terms of what they're able to do with us. 
With that introduction, Dirk, I'd love to get your perspective and then maybe Wyatt. Dirk."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew, and Lance, for the question. So of course, we've continued to see telehealth be a broadly desired consumer access vehicle to the health system. We've seen that grow. We're hoping we get to the sort of the next generation. And we think",166,"Yes. Thanks, Andrew, and Lance, for the question. So of course, we've continued to see telehealth be a broadly desired consumer access vehicle to the health system. We've seen that grow. We're hoping we get to the sort of the next generation. And we think a lot of that begins with, like, for example, with OptumCare physicians being able to deliver that because, as Andrew said, people have a good preference to go to their own physician. 
The product with respect to Virtual First, to answer your specific question, we plan on rolling that out in 8, 9 markets in UnitedHealthcare at the end of this year. What it will basically be is think of it as sort of a virtual PCP with an OptumCare dock being the quarterback with UnitedHealthcare Navigate network back in and up for the physical access. So we're starting to sort of what I would refer to as productize this, and we're hopeful -- which will aid to UnitedHealthcare's commercial growth"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks. Sure. Thanks. Wyatt, would you like to just give a little more on Optum virtual and what you've been building inside OptumHealth?",23,"Thanks. Sure. Thanks. Wyatt, would you like to just give a little more on Optum virtual and what you've been building inside OptumHealth?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Lance, for the question. We are bringing together the virtual care experience that we stood up rapidly during the pandemic with over 18,000 providers on to, as Dirk mentioned, a next-generation technical solution that we've created, which cre",160,"Yes. Thanks, Lance, for the question. We are bringing together the virtual care experience that we stood up rapidly during the pandemic with over 18,000 providers on to, as Dirk mentioned, a next-generation technical solution that we've created, which creates the opportunity to seamlessly onboard and triage an individual virtually. So we make sure they're getting the right care in the right environment, whether that's virtual, physical or a behavioral health care need. And we believe that, that is a differentiated patient experience. 
And the second, which Dirk mentioned, but I'll underscore, is a focus on primary care delivery and keeping people tethered to their trusted and known providers. And as this matures, we're live today in all 50 states, to be clear, and we'll continue to roll this out in a more comprehensive way to our OptumCare patients as well as members of UHC and other payers and look forward to continued conversations about our capabilities here. Thank you."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Wyatt. I think, Lance, just to close this out. This is -- I'm excited about what's been built in OptumHealth. If you think about this build-out of ambulatory clinic facilities and other attendant services perhaps in the pharmacy space, you think a",204,"Thanks, Wyatt. I think, Lance, just to close this out. This is -- I'm excited about what's been built in OptumHealth. If you think about this build-out of ambulatory clinic facilities and other attendant services perhaps in the pharmacy space, you think about the home and community agenda really investing to make sure that folks who want to spend as much time at home as possible are able to do that, and then you see Optum virtually essentially pooling all of that together. This -- you've got to think about this as all 3 of those elements essentially all at play at the same time. 
The very -- I think it's a very important step forward. It gives us a really significant opportunity to ensure that we deliver a much more seamless experience. We're much more responsive to consumer need, and we can focus on bringing costs down, delivering better care. That's what we really believe we can do here. This is is -- you're going to hear a lot more about this. It's an important step-up in the energy around our OptumHealth strategy. 
We just have time, I'm afraid, for one last question. So Alan, if you could ask for last question, please."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll take our last question from Matt Borsch with BMO Capital Markets.",13,"We'll take our last question from Matt Borsch with BMO Capital Markets."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Okay. I realize you're parsing through everything that happened last year and now the catch-up in care this year. Are you getting a perspective yet on how much of the care was unnecessary that would have happened but is not actually going to occur. And I",76,"Okay. I realize you're parsing through everything that happened last year and now the catch-up in care this year. Are you getting a perspective yet on how much of the care was unnecessary that would have happened but is not actually going to occur. And I guess you put that into -- was unnecessary, but maybe what's necessary at the time because the person to know and care that was just unnecessary proactively and in hindsight?"
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Matt, thanks so much for the question. It's a really -- it's a great question. And you would have to expect that the answer is that some of it would have been unnecessary. I think at this distance, it's a little hard to really call that at this point",372,"Yes, Matt, thanks so much for the question. It's a really -- it's a great question. And you would have to expect that the answer is that some of it would have been unnecessary. I think at this distance, it's a little hard to really call that at this point. I mean there are some tantalizing signals in some of the trends. So if you look at emergency department use, for example, it looks pretty sustained down and doesn't seem to be coming back. 
And certainly, if you look at our Advisory Board surveys that we're running with many, many non-UHC providers and institutions across American Healthcare, people don't -- a lot of people don't expect that ED utilization to come back. Now that may be because they would be unnecessarily used. Maybe folks have realized that urgent care centers are a much better option. Maybe virtual is a much better option that they can get what they need at a much lower cost. 
So whether it's unnecessary, whether or not the pandemic has disturbed people's allegiance for certain types of sites of care and people are a little bit more open-minded about where to go, all of that, I think, is in play. I would say it's premature to call it. I think we're watching it really carefully. I could build those theories I just shared with you. I'm not going to tell you that those are [indiscernible]. I think there is tantalizing signals in the data. It's going to take another 6, 12 months before you can really settle out how this all plays. But Matt, thanks for the question, and we'll probably loop back on that one again, I'm sure. 
Listen, everybody, I want to say thank you for all of your attention today, for your participation. Very much appreciated. And we hope very much that what you've heard from our team gives you a flavor of why we have such confidence in the outlook for our company and in the ability of Optum and UnitedHealthcare separately and together to improve the lives of those we serve and the health system overall. And with that, I'd like to say thank you very much and to close this morning's call."
104673,1671940210,2345995,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","That does conclude today's conference. We thank everyone again for their participation.",13,"That does conclude today's conference. We thank everyone again for their participation."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Good morning, everyone. Welcome to today's UnitedHealth Group Second Quarter 2021 Earnings Conference Call. As a reminder, this call is being recorded. Here is some important introductory information. This call contains forward-looking statements under U.",185,"Good morning, everyone. Welcome to today's UnitedHealth Group Second Quarter 2021 Earnings Conference Call. As a reminder, this call is being recorded. Here is some important introductory information. This call contains forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings. 
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the financial and earnings reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated July 15, 2021, which may be accessed from the Investor Relations page of the company's website. I will now turn the call over to the Chief Executive Officer of UnitedHealth Group, Andrew Witty. Please go ahead, sir."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us. As we discuss our enterprise today, I hope you sense its growing momentum as we advance on our path of improving the quality, cost and experience of health care for everyone we serve. Both Optum and UnitedHealth",617,"Good morning, and thank you for joining us. As we discuss our enterprise today, I hope you sense its growing momentum as we advance on our path of improving the quality, cost and experience of health care for everyone we serve. Both Optum and UnitedHealthcare grew and delivered on our long-standing strategy, and we've increased our outlook for the year to a range of $18.30 to $18.80 per share. 
We continue to prioritize 3 key themes that we believe will underpin the next era of growth for our enterprise: first, unlock the collaborative opportunities within and between Optum and UnitedHealthcare; second, increasingly apply technology to improve patient care and experience and to help the system run better; and third, strengthen our consumer focus, capabilities and value. 
During the quarter, we accelerated our efforts to develop and deploy new and innovative products, informed by the insights of both Optum and UnitedHealthcare. In areas such as oncology care delivery, rare disease drug management, Optum Virtual, Optum Financial Services and many others. We're doubling down on efforts to both expand and link services where it creates value for consumers and patients to make their health care journey easier, simpler and more intuitive. 
We constantly challenge ourselves to develop capabilities, which lead to improved care, better value and a simpler system. Our sales to clients and partners across all parts of the health system demonstrate the strong relevance of our innovation. And the strengthening of our sales pipeline is a key opportunity as we emerge from the COVID market pause. 
A good example of bringing our collective strengths together at scale is the Optum home and community care platform, through which we care for nearly 10 million people. This platform includes our well-known HouseCalls service, comprehensive post-acute care for smoother transitions to home and integrated primary and behavioral care for Medicare Advantage patients who prefer to receive their care at home. Home and community platform services can reduce post-acute medical care cost by quart, unnecessary readmissions by up to 1/5 and hospital admissions by up to 25%. 
In Medicaid, we're addressing consumer needs by expanding our long-term collaboration with public housing authorities, working with government agencies and community-based organizations to identify and address specific health care issues for people who are hard to reach and support. In just the past 6 months, we've introduced new partnerships in over 20 communities to close gaps in care and address health equity challenges. 
Using data and analytic capabilities, we're able to rapidly identify local health trends and gaps and then work with community partners to inform guidelines, training materials, processes and create better tools to advance health. We believe this will result in better health of community members and help to optimize limited state resources. These and other targeted initiatives on the social determinants of health are essential elements and illustrative of our natural and long-standing ESG impact.
Our recently published sustainability report captures the full range of efforts we've dedicated ourselves to in areas of crucial concern to our stakeholders, none more so than advancing health and health equity. This agenda is an essential part of our way of doing business. I'd like to thank our 330,000 colleagues from across the company for the passion and diligence they show every day in helping to deliver improvements in serving our members, clients and patients. I have great confidence that we're emerging from the last 18 months of disruption with an unprecedented set of opportunities to help improve the health system for all of those we can serve. And now I'll turn it over to President and Chief Operating Officer, Dirk McMahon, to provide more detail on the initiatives to drive performance across the organization"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Andrew. In an enterprise with our breadth of market engagement, we have many ways to assess how we're doing. I'd like to share some of those metrics with you, picking up on Andrew's commentary on our 3 key strategic themes. First, collaborati",613,"Thank you, Andrew. In an enterprise with our breadth of market engagement, we have many ways to assess how we're doing. I'd like to share some of those metrics with you, picking up on Andrew's commentary on our 3 key strategic themes. 
First, collaboration. UnitedHealthcare's value proposition is rooted in lower costs, better outcomes and a better experience. Optum supports this value proposition for UnitedHealthcare and other health plans with ambulatory services, which patients and their doctors value. 
In this quarter, we met the ambulatory surgery needs of over 250,000 patients, delivering exceptional care in convenient and affordable settings with revenue growth approaching 20% over the non-pandemic affected 2019 second quarter. These centers are meeting higher acuity and more complex needs, such as total joint replacement spine and cardiovascular procedures, which are performed at an increasing number of centers. Our ambulatory settings received a consumer NPS of 92, and we deliver better and more consistent quality outcomes at about half the cost of traditional settings. 
OptumCare has over 1,600 clinics and is rapidly expanding virtual offerings to serve patients in settings where they feel the most comfortable and, importantly, with their own physician. Seniors served by OptumCare under our integrated care approach spend considerably more time with their primary care physicians than seniors in traditional Medicare and, as a result, spend 1/3 fewer days in a hospital. 
Second is our strategy to increase the application of technology to improve patient care and help the system run better. We recently announced the partnership with Bassett Healthcare, another strong example of how OptumInsight is helping health systems to expand and scale essential capabilities, including revenue cycle management and digital modernization to improve health outcomes and patients' health care experiences. We expect to continue to add new partnerships like this. 
Also at OptumInsight, we've been tackling the most resource-intensive operations through the deployment of advanced technology and other approaches. For example, we have transformed what were once largely manual chart review processes into highly automated operations. 
Third, we have been hard at work advancing our consumer capabilities. UnitedHealthcare has made significant advances in the management of complex conditions. We're focused on making sure that patients with the highest acute care needs are able to access the most appropriate site of care by assigning them advocates to help navigate the system. Nearly 1 million of these members are matched with a personal navigator to help them manage and improve their health. 
OptumRx continues to improve access and affordability of home delivery for patients, leading to significant improvements in continuity of care and having already reduced the cost to process and dispense prescriptions by nearly 20% in just the past 2 years. Also, along consumer cost savings lines, for those who prefer an in-store retail experience, we now offer tools to find the lowest cost prescriptions near them regardless of the health benefits -- of their health benefits coverage status. These tools can save self-paying consumers up to 80% on their medications. 
Consumer preference is also having an impact in behavioral health. Already this year, the OptumHealth behavioral platform has delivered over 500,000 virtual visits, an option we initiated in just the last year. Many consumers and clinicians prefer these virtual encounters since they offer enhanced accessibility, flexibility and simplicity. Care encounters delivered through our dedicated channel have a patient satisfaction of 98%.  
These are just a few of the many initiatives we are executing on as we apply technology, data and analytics to make our strategic growth agenda come alive. We look forward to updating you on our progress over the quarters to come. With that, now I'll turn it over to Chief Financial Officer, John Rex."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dirk. Our first half performance supports the foundation for strong and expanding growth for the remainder of this year and beyond. Before I review business performance, I'll offer a brief perspective on the pandemic-driven trends we're observi",631,"Thank you, Dirk. Our first half performance supports the foundation for strong and expanding growth for the remainder of this year and beyond. Before I review business performance, I'll offer a brief perspective on the pandemic-driven trends we're observing. The core takeaway is that our outlook for COVID-19 impact is consistent with our past commentary. The second quarter showed overall care activity continuing to trend toward baseline or normalized levels, albeit with variation across lines of business. For example, in commercial markets, care activity was above baseline as members were willing and able to obtain needed care, some of which was deferred from prior periods. Our public sector markets continue to run below baseline, even as we are actively encouraging people to get the care they need. We were gratified to see care activity for these populations begin to progress over the course of the quarter as vaccination rates advanced. We continue to estimate approximately $1.80 per share of unfavorable COVID-19 impacts for full year 2021 and to expect the majority of these effects to occur in the second half. 
Moving to overall business performance. OptumHealth's second quarter revenue and earnings increased 46% and 34%, respectively, year-over-year. Revenue per consumer grew by 43%, reflecting the impact of accountable arrangements and our expanding home and community health platform, combined with the growing complexity of the needs we're serving. Of the 20 million patients we serve through OptumCare, over 2 million are in fully accountable or capitated care arrangements, an increase of 17% from a year ago, and we expect this pacing to accelerate strongly in the years ahead. 
OptumInsight's revenue grew 12% in the quarter and earnings grew 36% with the revenue backlog increasing by $1.9 billion to $21.3 billion. Key growth drivers were managed services, the continued recovery of care activity to more normal levels and further implementations of technology-enabled services. In particular, we are seeing strong sales momentum in the services, software and analytics businesses, which serve care providers. 
OptumRx revenue and earnings increased 5% and 19% year-over-year, and script growth was 8%, with this comparison impacted by last year's pandemic-affected care patterns. Our expanding pharmacy care and specialty services continue to grow strongly now comprising just under half of OptumRx revenues. 
Turning to UnitedHealthcare. We are encouraged by the receptivity to our expanding set of responsive commercial benefits centered around Virtual First, on-demand and physician-led offerings. Year-to-date, we have added about 150,000 members in such innovative commercial offerings, even with the evolving and uneven labor market trends which impacted second quarter membership. Medicare Advantage membership has grown by 675,000 year-to-date, tracking well to our full year outlook. Our HouseCalls clinicians have been able to provide their vital services to seniors conducting over 1.1 million home visits in the first half, more than double the year ago level. 
People served in managed Medicaid programs grew by nearly 920,000 over the year ago quarter in part as state-based redetermination activities remained on hold. Our Medicaid offerings continue to deliver a positive consumer experience and demonstrable cost effectiveness for our state government partners, and we look for this momentum to build heading into next year. 
Our liquidity and capital positions remain strong with second quarter cash flows from operations at $5.5 billion or 1.3x net income. -- and we ended the quarter with a debt-to-capital ratio of 40%. And in early June, our Board of Directors increased the dividend by 16%. 
As noted earlier, given the strength of our business performance, we've updated our full year adjusted earnings per share outlook to a range of $18.30 to $18.80 per share. inclusive of the COVID-19 impact incorporated into our full year view. Within this, we expect the pacing through the second half to be fairly level. Now I'll turn it back to Andrew."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John. what we tried to provide you with this quarter as we do each time is a sense not only of what UnitedHealth Group's results are but how we achieve them. The examples we've referenced and countless others throughout this enterprise, along with",108,"Thanks, John. what we tried to provide you with this quarter as we do each time is a sense not only of what UnitedHealth Group's results are but how we achieve them. The examples we've referenced and countless others throughout this enterprise, along with the consistent execution by our colleagues, are what underpin our confidence in our long-term 13% to 16% EPS growth rate target and in our ability to help people live healthier lives and help the health system work better for everyone over the years to come. With that, operator, let's open up the call for questions. One question per caller, please. Alan, over to you."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] The first person we'll take a question from will be Kevin Fischbeck with Bank of America.",18,"[Operator Instructions] The first person we'll take a question from will be Kevin Fischbeck with Bank of America."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","All right. Great. I guess you guys reported 2 quarters in a row but raised guidance both times by less than the beat. You signaled out the $1.80 headwind included in the guidance. Is there any other kind of major onetime positives or negatives in the guid",86,"All right. Great. I guess you guys reported 2 quarters in a row but raised guidance both times by less than the beat. You signaled out the $1.80 headwind included in the guidance. Is there any other kind of major onetime positives or negatives in the guidance that we should think about when thinking about this year as a base for how to forecast future numbers? And is there anything offsetting the upside in the first half that we should think about in the back half?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, thanks so much for the question. Before I ask John to give a little bit more detail. I mean a couple of things. obviously, still too early to give you kind of real shape in for 2022. So you won't be surprised we won't go there. And I would say the",263,"Kevin, thanks so much for the question. Before I ask John to give a little bit more detail. I mean a couple of things. obviously, still too early to give you kind of real shape in for 2022. So you won't be surprised we won't go there. And I would say the overwhelming story for this year is, of course, the dynamic of COVID in terms of the various puts and takes, which are taking place under the surface. And as we've done for the last several quarters, we've tried to kind of dimension that within the $1.80. But as we've also said repeatedly, the bulk of that $1.80 sits in the rest of the year, the year to go between now and the end of 2021. And so really, really pleased with the momentum and underlying performance of the company in the first 2 quarters of this year but also respectful of uncertainties that remain around the COVID puts and takes. And -- And of course, and that all feeds into how we make the judgment on raising the earnings expectation for the rest of the year. 
I think where I sit, I feel great about that underlying performance. So far, broadly speaking, the COVID dynamic has played the way we would have anticipated more or less. But there's still a ways to go and there are uncertainties within that. And maybe, John, you might go a little further and take that $1.80 apart and maybe reflect a little bit on how you're seeing those different elements of the driver of that."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, good morning. It's John Rex. Yes, just to get a little further into those. So within the $1.80, we still expect about 70% of that to occur within -- in the second half of the year. So the vast majority, a lot to be seen on how that $1.80 really pla",315,"Kevin, good morning. It's John Rex. Yes, just to get a little further into those. So within the $1.80, we still expect about 70% of that to occur within -- in the second half of the year. So the vast majority, a lot to be seen on how that $1.80 really plays out. Keep in mind, kind of the main elements of that comprises. It's the direct treatment and testing costs that we would see offset by elective care deferral that might continue to occur or not in the rest of the year; the potential for higher acuity for those that have missed or deferred care; and at least within 2021, the impact of the care deferrals that occurred last year. So those are all super important components here. Within those elements, the things to play out would be most around the direct treatment and testing costs and the potential for higher acuity and how much care occurs in the back half. 
The other elements within the $1.80, I would say, are more steady throughout the course of the year. So that point being around care deferral in 2020 and the related revenue impacts for 2021, those should be relatively steady and I would say are running in line with the expectations that were set out for you back in December. So I don't think we've had a surprise on that element within our outlook. And I would say the kind of economic impacts, also pretty relatively steady over the course of the year in terms of the quarterly progression. So those are really the elements we continue to look for. 
You're right. Look, we saw good strength in a lot of the business, growth across the platform, really, we could point to every business. But it's a look-out to really understanding how those trends play in the second half of the year. Thank you."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll next go to Josh Raskin with Nephron Research.",10,"We'll next go to Josh Raskin with Nephron Research."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","So our question again this quarter is around OptumCare. And I think the question is really how do you think about the capacity constraints for OptumCare. Is that more on the provider side or gaining consumers in the totality of OptumHealth? And with all o",122,"So our question again this quarter is around OptumCare. And I think the question is really how do you think about the capacity constraints for OptumCare. Is that more on the provider side or gaining consumers in the totality of OptumHealth? And with all of these sort of new options or what appear to be new options available to physicians, how are you convincing docs that Optum is the best solution? 
And lastly, and I know I apologize for the last part here, but -- is there an argument we made that OptumCare and not Optum overall, but just the Optum Care segment would be more valuable to shareholders as a stand-alone company because of the physician independence issue that comes up?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So Josh, thanks so much for the questions. And before I -- I'm going to ask Dr. Decker to make a few comments in a minute or 2 but maybe just make a couple of introductory observations. So first off, I think you're really starting to see OptumHealth bro",467,"So Josh, thanks so much for the questions. And before I -- I'm going to ask Dr. Decker to make a few comments in a minute or 2 but maybe just make a couple of introductory observations. 
So first off, I think you're really starting to see OptumHealth broadly. And within that business, in particular, Optum Care and, of course, home And community really starting to demonstrate their capacity for growth because of the scale of the footprint that they now establish across the country. And I think you're starting to see these businesses move into a kind of critical mass dynamic. That's reflected in its overall growth. It's also reflected in this very rapid expansion of OptumHealth revenue per consumer up over 40% this quarter. That's reflective of the quality of services which are being delivered and the perceived value that they obviously reflect. So we feel very good about that. 
Your question around capacity constraints is a really good question. We continue to extend rapidly the number of physicians and clinicians in our organization either directly or through affiliation. This year, we expect to add about 10,000. We're well over halfway through that journey, so going super well on that front. 
I would say one of the key elements is really making sure that those practices as rapidly as possible start to develop the skills to be able to manage capitated risk, which is really what then drives a tremendous amount of the distinctive behavior and value creation for patients and, of course, for the system. That process, I think, has been continually refined. As you would be well aware, in the marketplace, people have tried different models. They don't always work super well. I'll maybe ask Dr. Decker in a second to dive a little bit more detail into some of the work they're doing there to accelerate that dimension of capacity because it's not simply having the practices and the clinicians. It's having that way of working which really drives the change in what we're able to do. 
As far as your last question is concerned, I actually think that the Optum Care clinics within the broader Optum and UHG organization, that's where some of the magic really sits here in terms of being able to leverage many different aspects. And as you see these elements of OptumHealth and Optum Care, in particular, develop, you're also seeing [Audio Gap] and health, if you will, being provided by other businesses across the organization. Payment integrity, good example, beginning to be adopted by parts of Optum Care. 
So with all of that, I'd like Dr. Decker, maybe just to go a little deeper on how we move or how we help practices develop the capabilities which allow them to deliver the value we're now seeing."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew. Thanks, Josh, for the question. To Andrew's comment, we are increasingly bringing our depth and breadth in value-based care delivery to new markets that have been historically fee-for-service. And you'll see this unfolding right now a",182,"Yes. Thanks, Andrew. Thanks, Josh, for the question. To Andrew's comment, we are increasingly bringing our depth and breadth in value-based care delivery to new markets that have been historically fee-for-service. And you'll see this unfolding right now and over the next year or 2 in markets like the Pacific Northwest and the Northeast, where we have -- we've acquired and grown considerable clinical delivery assets. But we are now bringing the expertise in markets like Texas and Southern California that have been delivering value-based and full risk capitated care for years. And so that really is a differentiator for us. 
And the other piece I'd build on is Andrew's comment around how we are creating a comprehensive set of offerings that address virtually every aspect of an individual's health care journey from a focus on primary care and keeping you healthy and well to post-acute care to end-of-life care and complex care in all environments, virtual, home and in the clinic. And that, to us, as we bring that together and connect the dots, is a differentiator in all markets. Thanks."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ricky Goldwasser with Morgan Stanley.",9,"Next, we'll go to Ricky Goldwasser with Morgan Stanley."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","So many of the initiatives that you are putting in place and the asset that you're putting together are leading to lower utilization, at least the hospital setting, in a move to lower cost setting. So keeping this in mind, and when we see the lower utiliz",66,"So many of the initiatives that you are putting in place and the asset that you're putting together are leading to lower utilization, at least the hospital setting, in a move to lower cost setting. So keeping this in mind, and when we see the lower utilization, at least on the public side, do you still think that 2019 is the right baseline for utilization?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ricky, that's a great question. So you're quite right that a lot of what we're -- we focus on is, well, first and foremost, to try and understand what is the very best care that an individual needs and to make sure that they get access to that. And one of",384,"Ricky, that's a great question. So you're quite right that a lot of what we're -- we focus on is, well, first and foremost, to try and understand what is the very best care that an individual needs and to make sure that they get access to that. And one of the big things we've been doing this year is trying to get people, particularly seniors, back into the system, those who may be held back because of the pandemic. And as you heard earlier, we're glad to see some of that move in, albeit some way to go. 
Now within that, we also recognize there are a whole series of places, where, frankly, there are better, more effective ways to deliver care. I'm going to pick out one very simple example just to build on what you described. So if I think about some of the work that's going on at OptumRx and within our Optum infusion business, you can take drugs where perhaps $10,000, $15,000 per treatment for a hospital outpatient, exactly the same drug being delivered by Optum at-home infusion, $3,500. I mean, just that's the kind of impact that we can deliver through really thoughtful application of location of delivery and the like. And that's just one example. UHC are very much focused on this in much of their guidance, and of course, Optum is building a variety of different capabilities. 
Having said all of that, I think the reality is it's very early days, even for us in terms of change in behavior against the overall trend of the health care system. So I think that baseline in of 2019 probably is the right rational piece. Over time, I think these practices will start to bear down on the overall trend of cost. But of course, that's -- that will happen as we see those capabilities spread more broadly as we see them get more adoption and that starts to change the price point in the marketplace for some of these treatments or therapies, which are frankly overpriced. And what our clients are looking for us to do, both through UnitedHealthcare and doctors who find ways to get great care at lower cost, and that's exactly what we're focused on doing. So Ricky, thanks so much for the question."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to A.J. Rice with Credit Suisse.",9,"Next, we'll go to A.J. Rice with Credit Suisse."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I might just continue to focus on OptumRx. You've got good script growth and a pickup in margin. there. There are 2 things that are sort of impacting script growth. It seems like to me across some of the companies that are reporting it One is how quickly",141,"I might just continue to focus on OptumRx. You've got good script growth and a pickup in margin. there. There are 2 things that are sort of impacting script growth. It seems like to me across some of the companies that are reporting it One is how quickly we're seeing the rebound of sort of the acute scripts as people start going back to the doctor and get new prescriptions. Can you comment on where we're at relative to prepandemic levels on that? And then vaccines and some of the script reporting is having an impact. I'm not sure that, that's relevant for you guys in OptumRx, but can you sort of parse that out in any way? And then I guess, just any comments on the selling season for OptumRx and for this year going into next that you see?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, listen, that's a great question, A.J. And before I hand it over to Heather Cianfrocco, our Head of OptumRx, let me just make a couple of introductory remarks. That 8% script growth, about half of that is we would estimate kind of bounce back fr",161,"Yes. No, listen, that's a great question, A.J. And before I hand it over to Heather Cianfrocco, our Head of OptumRx, let me just make a couple of introductory remarks. 
That 8% script growth, about half of that is we would estimate kind of bounce back from the suppression of this time last year caused by the COVID -- the initial waves of the COVID disruption. But even having said that, the 4% residual growth is great. And we feel very good about the performance of the OptumRx business across its breadth of businesses. So within the kind of core PBM, but also across all of its various other pharmacy services businesses, which the company has been invested in over the last several years. We did about 10 million vaccine prescriptions, I think, year-to-date. 
To give you a little bit more detail on that and a little bit further into selling season observation, maybe hand over to Heather. Heather, go ahead."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Andrew. Thanks, A.J., for the question. So yes, I think as Andrew said, so maybe I'll take script volume quickly and then just to finish that off and then maybe talk a little bit about selling season. So as Andrew said, really, if you look at whet",433,"Thanks, Andrew. Thanks, A.J., for the question. So yes, I think as Andrew said, so maybe I'll take script volume quickly and then just to finish that off and then maybe talk a little bit about selling season. So as Andrew said, really, if you look at whether ours is indicative of other things you've seen, what I'd say is specific to us, what you've seen over the last year is, yes, about half of that is the rebound from compression. And the rest of that is really a little bit of vaccine volume, and Andrew gave you the number there but that really hits volumes for us more than anything else because of the -- just the ratio of revenue to script there. And then in addition to that, there's a continued double-digit growth in the pharmacy services businesses. So that's making up the bulk of the additional growth that you're seeing year-over-year there. 
As far as the split of acute maintenance, et cetera. So I guess I would say we just had this discussion about what baseline is. I guess, again, we're kind of watching this in quarterly progressions. But I'd basically say that we're seeing second quarter look more like '19 than it certainly did from the -- looking like second quarter of 2020. And we basically don't see anything unique there as far as acute versus -- as far as acute ratio kind of back to what we saw prepandemic for this quarter. 
Maybe let me switch quickly to selling season. So we're still in the midst of it this year, and that's for all segments that's for employer. It's for health plan, public sector and coalition. And I'd say, generally, same activity, maybe a little different pacing of decision-making right now, but really in the midst of it. The biggest thing I would say about the selling season is clients are very interested in solutions to address high cost of specialty drugs and getting to medications and therapies that really help on the medical and the pharmacy side. So for us, we're very focused on those solutions, and we're finding that our site of care services for alternative sites and alternative therapies like biosimilars, together with some of our specialty programs that work through OptumHealth and OptumRx and straddle the medical and pharmacy benefit, are really resonating, together with our really intense clinical consulting that we're bringing to the market right now. So we're finding that resonating in the selling season, and we think we've got a lot of value out there. So hopefully, that answers your question."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Heather. Really appreciate it. I might just add, A.J., one other dimension that's under Heather's leadership, which is really pertinent is behavioral health. And as I think we all recognize, that's a huge issue across the U.S. I think many of us a",212,"Thanks, Heather. Really appreciate it. I might just add, A.J., one other dimension that's under Heather's leadership, which is really pertinent is behavioral health. And as I think we all recognize, that's a huge issue across the U.S. I think many of us anticipate the COVID pandemic and various impacts from that may well exacerbate some of the trend there. But I just wanted to call out the progress of Genoa pharmacy within that. It's a business that came into our organization 2 or 3 years ago. We're going to open 60 more of those centers this year. We're already up to 582 of those centers. We're well on the way to close to double what we had when they first became part of the organization. And the impact that, that group has is extraordinary, both from a consumer NPS score 95, provider NPS score 80. The impact they have in terms of helping improve adherence for highly complex patients, particularly those patients who are served through our Medicaid books of business, is super important. So to mention that alongside the other elements of OptumRx, another key part of the growth and a key part where OptumRx is really helping our Medicaid business deliver really high-quality service for folks who need it."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Justin Lake with Wolfe Research.",9,"Next, we'll go to Justin Lake with Wolfe Research."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wanted to follow up on the helpful comments that John gave during the prepared remarks on medical cost trend. So for instance, John, you mentioned that commercial utilization was back above kind of typical. Would love to know how that progressed during",134,"I wanted to follow up on the helpful comments that John gave during the prepared remarks on medical cost trend. So for instance, John, you mentioned that commercial utilization was back above kind of typical. Would love to know how that progressed during the quarter and kind of how far above typical you saw it coming out of the quarter, what you're thinking for the rest of the year. And then any other commentary on Medicare and Medicaid there? And then also, if you could give us your view on this new Biogen Alzheimer's drug in terms of how you think things develop in terms of price -- in terms of pricing and physician take-up or patient take-up rates and how you think you're going to manage this process would be great as well."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Justin, thanks so much. I'll address the Alzheimer's drug issue in a second. But first of all, I'd like John maybe to pick up on your broader MCR questions.",30,"Yes, Justin, thanks so much. I'll address the Alzheimer's drug issue in a second. But first of all, I'd like John maybe to pick up on your broader MCR questions."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, good morning. A little color perhaps on how that progression occurred in the quarter here. So as it relates particularly thinking about the quarterly progression that we saw, perhaps not unsurprisingly, COVID testing and treatment costs were highe",165,"Justin, good morning. A little color perhaps on how that progression occurred in the quarter here. So as it relates particularly thinking about the quarterly progression that we saw, perhaps not unsurprisingly, COVID testing and treatment costs were highest in the month of April, actually trending up a little bit from what we saw in March, and that tracks with the incidence rates and the hospitalization rates that we would have been seeing and then that trending down pretty rapidly in May and June in terms of the number of individuals in hospital beds and the treatment costs. 
In terms of utilization in commercial populations, interestingly, that was also the highest course of the quarter but still just marginally -- very marginally above baseline as we -- in June as we exited June. Just to give you a little color commentary on how that was progressing. So that was really the trending that we saw within that. And Andrew, I'll turn it back to you."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, great. Thanks, John. The other thing I'd say, Justin, is there's plenty of noise within those numbers that John just described, right? So you see inpatient outpatient physician visit trends different by different books of business. It's a more co",171,"Yes. No, great. Thanks, John. The other thing I'd say, Justin, is there's plenty of noise within those numbers that John just described, right? So you see inpatient outpatient physician visit trends different by different books of business. It's a more complex picture than it looks on the surface. 
As far as the Alzheimer's drug is concerned, I'm going to -- in a second, I'm going to ask Dr. Migliori, our Chief Medical Officer, to make a couple of comments on this particular thing. I mean overall bottom line from our perspective is this remains obviously a super important area for patients' families to look for progress in. We all want to see that progress happen I think from where we stand today, there's still a lot of information that we need to be able to make really clear decisions. And I think we're not the only ones in that regard looking for greater clarity in this arena. Maybe Dr. Migliori, you might give a perspective from the medical perspective, please."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew, and you said it well. We are encouraged to see meaningful progress being made against this devastating disease and advances in its treatment. We are continuing to develop our clinical policy as well as our ultimate position on coverag",109,"Yes. Thanks, Andrew, and you said it well. We are encouraged to see meaningful progress being made against this devastating disease and advances in its treatment. We are continuing to develop our clinical policy as well as our ultimate position on coverage. But in doing so, we're looking forward to getting the guidance that we need from Medicare and also, looking at the continually contributing clinical outcomes that are coming from the clinical evidence that comes from the ongoing clinical trials. But most importantly, we're looking for the advice from those expert professional organizations, the physicians who have committed their career to helping people with this devastating disease. Andrew?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks so much, Dr. Migliori in. Justin, I think bottom line is I think this has some way to go before we get to real clarity. So I wouldn't guide you to expect a very rapid decision-making on this piece, not because we don't want to see these good e",167,"Yes. Thanks so much, Dr. Migliori in. Justin, I think bottom line is I think this has some way to go before we get to real clarity. So I wouldn't guide you to expect a very rapid decision-making on this piece, not because we don't want to see these good effective treatments being made available. Of course, we do. But it's really important to have a real clear understanding of really how they should be used, what their value is in utilization and Dr. Migliori already said really well, really understanding where CMS get recognized in the MA population likely to be a very significant fraction of utilizers. We need to understand where all of that is. 
So I think this is potentially good news, but it's still early days, and we have a lot more to learn before we can be more definitive than that. So can't be too much more helpful at this point. I'm afraid, Justin. But thank you so much for the question."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ralph Giacobbe with Citi.",8,"Next, we'll go to Ralph Giacobbe with Citi."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to stick on to that last question. So it sounds like commercial was marginally above baseline for the quarter. Hoping you can give us similar comments on sort of magnitude of how much lower Medicare and Medicaid are. And then also, if you could pro",93,"I want to stick on to that last question. So it sounds like commercial was marginally above baseline for the quarter. Hoping you can give us similar comments on sort of magnitude of how much lower Medicare and Medicaid are. And then also, if you could provide any sense of magnitude of the rising you embed in guidance at this point for the second half of the year, if you could frame that just in terms of what normal growth would be and maybe what you're embedding or how much higher guidance contemplates"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Ralph, thanks so much. I'm going to ask John to reflect on the second part of your question in terms of forward-looking for the second half of the year. Just to nail this first part, though,  the commercial book, as you've heard already now from John",100,"Yes, Ralph, thanks so much. I'm going to ask John to reflect on the second part of your question in terms of forward-looking for the second half of the year. Just to nail this first part, though,  the commercial book, as you've heard already now from John a couple of times, basically right on baseline, maybe a hair above but right there. And then the 2 government books of business, a few percentage points below. So I won't go further than that. But maybe, John, you could give some insight into how you're seeing things within the next 6 months."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, Ralph. Yes. So then you blend a little bit -- just a little bit below overall, right? When you blend the books and you weight our books across in terms of what we are seeing in the second quarter. And then as you might expect, that trends up",353,"Good morning, Ralph. Yes. So then you blend a little bit -- just a little bit below overall, right? When you blend the books and you weight our books across in terms of what we are seeing in the second quarter. And then as you might expect, that trends up progressively every quarter, every quarter, you'd see rising in that overall level utilization and the expectations as we head into the end of the year. 
Embedded in that is also a view in terms of what happens with intensity, acuity levels. One comment that -- a question that we've often received is what are we seeing currently in acuity levels to progress. And part of the impact as we progress in the second half is an expectation that you do see rising acuity levels. I'd tell you, we haven't observed that yet, but it's still probably a little bit early to say. When we -- among the things we look at, we look at new cancer diagnoses, new cardiac diagnoses. Those are still running below baseline levels that we'd expect. But they're -- a view to that could continue to progress as we get into the back half of the year. 
The other element in terms of just thinking about utilization and rising in the back of the year is -- and ultimately, this is one of the calls, what occurs with COVID testing and treatment costs. Clearly, there's been the evidence of the new variants and their impact in other countries and then also moving into the U.S. And even in our own data, we can see that but I would tell you still fairly limited in terms of impact. And as I sit here and look at a number of members of our members that we have in receiving treatment today in hospital beds today as you say here this morning, still well below the levels even we sit here in mid-July, what we were seeing in the April level. but that could be a trend back factor also in the second half of the year as we see that progression."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next we'll go to Scott Fidel with Stephens.",9,"Next we'll go to Scott Fidel with Stephens."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to ask a question around Medicare Advantage. Just interested in terms of what you've been seeing progressing year-to-date around the risk scores and how that's been normalizing relative to the post-pandemic disruption. And then just also interested",65,"I want to ask a question around Medicare Advantage. Just interested in terms of what you've been seeing progressing year-to-date around the risk scores and how that's been normalizing relative to the post-pandemic disruption. And then just also interested if you've received the update yet from CMS on the midyear risk score updates. And if you could share how those came out relative to expectations."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, thanks so much for the question. I'm going to pass that over to our new CEO of UnitedHealthcare BT. BT, you and Tim might like to address those 2 points from Scott. BT?",34,"Scott, thanks so much for the question. I'm going to pass that over to our new CEO of UnitedHealthcare BT. BT, you and Tim might like to address those 2 points from Scott. BT?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. I'll start. I think as a follow-on, perhaps -- this is Brian Thompson. Thanks for the question. To the question around engagement levels, I think the piece that I am most encouraged by is the physician engagement levels. And in particular, in our se",96,"Sure. I'll start. I think as a follow-on, perhaps -- this is Brian Thompson. Thanks for the question. To the question around engagement levels, I think the piece that I am most encouraged by is the physician engagement levels. And in particular, in our senior communities, we're really seeing strong receptivity certainly reflective of the vaccination rates. And I think that's really giving us encouraging signals overall not only to 2022 but just the population and health at large. With that, I'll turn it over to Tim to talk a little bit more specifically about MA."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, thanks for the question. Yes. The revenue for 2021 and the risk scores that support those are totally in line with our expectations, as John indicated in his remarks. And yes, we did receive the midyear payment from CMS, which gives us a more fulso",80,"Scott, thanks for the question. Yes. The revenue for 2021 and the risk scores that support those are totally in line with our expectations, as John indicated in his remarks. And yes, we did receive the midyear payment from CMS, which gives us a more fulsome view into what 2021 revenue is. And again, that aligns to our expectations. And at this point, we consider 2021 revenue to be pretty complete in terms of what we'll know about risk scores."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Dave Windley with Jefferies.",8,"Next, we'll go to Dave Windley with Jefferies."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wondered, relative to your conversations about the relative headwinds. Does your view of your ability to recoup the $1.80 in '22, is that influenced at all by the timing of when these things hit if they do in the second half of '21? So be curious about",52,"I wondered, relative to your conversations about the relative headwinds. Does your view of your ability to recoup the $1.80 in '22, is that influenced at all by the timing of when these things hit if they do in the second half of '21? So be curious about your comments there, please."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. And I'll ask John in a sec to give you more on this. I mean, first off, obviously, again, we're not going to be really shining the light on our expectation for '22 yet. Having said that, we also think the majority of the $1.80 headwind will have been",104,"Yes. And I'll ask John in a sec to give you more on this. I mean, first off, obviously, again, we're not going to be really shining the light on our expectation for '22 yet. Having said that, we also think the majority of the $1.80 headwind will have been utilized this year will essentially be recurring -- Of course, that depends on some assumptions around the pandemic itself remaining under control. I mean, so that is an observation which has to be taken in. John, you may want to go a little deeper on how each of the elements perhaps you think about."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. A few factors on that and how timing might impact, though. So maybe just to refresh a little bit on that. Tim did a nice job describing the impacts in terms of -- the revenue impacts from particularly our Medicare Advantage members being able to be",293,"Sure. A few factors on that and how timing might impact, though. So maybe just to refresh a little bit on that. Tim did a nice job describing the impacts in terms of -- the revenue impacts from particularly our Medicare Advantage members being able to be seen by their physicians. We are encouraged by what's going on in our HouseCalls activity, very strong receptivity to those. BT just mentioned, encouraged by what we're seeing in terms of seniors and their receptivity to even going in and seeing their physicians. That's all super important. 
I don't know if timing is so important on that piece. It just needs to occur during the year in terms of when that activity occurs. So that would be more the more important factor as it relates to 2022. Does it occur in 2021? Do they get in? So that's an important factor. 
Other factors here, I would say. So there's care that didn't occur in 2020 and probably hasn't occurred in '21 yet that was deferred and needs to occur. So that's more about also an element of, does it not occur at all in this year; does it work its way into 2022 and the potential for and kind of the resident impact of whether or not there's an increase in acuity or that -- from those populations. 
That -- those are really kind of the main elements, I would say, in terms of what I would call timing-related. The other elements are more just -- would be around this concept around the occurrence of COVID-19 incidents, direct treatment and testing costs, how that progresses over the back half of the year, too. But those would be the elements that would be sensitive to timing factors."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Lance Wilkes with Bernstein.",8,"Next, we'll go to Lance Wilkes with Bernstein."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Yes. You made a comment about Virtual First offerings helping to drive incremental membership growth this year. Can you talk a little bit about what the digital first and or Virtual First offerings look like? And then is that contribution in '21? Or -- an",66,"Yes. You made a comment about Virtual First offerings helping to drive incremental membership growth this year. Can you talk a little bit about what the digital first and or Virtual First offerings look like? And then is that contribution in '21? Or -- and if it is, could you talk a little bit about in the sales cycle, how it's looking for uptake in '22?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great question, Lance. Thanks. I'm going to ask Dirk in a second to make a couple of comments around the overall shift towards digital first, virtual first and may also ask Dr. Decker to refer to some of further what's going on within OptumHealth, which i",273,"Great question, Lance. Thanks. I'm going to ask Dirk in a second to make a couple of comments around the overall shift towards digital first, virtual first and may also ask Dr. Decker to refer to some of further what's going on within OptumHealth, which is an important around Optum virtual. 
As I've made super clear over the last couple of quarters, really elevating our consumer focus is a top priority for the whole company. And that really speaks to ensuring that we're delivering simpler, more intuitive experiences that we're thinking about the journey of the consumer and the patient in an end-to-end sense, that we're making it easier for them to make all of the various sequential decisions. And we also want to meet the consumer where they want to be met, whether that be outside of a facility in their home, online or in person. 
And we also -- we fully recognize how the premium that patients and consumers in particular put on being able to talk to the physicians they know rather than  just any physician. And so how we start to pool all of that together is essentially reflected in many of the different initiatives we have. 
Over the last few quarters, you've seen us build up things like Optum Virtual, Dr. Decker will talk to you in a second. But things like Optum Store just been rolled out under the OptumRx organization really starts to bring together a ton of access for consumers in terms of what they're able to do with us. 
With that introduction, Dirk, I'd love to get your perspective and then maybe Wyatt. Dirk."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew, and Lance, for the question. So of course, we've continued to see telehealth be a broadly desired consumer access vehicle to the health system. We've seen that grow. We're hoping we get to the sort of the next generation. And we think",166,"Yes. Thanks, Andrew, and Lance, for the question. So of course, we've continued to see telehealth be a broadly desired consumer access vehicle to the health system. We've seen that grow. We're hoping we get to the sort of the next generation. And we think a lot of that begins with, like, for example, with OptumCare physicians being able to deliver that because, as Andrew said, people have a good preference to go to their own physician. 
The product with respect to Virtual First, to answer your specific question, we plan on rolling that out in 8, 9 markets in UnitedHealthcare at the end of this year. What it will basically be is think of it as sort of a virtual PCP with an OptumCare dock being the quarterback with UnitedHealthcare Navigate network back in and up for the physical access. So we're starting to sort of what I would refer to as productize this, and we're hopeful -- which will aid to UnitedHealthcare's commercial growth"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks. Sure. Thanks. Wyatt, would you like to just give a little more on Optum virtual and what you've been building inside OptumHealth?",23,"Thanks. Sure. Thanks. Wyatt, would you like to just give a little more on Optum virtual and what you've been building inside OptumHealth?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Lance, for the question. We are bringing together the virtual care experience that we stood up rapidly during the pandemic with over 18,000 providers on to, as Dirk mentioned, a next-generation technical solution that we've created, which cre",160,"Yes. Thanks, Lance, for the question. We are bringing together the virtual care experience that we stood up rapidly during the pandemic with over 18,000 providers on to, as Dirk mentioned, a next-generation technical solution that we've created, which creates the opportunity to seamlessly onboard and triage an individual virtually. So we make sure they're getting the right care in the right environment, whether that's virtual, physical or a behavioral health care need. And we believe that, that is a differentiated patient experience. 
And the second, which Dirk mentioned, but I'll underscore, is a focus on primary care delivery and keeping people tethered to their trusted and known providers. And as this matures, we're live today in all 50 states, to be clear, and we'll continue to roll this out in a more comprehensive way to our OptumCare patients as well as members of UHC and other payers and look forward to continued conversations about our capabilities here. Thank you."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Wyatt. I think, Lance, just to close this out. This is -- I'm excited about what's been built in OptumHealth. If you think about this build-out of ambulatory clinic facilities and other attendant services perhaps in the pharmacy space, you think a",203,"Thanks, Wyatt. I think, Lance, just to close this out. This is -- I'm excited about what's been built in OptumHealth. If you think about this build-out of ambulatory clinic facilities and other attendant services perhaps in the pharmacy space, you think about the home and community agenda really investing to make sure that folks who want to spend as much time at home as possible are able to do that, and then you see Optum virtually essentially pooling all of that together. This -- you've got to think about this as all 3 of those elements essentially all at play at the same time. 
The very -- I think it's a very important step forward. It gives us a really significant opportunity to ensure that we deliver a much more seamless experience. We're much more responsive to consumer need, and we can focus on bringing costs down, delivering better care. That's what we really believe we can do here. This is  -- you're going to hear a lot more about this. It's an important step-up in the energy around our OptumHealth strategy. 
We just have time, I'm afraid, for one last question. So Alan, if you could ask for last question, please."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll take our last question from Matt Borsch with BMO Capital Markets.",13,"We'll take our last question from Matt Borsch with BMO Capital Markets."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Okay. I realize you're parsing through everything that happened last year and now the catch-up in care this year. Are you getting a perspective yet on how much of the care was unnecessary that would have happened but is not actually going to occur. And I",76,"Okay. I realize you're parsing through everything that happened last year and now the catch-up in care this year. Are you getting a perspective yet on how much of the care was unnecessary that would have happened but is not actually going to occur. And I guess you put that into -- was unnecessary, but maybe what's necessary at the time because the person to know and care that was just unnecessary proactively and in hindsight?"
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Matt, thanks so much for the question. It's a really -- it's a great question. And you would have to expect that the answer is that some of it would have been unnecessary. I think at this distance, it's a little hard to really call that at this point",372,"Yes, Matt, thanks so much for the question. It's a really -- it's a great question. And you would have to expect that the answer is that some of it would have been unnecessary. I think at this distance, it's a little hard to really call that at this point. I mean there are some tantalizing signals in some of the trends. So if you look at emergency department use, for example, it looks pretty sustained down and doesn't seem to be coming back. 
And certainly, if you look at our Advisory Board surveys that we're running with many, many non-UHC providers and institutions across American Healthcare, people don't -- a lot of people don't expect that ED utilization to come back. Now that may be because they would be unnecessarily used. Maybe folks have realized that urgent care centers are a much better option. Maybe virtual is a much better option that they can get what they need at a much lower cost. 
So whether it's unnecessary, whether or not the pandemic has disturbed people's allegiance for certain types of sites of care and people are a little bit more open-minded about where to go, all of that, I think, is in play. I would say it's premature to call it. I think we're watching it really carefully. I could build those theories I just shared with you. I'm not going to tell you that those are [indiscernible]. I think there is tantalizing signals in the data. It's going to take another 6, 12 months before you can really settle out how this all plays. But Matt, thanks for the question, and we'll probably loop back on that one again, I'm sure. 
Listen, everybody, I want to say thank you for all of your attention today, for your participation. Very much appreciated. And we hope very much that what you've heard from our team gives you a flavor of why we have such confidence in the outlook for our company and in the ability of Optum and UnitedHealthcare separately and together to improve the lives of those we serve and the health system overall. And with that, I'd like to say thank you very much and to close this morning's call."
104673,1671940210,2346015,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","That does conclude today's conference. We thank everyone again for their participation.",13,"That does conclude today's conference. We thank everyone again for their participation."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Good morning, everyone. Welcome to today's UnitedHealth Group Second Quarter 2021 Earnings Conference Call. A question-and-answer session will follow UnitedHealth Group's prepared remarks. As a reminder, this call is being recorded.Here is some importan",194,"Good morning, everyone. Welcome to today's UnitedHealth Group Second Quarter 2021 Earnings Conference Call. A question-and-answer session will follow UnitedHealth Group's prepared remarks. As a reminder, this call is being recorded.
Here is some important introductory information. This call contains forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings.
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the financial and earnings reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated July 15, 2021, which may be accessed from the Investor Relations page of the company's website.
I will now turn the call over to the Chief Executive Officer of UnitedHealth Group, Andrew Witty. Please go ahead, sir."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us. As we discuss our enterprise today, I hope you sense its growing momentum as we advance on our path of improving the quality, cost and experience of health care for everyone we serve. Both Optum and UnitedHealth",617,"Good morning, and thank you for joining us. As we discuss our enterprise today, I hope you sense its growing momentum as we advance on our path of improving the quality, cost and experience of health care for everyone we serve. Both Optum and UnitedHealthcare grew and delivered on our long-standing strategy. And we've increased our outlook for the year to a range of $18.30 to $18.80 per share.
We continue to prioritize 3 key themes that we believe will underpin the next era of growth for our enterprise: first, unlock the collaborative opportunities within and between Optum and UnitedHealthcare; second, increasingly apply technology to improve patient care and experience and to help the system run better; and third, strengthen our consumer focus, capabilities and value.
During the quarter, we accelerated our efforts to develop and deploy new and innovative products, informed by the insights of both Optum and UnitedHealthcare in areas such as oncology care delivery, rare disease drug management, Optum Virtual, Optum Financial Services and many others. We're doubling down on efforts to both expand and link services where it creates value for consumers and patients to make their health care journey easier, simpler and more intuitive.
We constantly challenge ourselves to develop capabilities which lead to improved care, better value and a simpler system. Our sales to clients and partners across all parts of the health system demonstrate the strong relevance of our innovation. And the strengthening of our sales pipeline is a key opportunity as we emerge from the COVID market pause.
A good example of bringing our collective strengths together at scale is the Optum home and community care platform, through which we care for nearly 10 million people. This platform includes our well-known HouseCalls service, comprehensive post-acute care for smoother transitions to home and integrated primary and behavioral care for Medicare Advantage patients who prefer to receive their care at home. Home and community platform services can reduce post-acute medical care cost by 1/4, unnecessary readmissions by up to 1/5 and hospital admissions by up to 25%.
In Medicaid, we're addressing consumer needs by expanding our long-term collaboration with public housing authorities, working with government agencies and community-based organizations to identify and address specific health care issues for people who are hard to reach and support. In just the past 6 months, we've introduced new partnerships in over 20 communities to close gaps in care and address health equity challenges.
Using data and analytic capabilities, we're able to rapidly identify local health trends and gaps and then work with community partners to inform guidelines, training materials, processes and create better tools to advance health. We believe this will result in better health of community members and help to optimize limited state resources.
These and other targeted initiatives on the social determinants of health are essential elements and illustrative of our natural and long-standing ESG impact. Our recently published sustainability report captures the full range of efforts we've dedicated ourselves to in areas of crucial concern to our stakeholders, none more so than advancing health and health equity. This agenda is an essential part of our way of doing business.
I'd like to thank our 330,000 colleagues from across the company for the passion and diligence they show every day in helping to deliver improvements in serving our members, clients and patients. I have great confidence that we're emerging from the last 18 months of disruption with an unprecedented set of opportunities to help improve the health system for all of those we can serve.
And now I'll turn it over to President and Chief Operating Officer, Dirk McMahon, to provide more detail on the initiatives to drive performance across the organization."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Andrew. In an enterprise with our breadth of market engagement, we have many ways to assess how we're doing. I'd like to share some of those metrics with you, picking up on Andrew's commentary on our 3 key strategic themes. First, collaborati",613,"Thank you, Andrew. In an enterprise with our breadth of market engagement, we have many ways to assess how we're doing. I'd like to share some of those metrics with you, picking up on Andrew's commentary on our 3 key strategic themes. 
First, collaboration. UnitedHealthcare's value proposition is rooted in lower costs, better outcomes and a better experience. Optum supports this value proposition for UnitedHealthcare and other health plans with ambulatory services, which patients and their doctors value.
In this quarter, we met the ambulatory surgery needs of over 250,000 patients, delivering exceptional care in convenient and affordable settings, with revenue growth approaching 20% over the nonpandemic-affected 2019 second quarter. These centers are meeting higher acuity and more complex needs, such as total joint replacement spine and cardiovascular procedures, which are performed at an increasing number of centers. 
Our ambulatory settings received a consumer NPS of 92. And we deliver better and more consistent quality outcomes at about half the cost of traditional settings.
Optum Care has over 1,600 clinics and is rapidly expanding virtual offerings to serve patients in settings where they feel the most comfortable and, importantly, with their own physician. Seniors served by Optum Care under our integrated care approach spend considerably more time with their primary care physicians than seniors in traditional Medicare and, as a result, spend 1/3 fewer days in a hospital.
Second is our strategy to increase the application of technology to improve patient care and help the system run better. We recently announced the partnership with Bassett Healthcare, another strong example of how OptumInsight is helping health systems to expand and scale essential capabilities, including revenue cycle management and digital modernization to improve health outcomes and patients' health care experiences. We expect to continue to add new partnerships like this. 
Also at OptumInsight, we've been tackling the most resource-intensive operations through the deployment of advanced technology and other approaches. For example, we have transformed what were once largely manual chart review processes into highly automated operations.
Third, we have been hard at work advancing our consumer capabilities. UnitedHealthcare has made significant advances in the management of complex conditions. We're focused on making sure that patients with the highest acute care needs are able to access the most appropriate site of care by assigning them advocates to help navigate the system. Nearly 1 million of these members are matched with a personal navigator to help them manage and improve their health. 
OptumRx continues to improve access and affordability of home delivery for patients, leading to significant improvements in continuity of care and having already reduced the cost to process and dispense prescriptions by nearly 20% in just the past 2 years. Also, along consumer cost savings lines, for those who prefer an in-store retail experience, we now offer tools to find the lowest-cost prescriptions near them regardless of the health benefits -- of their health benefits coverage status. These tools can save self-paying consumers up to 80% on their medications.
Consumer preference is also having an impact in behavioral health. Already this year, the OptumHealth behavioral platform has delivered over 500,000 virtual visits, an option we initiated in just the last year. Many consumers and clinicians prefer these virtual encounters since they offer enhanced accessibility, flexibility and simplicity. Care encounters delivered through our dedicated channel have a patient satisfaction of 98%.
These are just a few of the many initiatives we are executing on as we apply technology, data and analytics to make our strategic growth agenda come alive. We look forward to updating you on our progress over the quarters to come.
With that, now I'll turn it over to Chief Financial Officer, John Rex."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dirk. Our first half performance supports the foundation for strong and expanding growth for the remainder of this year and beyond. Before I review business performance, I'll offer a brief perspective on the pandemic-driven trends we're observi",630,"Thank you, Dirk. Our first half performance supports the foundation for strong and expanding growth for the remainder of this year and beyond. Before I review business performance, I'll offer a brief perspective on the pandemic-driven trends we're observing.
The core takeaway is that our outlook for COVID-19 impact is consistent with our past commentary. The second quarter showed overall care activity continuing to trend toward baseline or normalized levels albeit with variation across lines of business. For example, in commercial markets, care activity was above baseline as members were willing and able to obtain needed care, some of which was deferred from prior periods. Our public sector markets continue to run below baseline even as we are actively encouraging people to get the care they need. We were gratified to see care activity for these populations begin to progress over the course of the quarter as vaccination rates advanced.
We continue to estimate approximately $1.80 per share of unfavorable COVID-19 impacts for full year 2021 and to expect the majority of these effects to occur in the second half.
Moving to overall business performance. OptumHealth's second quarter revenue and earnings increased 46% and 34%, respectively, year-over-year. Revenue per consumer grew by 43%, reflecting the impact of accountable arrangements and our expanding home and community health platform, combined with the growing complexity of the needs we're serving. Of the 20 million patients we serve through Optum Care, over 2 million are in fully accountable or capitated care arrangements, an increase of 17% from a year ago. And we expect this pacing to accelerate strongly in the years ahead.
OptumInsight's revenue grew 12% in the quarter and earnings grew 36%, with the revenue backlog increasing by $1.9 billion to $21.3 billion. Key growth drivers were managed services, the continued recovery of care activity to more normal levels and further implementations of technology-enabled services. In particular, we are seeing strong sales momentum in the services, software and analytics businesses, which serve care providers.
OptumRx revenue and earnings increased 5% and 19% year-over-year and script growth was 8%, with this comparison impacted by last year's pandemic-affected care patterns. Our expanding pharmacy care and specialty services continue to grow strongly, now comprising just under half of OptumRx revenues.
Turning to UnitedHealthcare. We are encouraged by the receptivity to our expanding set of responsive commercial benefits, centered around virtual-first, on-demand and physician-led offerings. Year-to-date, we have added about 150,000 members in such innovative commercial offerings even with the evolving and uneven labor market trends which impacted second quarter membership.
Medicare Advantage membership has grown by 675,000 year-to-date, tracking well to our full year outlook. Our HouseCalls clinicians have been able to provide their vital services to seniors, conducting over 1.1 million home visits in the first half, more than double the year ago level.
People served in managed Medicaid programs grew by nearly 920,000 over the year ago quarter, in part as state-based redetermination activities remained on hold. Our Medicaid offerings continue to deliver a positive consumer experience and demonstrable cost effectiveness for our state government partners. And we look for this momentum to build, heading into next year.
Our liquidity and capital positions remain strong with second quarter cash flows from operations at $5.5 billion or 1.3x net income. And we ended the quarter with a debt-to-capital ratio of 40%. And in early June, our Board of Directors increased the dividend by 16%.
As noted earlier, given the strength of our business performance, we've updated our full year adjusted earnings per share outlook to a range of $18.30 to $18.80 per share, inclusive of the COVID-19 impact incorporated into our full year view. Within this, we expect the pacing through the second half to be fairly level.
Now I'll turn it back to Andrew."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, John. What we tried to provide you with this quarter as we do each time is a sense not only of what UnitedHealth Group's results are but how we achieve them. The examples we've referenced and countless others throughout this enterprise, along with",108,"Thanks, John. What we tried to provide you with this quarter as we do each time is a sense not only of what UnitedHealth Group's results are but how we achieve them. The examples we've referenced and countless others throughout this enterprise, along with the consistent execution by our colleagues, are what underpin our confidence in our long-term 13% to 16% EPS growth rate target and in our ability to help people live healthier lives and help the health system work better for everyone over the years to come.
With that, operator, let's open up the call for questions. One question per caller, please. Alan, over to you."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions] The first person we'll take a question from will be Kevin Fischbeck with Bank of America.",18,"[Operator Instructions] The first person we'll take a question from will be Kevin Fischbeck with Bank of America."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","All right. Great. I guess you guys reported 2 quarters in a row but raised guidance both times by less than the beat. You singled out the $1.80 headwind included in the guidance. Is there any other kind of major onetime positives or negatives in the guida",86,"All right. Great. I guess you guys reported 2 quarters in a row but raised guidance both times by less than the beat. You singled out the $1.80 headwind included in the guidance. Is there any other kind of major onetime positives or negatives in the guidance that we should think about when thinking about this year as a base for how to forecast future numbers? And is there anything offsetting the upside in the first half that we should think about in the back half?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, thanks so much for the question. Before I ask John to give a little bit more detail, I mean a couple of things. Obviously, still too early to give you kind of real shape in -- for 2022. So you won't be surprised we won't go there.And I would say",262,"Kevin, thanks so much for the question. Before I ask John to give a little bit more detail, I mean a couple of things. Obviously, still too early to give you kind of real shape in -- for 2022. So you won't be surprised we won't go there.
And I would say the overwhelming story for this year is, of course, the dynamic of COVID in terms of the various puts and takes which are taking place under the surface. And as we've done for the last several quarters, we've tried to kind of dimension that within the $1.80. But as we've also said repeatedly, the bulk of that $1.80 sits in the rest of the year, the year to go between now and the end of 2021.
And so really, really pleased with the momentum and underlying performance of the company in the first 2 quarters of this year but also respectful of uncertainties that remain around the COVID puts and takes. And, of course -- and that all feeds into how we make the judgment on raising the earnings expectation for the rest of the year.
I think where I sit, I feel great about that underlying performance. So far, broadly speaking, the COVID dynamic has played the way we would have anticipated, more or less. But there's still a ways to go and there are uncertainties within that. 
Maybe, John, you might go a little further and take that $1.80 apart and maybe reflect a little bit on how you're seeing those different elements of the driver of that."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, it's John Rex. Yes, just to get a little further into those. So within the $1.80, we still expect about 70% of that to occur within -- in the second half of the year. So the vast majority, a lot to be seen on how that $1.80 really plays out.Keep",313,"Kevin, it's John Rex. Yes, just to get a little further into those. So within the $1.80, we still expect about 70% of that to occur within -- in the second half of the year. So the vast majority, a lot to be seen on how that $1.80 really plays out.
Keep in mind kind of the main elements that, that comprises. It's the direct treatment and testing costs that we would see, offset by elective care deferral that might continue to occur or not in the rest of the year. The potential for higher acuity for those that have missed or deferred care. And at least within 2021, the impact of the care deferrals that occurred last year.
So those are all super important components here. Within those elements, the things to play out would be most around the direct treatment and testing costs and the potential for higher acuity and how much care occurs in the back half.
The other elements within the $1.80, I would say, are more steady throughout the course of the year, so that point being around care deferral in 2020 and the related revenue impacts for 2021. Those should be relatively steady and I would say are running in line with the expectations that were set out for you back in December. So I don't think we've had a surprise on that element within our outlook. And I would say the kind of economic impacts, also pretty relatively steady over the course of the year in terms of the quarterly progression.
So those are really the elements we continue to look for. You're right. Look, we saw good strength in a lot of the business, growth across the platform. Really, we could point to every business. But it's that look-out to really understanding how those trends play in the second half of the year. Thank you."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll next go to Josh Raskin with Nephron Research.",10,"We'll next go to Josh Raskin with Nephron Research."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Here with Mr. Percher as well. So our question again this quarter is around Optum Care. And I think the question is really how do you think about the capacity constraints for Optum Care. Is that more on the provider side or gaining consumers in the totali",133,"Here with Mr. Percher as well. So our question again this quarter is around Optum Care. And I think the question is really how do you think about the capacity constraints for Optum Care. Is that more on the provider side or gaining consumers in the totality of OptumHealth? And with all of these sort of new options or what appear to be new options available to physicians, how are you convincing docs that Optum is the best solution? 
And lastly, and I know I apologize for the last part here, but -- is there an argument to be made that Optum Care -- and not Optum overall but just the Optum Care segment would be more valuable to shareholders as a stand-alone company because of the physician independence issue that comes up?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So Josh, thanks so much for the questions. And before I -- I'm going to ask Dr. Decker to make a few comments in a minute or 2 but maybe just make a couple of introductory observations.So first off, I think you're really starting to see OptumHealth broa",471,"So Josh, thanks so much for the questions. And before I -- I'm going to ask Dr. Decker to make a few comments in a minute or 2 but maybe just make a couple of introductory observations.
So first off, I think you're really starting to see OptumHealth broadly. And within that business, in particular, Optum Care and, of course, home and community really starting to demonstrate their capacity for growth because of the scale of the footprint that they now establish across the country. And I think you're starting to see these businesses move into a kind of critical mass dynamic. That's reflected in its overall growth.
It's also reflected in this very rapid expansion of OptumHealth revenue per consumer, up over 40% this quarter. That's reflective of the quality of services which are being delivered and the perceived value that they obviously reflect. So we feel very good about that.
Your question around capacity constraints is a really good question. we continue to extend rapidly the number of physicians and clinicians in our organization either directly or through affiliation. This year, we expect to add about 10,000. We're well over halfway through that journey, so going super well on that front.
I would say one of the key elements is really making sure that those practices, as rapidly as possible, start to develop the skills to be able to manage capitated risk, which is really what then drives a tremendous amount of the distinctive behavior and value creation for patients and, of course, for the system. That process, I think, has been continually refined.
As you would be well aware, in the marketplace, people have tried different models. They don't always work super well. I'll maybe ask Dr. Decker in a second to dive a little bit more detail into some of the work they're doing there to accelerate that dimension of capacity because it's not simply having the practices and the clinicians. It's having that way of working, which really drives the change in what we're able to do.
As far as your last question is concerned, I actually think that the Optum Care clinics within the broader Optum and UHG organization, that's where some of the magic really sits here in terms of being able to leverage many different aspects. And as you see these elements of OptumHealth and Optum Care, in particular, develop, you're also seeing significant amounts of support and health, if you will, being provided by other businesses across the organization. Payment integrity, a good example, beginning to be adopted by parts of Optum Care.
So with all of that, I'd like Dr. Decker, maybe just to go a little deeper on how we move -- or how we help practices develop the capabilities which allow them to deliver the value we're now seeing."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew, and thanks, Josh, for the question. To Andrew's comment, we are increasingly bringing our depth and breadth in value-based care delivery to new markets that have been historically fee-for-service. And you'll see this unfolding right n",183,"Yes. Thanks, Andrew, and thanks, Josh, for the question. To Andrew's comment, we are increasingly bringing our depth and breadth in value-based care delivery to new markets that have been historically fee-for-service. And you'll see this unfolding right now and over the next year or 2 in markets like the Pacific Northwest and the Northeast, where we have -- we've acquired and grown considerable clinical delivery assets. But we are now bringing the expertise in markets like Texas and Southern California that have been delivering value-based and full risk capitated care for years. And so that really is a differentiator for us.
And the other piece I'd build on is Andrew's comment around how we are creating a comprehensive set of offerings that address virtually every aspect of an individual's health care journey from a focus on primary care and keeping you healthy and well to post-acute care to end-of-life care and complex care in all environments, virtual, home and in the clinic. And that, to us, as we bring that together and connect the dots, is a differentiator in all markets. Thanks."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ricky Goldwasser with Morgan Stanley.",9,"Next, we'll go to Ricky Goldwasser with Morgan Stanley."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","So many of the initiatives that you are putting in place and the asset that you're putting together are leading to lower utilization, at least the hospital setting, in a move to lower cost setting. So keeping this in mind and when we see the lower utiliza",66,"So many of the initiatives that you are putting in place and the asset that you're putting together are leading to lower utilization, at least the hospital setting, in a move to lower cost setting. So keeping this in mind and when we see the lower utilization, at least on the public side, do you still think that 2019 is the right baseline for utilization?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ricky, that's a great question. So you're quite right that a lot of what we're -- we focus on is, well, first and foremost, to try and understand what is the very best care that an individual needs and to make sure that they get access to that. And one of",387,"Ricky, that's a great question. So you're quite right that a lot of what we're -- we focus on is, well, first and foremost, to try and understand what is the very best care that an individual needs and to make sure that they get access to that. And one of the big things we've been doing this year is trying to get people, particularly seniors, back into the system, those who may be held back because of the pandemic. And as you heard earlier, we're glad to see some of that move in albeit some way to go.
Now within that, we also recognize there are a whole series of places where, frankly, there are better, more effective ways to deliver care. I'm going to pick out one very simple example just to build on what you described. So if I think about some of the work that's going on at OptumRx and within our Optum infusion business, you can take drugs where perhaps $10,000, $15,000 per treatment for a hospital outpatient, exactly the same drug being delivered by Optum at-home infusion, $3,500.
I mean just -- that kind of -- that's the kind of impact that we can deliver through really thoughtful application of location of delivery and the like. And that's just one example. UHC are very much focused on this in much of their guidance. And of course, Optum is building a variety of different capabilities.
Having said all of that, I think the reality is it's very early days even for us in terms of change in behavior against the overall trend of the health care system. So I think that baseline of 2019 probably is the right rational piece. Over time, I think these practices will start to bear down on the overall trend of cost. But of course, that's -- that will happen as we see those capabilities spread more broadly, as we see them get more adoption and they start to change the price point in the marketplace for some of these treatments or therapies, which are frankly overpriced. And what our clients are looking for us to do, both through UnitedHealthcare and Optum, find ways to get great care at lower cost. And that's exactly what we're focused on doing. So Ricky, thanks so much for the question."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to A.J. Rice with Crdit Suisse AG.",10,"Next, we'll go to A.J. Rice with Crdit Suisse AG."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I might just continue to focus on OptumRx. You've got good script growth and a pickup in margin. there. There are 2 things that are sort of impacting script growth, it seems like to me, across some of the companies that are reporting it. One is how quickl",141,"I might just continue to focus on OptumRx. You've got good script growth and a pickup in margin. there. There are 2 things that are sort of impacting script growth, it seems like to me, across some of the companies that are reporting it. One is how quickly we're seeing the rebound of sort of the acute scripts as people start going back to the doctor and get new prescriptions. Can you comment on where we're at relative to prepandemic levels on that?
And then vaccines and some of the script reporting is having an impact. I'm not sure that that's relevant for you guys in OptumRx. But can you sort of parse that out in any way? And then I guess just any comments on the selling season for OptumRx and for this year going into next that you see."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, listen, that's a great question, A.J. And before I hand it over to Heather Cianfrocco, our Head of OptumRx, let me just make a couple of introductory remarks. That 8% script growth, about half of that is we would estimate kind of bounce back fr",161,"Yes. No, listen, that's a great question, A.J. And before I hand it over to Heather Cianfrocco, our Head of OptumRx, let me just make a couple of introductory remarks. 
That 8% script growth, about half of that is we would estimate kind of bounce back from the suppression of this time last year caused by the COVID -- the initial waves of the COVID disruption. But even having said that, the 4% residual growth is great. And we feel very good about the performance of the OptumRx business across its breadth of businesses. So within the kind of core PBM but also across all of its various other pharmacy services businesses, which the company has been invested in over the last several years.
We did about 10 million vaccine prescriptions, I think, year-to-date. To give you a little bit more detail on that and a little bit further into selling season observation, maybe hand over to Heather. Heather, go ahead."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Andrew. Thanks, A.J., for the question. So yes, I think as Andrew said -- so maybe I'll take script volume quickly and then -- just to finish that off and then maybe talk a little bit about selling season.So as Andrew said, really, if you look a",436,"Thanks, Andrew. Thanks, A.J., for the question. So yes, I think as Andrew said -- so maybe I'll take script volume quickly and then -- just to finish that off and then maybe talk a little bit about selling season.
So as Andrew said, really, if you look at whether ours is indicative of other things you've seen, what I'd say is specific to us, what you've seen over the last year is yes, about half of that is the rebound from compression. And the rest of that is really a little bit of vaccine volume, and Andrew gave you the number there. But that really hits volumes for us more than anything else because of the -- just the ratio of revenue to script there. 
And then in addition to that, there's a continued double-digit growth in the pharmacy services businesses. So that's making up the bulk of the additional growth that you're seeing year-over-year there.
As far as the split of acute maintenance, et cetera, so I guess I would say we just had this discussion about what baseline is. I guess, again, we're kind of watching this in quarterly progressions. But I'd basically say that we're seeing second quarter look more like '19 than it certainly did from the -- looking like second quarter of 2020. And we basically don't see anything unique there as far as acute versus -- as far as acute ratio, kind of back to what we saw prepandemic for this quarter.
Maybe let me switch quickly to selling season. So we're still in the midst of it this year. And that's for all segments. That's for employer. It's for health plan, public sector and coalition. And I'd say, generally, same activity. Maybe a little different pacing of decision-making right now but really in the midst of it.
The biggest thing I would say about the selling season is clients are very interested in solutions to address high cost of specialty drugs and getting to medications and therapies that really help on the medical and the pharmacy side. So for us, we're very focused on those solutions. And we're finding that our site of care services for alternative sites and alternative therapies like biosimilars, together with some of our specialty programs that work through OptumHealth and OptumRx and straddle the medical and pharmacy benefit, are really resonating, together with our really intense clinical client consulting that we're bringing to the market right now. So we're finding that resonating in the selling season. And we think we've got a lot of value out there. So hopefully, that answers your question."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Heather. Really appreciate it. I might just add, A.J., one other dimension that's under Heather's leadership, which is really pertinent to behavioral health. And as I think we all recognize, that's a huge issue across the U.S. I think many of us a",215,"Thanks, Heather. Really appreciate it. I might just add, A.J., one other dimension that's under Heather's leadership, which is really pertinent to behavioral health. And as I think we all recognize, that's a huge issue across the U.S. I think many of us anticipate the COVID pandemic and various impacts from that may well exacerbate some of the trend there.
But I just wanted to call out the progress of Genoa pharmacy within that. It's a business that came into our organization 2 or 3 years ago. We're going to open 60 more of those centers this year. We're already up to 582 of those centers. We're well on the way to close to double what we had when they first became part of the organization. And the impact that, that group has is extraordinary, both from a consumer NPS score 95, provider NPS score 80. The impact they have in terms of helping improve adherence for highly complex patients, particularly those patients who are served through our Medicaid books of business, is super important.
So I just want to mention that alongside the other elements of OptumRx, another key part of the growth and a key part where OptumRx is really helping our Medicaid business deliver really high-quality service for folks who need it."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Justin Lake with Wolfe Research.",9,"Next, we'll go to Justin Lake with Wolfe Research."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wanted to follow up on the helpful comments that John gave during the prepared remarks on medical cost trend. So for instance, John, you mentioned that commercial utilization was back above kind of typical. Would love to know how that progressed during",134,"I wanted to follow up on the helpful comments that John gave during the prepared remarks on medical cost trend. So for instance, John, you mentioned that commercial utilization was back above kind of typical. Would love to know how that progressed during the quarter and kind of how far above typical you saw it coming out of the quarter, what you're thinking for the rest of the year. And then any other commentary on Medicare and Medicaid there?
And then also, if you could give us your view on this new Biogen Alzheimer's drug in terms of how you think things develop in terms of price -- in terms of pricing and physician take-up or patient take-up rates and how you think you're going to manage this process would be great as well."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Justin, thanks so much. I'll address the Alzheimer's drug issue in a second. But first of all, I'd like John maybe to pick up on your broader MCR questions.",30,"Yes. Justin, thanks so much. I'll address the Alzheimer's drug issue in a second. But first of all, I'd like John maybe to pick up on your broader MCR questions."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, a little color perhaps on how that progression occurred in the quarter here. So as it relates particularly thinking about the quarterly progression that we saw, perhaps not unsurprisingly, COVID testing and treatment costs were highest in the mont",173,"Justin, a little color perhaps on how that progression occurred in the quarter here. So as it relates particularly thinking about the quarterly progression that we saw, perhaps not unsurprisingly, COVID testing and treatment costs were highest in the month of April, actually trending up a little bit from what we saw in March. And that tracks with the incidence rates and the hospitalization rates that we would have been seeing and then that trending down pretty rapidly in May and June in terms of the number of individuals in hospital beds and the treatment costs.
In terms of utilization in commercial populations, interestingly, that was also the highest in the month of April, trending down a bit over the course of the quarter but still just marginally, very marginally above baseline as we -- in June as we exited June. Just to give you a little color commentary on how that was progressing.
So that was really the trending that we saw within that. And Andrew, I'll turn it back to you."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. No, great. Thanks, John. The other thing I'd say, Justin, is there's plenty of noise within those numbers that John just described, right? So you see inpatient, outpatient physician visit trends different by different books of business. It's a more c",170,"Yes. No, great. Thanks, John. The other thing I'd say, Justin, is there's plenty of noise within those numbers that John just described, right? So you see inpatient, outpatient physician visit trends different by different books of business. It's a more complex picture than it looks on the surface.
As far as the Alzheimer's drug is concerned, I'm going to -- in a second, I'm going to ask Dr. Migliori, our Chief Medical Officer, to make a couple of comments on this particular thing.
I mean overall bottom line from our perspective is this remains obviously a super important area for patients' families to look for progress in. We all want to see that progress happen. I think from where we stand today, there's still a lot of information that we need to be able to make really clear decisions. I think we're not the only ones in that regard, looking for greater clarity in this arena.
Maybe Dr. Migliori, you might give a perspective from the medical perspective, please."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew, and you said it well. We are encouraged to see meaningful progress being made against this devastating disease and advances in its treatment. We are continuing to develop our clinical policy as well as our ultimate position on coverag",109,"Yes. Thanks, Andrew, and you said it well. We are encouraged to see meaningful progress being made against this devastating disease and advances in its treatment. We are continuing to develop our clinical policy as well as our ultimate position on coverage. But in doing so, we're looking forward to getting the guidance that we need from Medicare and also looking at the continually contributing clinical outcomes that are coming from the clinical evidence that comes from the ongoing clinical trials. But most importantly, we're looking for the advice from those expert professional organizations, the physicians who have committed their career to helping people with this devastating disease. Andrew?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks so much, Dr. Migliori. And, Justin, I think bottom line is, I think, this has some way to go before we get to real clarity. So I wouldn't guide you to expect a very rapid decision-making on this piece, not because we don't want to see these go",168,"Yes. Thanks so much, Dr. Migliori. And, Justin, I think bottom line is, I think, this has some way to go before we get to real clarity. So I wouldn't guide you to expect a very rapid decision-making on this piece, not because we don't want to see these good effective treatments being made available. Of course, we do. But it's really important to have a real clear understanding of really how they should be used, what their value is in utilization. And Dr. Migliori already said really well, really understanding where CMS get recognized in that the MA population likely to be a very significant fraction of utilizers. We need to understand where all of that sits.
So I think this is potentially good news. But it's still early days and we have a lot more to learn before we can be more definitive than that. So can't be too much more helpful at this point, I'm afraid, Justin. But thank you so much for the question."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ralph Giacobbe with Citi.",8,"Next, we'll go to Ralph Giacobbe with Citi."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to stick on to that last question. So it sounds like commercial was marginally above baseline for the quarter. Hoping you can give us similar comments on sort of magnitude of how much lower Medicare and Medicaid are.And then also, if you could pr",94,"I want to stick on to that last question. So it sounds like commercial was marginally above baseline for the quarter. Hoping you can give us similar comments on sort of magnitude of how much lower Medicare and Medicaid are.
And then also, if you could provide any sense of magnitude of the rising utilization you embed in guidance at this point for the second half of the year. If you could frame that just in terms of what normal growth would be and maybe what you're embedding or how much higher guidance contemplates."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Ralph, thanks so much. I'm going to ask John to reflect on the second part of your question in terms of forward-looking for the second half of the year.Just to nail this first part, though. The commercial book, as you've heard already now from John",100,"Yes. Ralph, thanks so much. I'm going to ask John to reflect on the second part of your question in terms of forward-looking for the second half of the year.
Just to nail this first part, though. The commercial book, as you've heard already now from John a couple of times, basically right on baseline, maybe a hair above but right there. And then the 2 government books of business, a few percentage points below.
So I won't go further than that. But maybe, John, you could give some insight into how you're seeing things within the next 6 months."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ralph, yes. So then you blend a little bit, just a little bit below overall, right, when you blend the books and you weight our books across in terms of what we are seeing in the second quarter. And then as you might expect, that trends up progressively e",354,"Ralph, yes. So then you blend a little bit, just a little bit below overall, right, when you blend the books and you weight our books across in terms of what we are seeing in the second quarter. And then as you might expect, that trends up progressively every quarter. Every quarter, you'd see rising in that overall level of utilization and the expectations as we head into the end of the year.
Embedded in that is also a view in terms of what happens with intensity, acuity levels. One comment that -- a question that we've often received is what are we seeing currently in acuity levels to progress. And part of the impact as we progress in the second half is an expectation that you do see rising acuity levels.
I'd tell you, we haven't observed that yet. But it's still probably a little bit early to say. When we -- among the things we look at, we look at new cancer diagnoses, new cardiac diagnoses. Those are still running below baseline levels that we'd expect. But they're -- a view to that could continue to progress as we get into the back half of the year.
The other element in terms of just thinking about utilization and rising in the back of the year is -- and then ultimately, this is one of the -- what occurs with COVID testing and treatment costs. Clearly, there's been the evidence of the new variants and their impact in other countries and then also moving into the U.S.
And even in our own data, we can see that but I would tell you still fairly limited in terms of impact. And as I sit here and look at the number of members -- of our members that we have in -- receiving treatment today in hospital beds today as we sit here this morning, still well below the levels even we sit here in mid-July, what we were seeing in the April levels. But that could be a trend back factor also in the second half of the year as we see that progression."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next we'll go to Scott Fidel with Stephens.",9,"Next we'll go to Scott Fidel with Stephens."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I want to just ask a question around Medicare Advantage. Just interested in terms of what you've been seeing progressing year-to-date around the risk scores and how that's been normalizing relative to the post-pandemic disruption.And then just also inte",66,"I want to just ask a question around Medicare Advantage. Just interested in terms of what you've been seeing progressing year-to-date around the risk scores and how that's been normalizing relative to the post-pandemic disruption.
And then just also interested if you've received the update yet from CMS on the midyear risk score updates. And if you could share how those came out relative to expectations."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, thanks so much for the question. I'm going to pass that over to our new CEO of UnitedHealthcare, BT. BT, you and Tim might like to address those 2 points from Scott. BT?",34,"Scott, thanks so much for the question. I'm going to pass that over to our new CEO of UnitedHealthcare, BT. BT, you and Tim might like to address those 2 points from Scott. BT?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. I'll start. I think as a follow-on perhaps -- this is Brian Thompson. Thanks for the question. To the question around engagement levels, I think the piece that I am most encouraged by is the physician engagement levels. And in particular, in our sen",96,"Sure. I'll start. I think as a follow-on perhaps -- this is Brian Thompson. Thanks for the question. To the question around engagement levels, I think the piece that I am most encouraged by is the physician engagement levels. And in particular, in our senior communities, we're really seeing strong receptivity, certainly reflective of the vaccination rates. And I think that's really giving us encouraging signals overall, not only to 2022 but just the population and health at large.
With that, I'll turn it over to Tim to talk a little bit more specifically about MA."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, thanks for the question. Yes. The revenue for 2021 and the risk scores that support those are totally in line with our expectations, as John indicated in his remarks. And yes, we did receive the midyear payment from CMS, which gives us a more fulso",80,"Scott, thanks for the question. Yes. The revenue for 2021 and the risk scores that support those are totally in line with our expectations, as John indicated in his remarks. And yes, we did receive the midyear payment from CMS, which gives us a more fulsome view into what 2021 revenue is. And again, that aligns to our expectations. And at this point, we consider 2021 revenue to be pretty complete in terms of what we'll know about risk scores."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Dave Windley with Jefferies.",8,"Next, we'll go to Dave Windley with Jefferies."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wondered, relative to your conversations about the relative headwinds. Does your view of your ability to recoup the $1.80 in '22, is that influenced at all by the timing of when these things hit if they do in the second half of '21? So be curious about",52,"I wondered, relative to your conversations about the relative headwinds. Does your view of your ability to recoup the $1.80 in '22, is that influenced at all by the timing of when these things hit if they do in the second half of '21? So be curious about your comments there, please."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. And I'll ask John in a sec to give you more on this. I mean first off, obviously, again, we're not going to be really shining the light on our expectation for '22 yet. Having said that, we also think the majority of the $1.80 headwind will have been",116,"Yes. And I'll ask John in a sec to give you more on this. I mean first off, obviously, again, we're not going to be really shining the light on our expectation for '22 yet. Having said that, we also think the majority of the $1.80 headwind will have been utilized this year will essentially be nonrecurring.
Of course, that depends on some assumptions around the pandemic itself remaining under control. I mean so that is an observation which has to be taken in that context. But as we sit today, I think that's a prudent view. 
John, you may want to go a little deeper on how each of the elements perhaps you think about."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. A few factors on that and how timing might impact, those. So maybe just to refresh a little bit on that. Tim did a nice job describing the impacts in terms of -- the revenue impacts from particularly our Medicare Advantage members being able to be s",294,"Sure. A few factors on that and how timing might impact, those. So maybe just to refresh a little bit on that. Tim did a nice job describing the impacts in terms of -- the revenue impacts from particularly our Medicare Advantage members being able to be seen by their physicians. We are encouraged by what's going on in our HouseCalls activity, very strong receptivity to those. BT just mentioned, encouraged by what we're seeing in terms of seniors and their receptivity to even going in and seeing their physicians. That's all super important.
I don't know if timing is so important on that piece. It just needs to occur during the year in terms of when that activity occurs. So that would be more -- the more important factor as it relates to 2022. Does it occur in 2021? Do they get in? So that's an important factor.
Other factors here, I would say. So there's care that didn't occur in 2020 and probably hasn't occurred in '21 yet that was deferred and needs to occur. So that's more about also an element of, does it not occur at all in this year, does it work its way into 2022 and the potential for that and kind of the resident impact of whether or not there's an increase in acuity or -- from those populations.
That -- those are really kind of the main elements, I would say, in terms of what I would call timing-related. The other elements are more just -- would be around this concept around the occurrence of COVID-19 incidents, direct treatment and testing costs, how that progresses over the back half of the year, too. But those would be the elements that would be sensitive to timing factors."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Lance Wilkes with Bernstein.",8,"Next, we'll go to Lance Wilkes with Bernstein."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Yes. You made a comment about virtual-first offerings helping to drive incremental membership growth this year. Can you talk a little bit about what the digital-first and/or virtual-first offerings look like? And then is that contribution in '21? Or -- an",62,"Yes. You made a comment about virtual-first offerings helping to drive incremental membership growth this year. Can you talk a little bit about what the digital-first and/or virtual-first offerings look like? And then is that contribution in '21? Or -- and if it is, could you talk a little bit about in the sales cycle, how it's looking for uptake in '22?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Great question, Lance. Thanks. I'm going to ask Dirk in a second to make a couple of comments around the overall shift towards digital-first, virtual-first and may also ask Dr. Decker to refer to some -- further what's going on within OptumHealth, which i",270,"Great question, Lance. Thanks. I'm going to ask Dirk in a second to make a couple of comments around the overall shift towards digital-first, virtual-first and may also ask Dr. Decker to refer to some -- further what's going on within OptumHealth, which is important around Optum Virtual. 
As I've made super clear over the last couple of quarters, really elevating our consumer focus is a top priority for the whole company. And that really speaks to ensuring that we're delivering simpler, more intuitive experiences, that we're thinking about the journey of the consumer and the patient in an end-to-end sense, that we're making it easier for them to make all of the various sequential decisions.
And we also want to meet the consumer where they want to be met, whether that be outside of a facility, in their home, online or in person. And we also -- we fully recognize how the premium that patients and consumers in particular put on being able to talk to the physicians they know rather than just any physician.
And so how we start to pool all of that together is essentially reflected in many of the different initiatives we have. Over the last few quarters, you've seen us build up things like Optum Virtual. Dr. Decker will talk to you in a second. But things like Optum Store, just been rolled out under the OptumRx organization, really start to bring together a ton of access for consumers in terms of what they're able to do with us.
With that introduction, Dirk, I'd love to get your perspective and then maybe Wyatt. Dirk."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Andrew, and, Lance, for the question. So of course, we've continued to see telehealth be a broadly desired consumer access vehicle to the health system. We've seen that grow. We're hoping we get to the sort of the next generation. And we thin",168,"Yes. Thanks, Andrew, and, Lance, for the question. So of course, we've continued to see telehealth be a broadly desired consumer access vehicle to the health system. We've seen that grow. We're hoping we get to the sort of the next generation. And we think a lot of that begins with, like, for example, with Optum Care, physicians being able to deliver that because, as Andrew said, people have a good preference to go to their own physician.
The product with respect to virtual-first, to answer your specific question, we plan on rolling that out in 8, 9 markets in UnitedHealthcare at the end of this year. What it will basically be is think of it as sort of a virtual PCP with an Optum Care dock being the quarterback with UnitedHealthcare navigate network backing it up for the physical access.
So we're starting to sort of what I would refer to as productize this. And we're hopeful we will -- which will aid to UnitedHealthcare's commercial growth."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks. Sure. Thanks. Wyatt, we'd like to just give you a little more on Optum Virtual and what you've been building inside OptumHealth?",23,"Thanks. Sure. Thanks. Wyatt, we'd like to just give you a little more on Optum Virtual and what you've been building inside OptumHealth?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks, Lance, for the question. We are bringing together the virtual care experience that we stood up rapidly during the pandemic, with over 18,000 providers on to, as Dirk mentioned, a next-generation technical solution that we've created, which cr",162,"Yes. Thanks, Lance, for the question. We are bringing together the virtual care experience that we stood up rapidly during the pandemic, with over 18,000 providers on to, as Dirk mentioned, a next-generation technical solution that we've created, which creates the opportunity to seamlessly onboard and triage an individual virtually. So we make sure they're getting the right care in the right environment, whether that's virtual, physical or a behavioral health care need. And we believe that, that is a differentiated patient experience. 
And the second, which Dirk mentioned but I'll underscore, is a focus on primary care delivery and keeping people tethered to their trusted and known providers. And as this matures -- we're live today in all 50 states, to be clear. And we'll continue to roll this out in a more comprehensive way to our Optum Care patients as well as members of UHC and other payers and look forward to continued conversations about our capabilities here. Thank you."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, Wyatt. I think, Lance, just to close this out. This is -- I'm excited about what's been built in OptumHealth. If you think about this build-out of ambulatory clinic facilities and other attendant services perhaps in the pharmacy space, you think a",203,"Thanks, Wyatt. I think, Lance, just to close this out. This is -- I'm excited about what's been built in OptumHealth. If you think about this build-out of ambulatory clinic facilities and other attendant services perhaps in the pharmacy space, you think about the home and community agenda really investing to make sure that folks who want to spend as much time at home as possible are able to do that, and then you see Optum virtually essentially pooling all of that together. This -- you've got to think about this as all 3 of those elements essentially all at play at the same time.
They're very -- I think it's a very important step forward. It gives us a really significant opportunity to ensure that we deliver a much more seamless experience, we're much more responsive to consumer need and we can focus on bringing costs down, delivering better care. That's what we really believe we can do here. This is -- you're going to hear a lot more about this. It's an important step-up in the energy around our OptumHealth strategy.
We just have time, I'm afraid, for one last question. So Alan, if you could ask for last question, please."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll take our last question from Matt Borsch with BMO Capital Markets.",13,"We'll take our last question from Matt Borsch with BMO Capital Markets."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Okay. I realize you're parsing through everything that happened last year and now the catch-up in care this year. Are you getting a perspective yet on how much of the care was unnecessary that would have happened but is not actually going to occur? And I",88,"Okay. I realize you're parsing through everything that happened last year and now the catch-up in care this year. Are you getting a perspective yet on how much of the care was unnecessary that would have happened but is not actually going to occur? And I guess you put that into categories of care that you can see in hindsight was unnecessary but maybe what's necessary at the time because the person didn't know and care if it was -- that was just unnecessary proactively and in hindsight?"
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Matt, thanks so much for the question. It's a really -- it's a great question. And you would have to expect that the answer is that some of it would have been unnecessary.I think at this distance, it's a little hard to really call that at this poin",372,"Yes. Matt, thanks so much for the question. It's a really -- it's a great question. And you would have to expect that the answer is that some of it would have been unnecessary.
I think at this distance, it's a little hard to really call that at this point. I mean there are some tantalizing signals in some of the trends. So if you look at emergency department use, for example, it looks pretty sustained down and doesn't seem to be coming back. And certainly, if you look at our Advisory Board surveys that we're running with many, many non-UHC providers and institutions across American Healthcare, people don't -- a lot of people don't expect that ED utilization to come back.
Now that may be because they would be unnecessarily used. Maybe folks have realized that urgent care centers are a much better option. Maybe virtual is a much better option that they can get what they need at a much lower cost. So whether it's unnecessary, whether or not the pandemic has disturbed people's allegiance for certain types of sites of care and people are a little bit more open-minded about where to go, all of that, I think, is in play.
I would say it's premature to call it. I think we're watching it really carefully. I could build those theories I just shared with you. I'm not going to tell you that those are proven. I think there is tantalizing signals in the data. It's going to take another 6, 12 months before you can really settle out how this all plays. But Matt, thanks for the question, and we'll probably loop back on that one again, I'm sure.
Listen, everybody, I want to say thank you for all of your attention today, for your participation. Very much appreciated. And we hope very much that what you've heard from our team gives you a flavor of why we have such confidence in the outlook for our company and in the ability of Optum and UnitedHealthcare, separately and together, to improve the lives of those we serve and the health system overall.
And with that, I'd like to say thank you very much and to close this morning's call."
104673,1671940210,2346110,"UnitedHealth Group Incorporated, Q2 2021 Earnings Call, Jul 15, 2021",2021-07-15,"Earnings Calls","UnitedHealth Group Incorporated","Operator","That does conclude today's conference. We thank everyone, again, for their your participation.",14,"That does conclude today's conference. We thank everyone, again, for their your participation."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Good morning, everyone, and welcome to the UnitedHealth Group's Third Quarter 2021 earnings conference call. [Operator Instructions]. As a reminder, this call is being recorded. Here is some important introductory information. This call contains forward-l",190,"Good morning, everyone, and welcome to the UnitedHealth Group's Third Quarter 2021 earnings conference call. [Operator Instructions]. As a reminder, this call is being recorded. Here is some important introductory information. This call contains forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings. 
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the financial and earnings reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated October 14, 2021, which may be accessed from the Investor Relations page of the company's website. I will now turn the conference over to the President and Chief Operating Officer for UnitedHealth Group, Dirk McMahon. Please go ahead, sir."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us today. Unfortunately, our CEO and colleague, Andrew is not with us this morning since he had an urgent but straightforward procedure last night for a kidney stone. All went very well, and we expect him fully back",1177,"Good morning, and thank you for joining us today. Unfortunately, our CEO and colleague, Andrew is not with us this morning since he had an urgent but straightforward procedure last night for a kidney stone. All went very well, and we expect him fully back in just a few days. I'm quite confident he is listening now, so I hope you're doing well, Boss. 
John Rex and I will be subbing for Andrew this morning, and we have our management team with us as usual to help with your questions. 
We're here today to discuss third quarter results and the expanding opportunities we see looking ahead. As a result of the progress at both Optum and UnitedHealthcare, we have increased our 2021 adjusted earnings outlook to a range of $18.65 to $18.90 per share. We continue to prioritize 3 themes Andrew has discussed before which are -- before which are foundational to the growth of our enterprise. First, unlocking the collaborative potential within Optum and UnitedHealthcare for the benefit of all; second, further developing our technology and data science platform to aid patient care and experience and to help the system run better; third, strengthening our consumer experience, capabilities and value. 
I'll briefly highlight a couple of items for you. You likely have seen the CMS Medicare Advantage Star -- Medicare Advantage Star Quality rating showing 95% of our UnitedHealthcare members will be in 4-star-rated plans or better for 2023, up from 78% for 2022 and a new high for our company. Within Optum Care, on behalf of the many payers we serve, 99% of Medicare Advantage patients will be in 4-star plans or better for 2023. A second important highlight in the quarter, we were encouraged by the ongoing strength in our employer and individual business, which has now grown by over 330,000 people this year with revenue up 7% year-over-year. We continue to see active interest in our product innovations, such as our All Savers level-funded offering and are encouraged by our competitiveness in the market and momentum heading into '22. We also elevated consumer connectivity by incorporating fitness offerings from industry-leading partners. 
OptumHealth continues to build momentum as well. Entering the open enrollment period for Medicare Advantage, we have more than 2.2 million people served under physician-led, fully accountable arrangements and expect '22 to be another year of record expansion in this key part of our portfolio. Our broad home-based clinical care initiatives at Optum and UnitedHealthcare are central to improving near and longer-term health outcomes for people with medical, behavioral and social needs. These efforts include Optum at Home, which delivers high-quality primary care services in the convenience of the home setting and support recovery after hospitalizations. Seniors served by our home and community offering experienced a 14% lower rate of hospital admissions and about a 4% higher rate of physician encounters. 
In addition to caring for people in their homes, we continue to expand capabilities in other optimal sites of care, including via digital means. Optum is distinctively enabling virtual care for patients using their own primary care physicians and with behavioral clinicians. For example, a physician engaging in a virtual visit with a patient can easily bring in a behavioral health professional for a real-time consultation. UnitedHealthcare is using Optum's virtual capabilities to introduce a new suite of digital-first products, offering a near seamless experience between virtual and traditional primary specialty and urgent care. 
We expect during 2022 and beyond to further build on these opportunities to connect and integrate multiple channels of care, simplify the experience for patients and providers and deliver quality care that is affordable and in the optimal setting. Let me now go a little deeper in a few areas to give you an assessment of how we're doing on the themes I mentioned at the outset. OptumInsight continues to drive better clinical and operational performance at the health system level. Last week, we reached a new multiyear partnership with a leading and innovative health system, SSM Health, whose 40,000 employees, 33 hospitals and post-acute facilities and 300 physician clinics serve the people of Missouri, Oklahoma, Wisconsin and Illinois. OptumInsight brings real value in helping systems strengthen and scale essential functions, such as care coordination, revenue cycle management and digital modernization, all to improve health outcomes and patient care experiences. 
These and similar efforts to simplify processes, reduce administrative burdens and help our partners focus -- help our partners focus more attention on their care -- on their core missions of patient care. OptumRx continues to deliver to health system partners, such as its new multiyear agreement with Point 32 Health, which serves more than 2 million people in New England through its founding organizations, Harbor Pilgrim Healthcare and [ TugsHealthPlan ]. OptumRx will provide integrated pharmacy benefit and specialty offerings that will enhance services and deliver improved affordability for their plan members. OptumRx is having a substantial impact through its community behavioral health pharmacies, which now serve nearly 700,000 people with mental health, addiction and other conditions through more than 600 dispensaries across 47 states. The pharmacies deliver a high-touch approach to care that contributes to a more than 90% medication adherence rate and lowers emergency room visits and hospitalizations by 18% and 40%, respectively, driving better outcomes and a lower total cost of care. 
Within our UnitedHealthcare government businesses, we have increased processing efficiency by 25% over the last year by using Optum technology to improve auto adjudication rates and intelligent work distribution to appropriately skilled channels. We have many such initiatives underway across the enterprise in affordability, provider experience and product development as we employ advanced technology and data analytics to drive even greater value for the people we serve and the health system. 
Before turning over the call to John, a quick word on our pending combination with Change Healthcare. We continue to work diligently to satisfy regulatory requests and now believe, based on our experience so far, the transaction should close in the first part of 2022. 
We are highly energized about the positive impact we can have working together with the exceptional change team, a team aligned with our mission and values and focused on delivering substantial benefits for the health care system. These benefits will include helping clinicians by simplifying access to real-time evidence-based guidance as they are serving patients, closing gaps in care more rapidly to improve health outcomes and lower cost, reducing unnecessary complexity by removing administrative waste and obstruction to make the care process simpler, more cost effective and more transparent. And bringing greater convenience and simplicity to managing consumer health finances, while ensuring care providers get paid more quickly and accurately. Optum and Change Healthcare's capabilities fundamentally are complementary and distinct. Because both companies already successfully serve health plans and state governments, care providers and consumers in a highly competitive market, we believe this combination will make the health care system work better for everyone and bring exceptional value to those we serve. With that, I'll turn it over to our Chief Financial Officer, John Rex."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dirk. This morning, we reported third quarter and year-to-date revenues of $72 million and $214 million, respectively, growth of 11% and 12% over last year. This growth was led by OptumHealth, primarily our care businesses. In the third quart",760,"Thank you, Dirk. 
This morning, we reported third quarter and year-to-date revenues of $72 million and $214 million, respectively, growth of 11% and 12% over last year. This growth was led by OptumHealth, primarily our care businesses. In the third quarter, the Optum platform comprised 54% of enterprise operating earnings and continues to show strong growth momentum. Our performance reflects the diverse and complementary strengths of our business, setting the stage for growth in the years ahead. Our updated full year '21 outlook includes unfavorable COVID impacts consistent with the expectations we have discussed throughout the year. During the third quarter, while direct COVID care and testing costs ran above the expectations we had nearly a year ago,  we again saw elective care offsetting the impacts of higher case rates, much like previous cycles in the pandemic. This quarter, there were approximately 60,000 COVID hospitalizations meaningfully above the second quarter, with the month of August peaking at nearly 30,000 and then declining in September. 
Looking at specific business performance. OptumHealth's third quarter revenue and earnings increased 32% and 37%, respectively, year-over-year. Revenue per consumer grew by 30%. This reflects the increasing impact and number of value-based relationships within OptumCare. The expansion of our in-home and community health platform as well as the growing acuity of the needs we can serve. 
OptumInsight's revenue grew 13% in the quarter, and earnings grew 15% as the revenue backlog increased by 12% to $22.3 billion. We see overall business development sourcing and activity levels increasing, particularly with care provider customers, and for our software and analytics offerings. OptumRx revenue and scripts grew 6% year-over-year and earnings 5%. OptumRx has seen both strong customer retention levels and sales success for the largely completed '22 selling season and early activity for '23. 
Turning to UnitedHealthcare. The third quarter showed increasing member growth in our commercial offerings, particularly in employer-sponsored benefits. Increased employment is a broad underlying contributor, but we are particularly encouraged by the growth we are achieving in our affordable consumer-centric offerings. Medicare Advantage membership has grown 745,000 this year. Inclusive of plans which serve dual special needs members, we expect to add a total of over 900,000 Medicare Advantage members. The number of people served through managed Medicaid grew by more than 1 million members over last year as we began to serve people in new regions such as North Carolina, Kentucky and Indiana, and as state-based redetermination activities remained paused. We were honored to begin serving people in the Missouri Medicaid expansion this month. Our liquidity and capital positions remain strong with third quarter cash flows from operations at $7.6 billion or 1.8x net income, and we ended the quarter with a debt-to-capital ratio of 39%. As noted earlier, given the strength of our business performance,  this morning, we updated our 2021 adjusted earnings outlook to a range of $18.65 to $18.90 per share. 
Now with the close of the third quarter, your attention understandably turns to next year. As is our custom, we will offer a few early observations here while reserving the majority of this conversation for our November 30 investor conference, which we hope will be held in person in New York. 
Our businesses are both growing and operating well with strong momentum heading into next year. While the pandemic-related impacts remain difficult to predict, given the current trends, we would expect a lower unfavorable COVID impact than experienced in '21. Still, as the dramatic variation over the last 20 months has demonstrated to all, prudent management suggests we should offer an outlook respectful of the fact that the current situation is without precedent. 
Taking all elements together at this distance, we see current analyst consensus as reasonably beginning to calibrate a '22 outlook. Envisioning that consensus as being toward the upper end of our initial adjusted earnings per share outlook range with the range being similar to that offered initially for '21.  The still untapped collaborative potential between UnitedHealthcare and Optum to benefit individuals in the system, the power of applied technology to advance care and service, improved opportunities in consumer health and experience and the passion of our people, these and so many other elements lead us to believe our performance expectations for the years ahead remain fully supportive of our long-term 13% to 16% earnings per share growth outlook. We look forward to going into more detail on both our view of '22 and the many years of growth beyond at our investor conference. With that, operator, let's open it up for questions. One per caller, please."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions]. So we'll go ahead and take our first caller, Matt Borsch with BMO Capital Markets.",17,"[Operator Instructions]. So we'll go ahead and take our first caller, Matt Borsch with BMO Capital Markets."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","All right. Squeaky clean quarter. I was hoping maybe you could just talk about how United and to the extent you have visibility on others are approaching commercial -- group commercial fully insured rate increases for 2022?",37,"All right. Squeaky clean quarter. I was hoping maybe you could just talk about how United and to the extent you have visibility on others are approaching commercial -- group commercial fully insured rate increases for 2022?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Why don't we let Brian Thompson take that question? Go ahead, BT?",13,"Yes. Why don't we let Brian Thompson take that question? Go ahead, BT?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question, Matt. Certainly, as we look forward to 2022, the picture is a lot more clear. Then as we look at the past 20 months, I would say that we feel optimistic not only about our pricing and the rationality of the market, but most i",64,"Yes. Thanks for the question, Matt. Certainly, as we look forward to 2022, the picture is a lot more clear. Then as we look at the past 20 months, I would say that we feel optimistic not only about our pricing and the rationality of the market, but most importantly, the value that we're bringing to customers. So we're optimistic as we look forward."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Yes, we'll go to Josh Raskin with Nephron Research.",9,"Yes, we'll go to Josh Raskin with Nephron Research."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","My question relates to the value-based care, but more from the UnitedHealthcare side. And so how does UHC think about the use of value-based care providers and maybe some expectations on the movement of membership into fully cap arrangements in 2022. I th",90,"My question relates to the value-based care, but more from the UnitedHealthcare side. And so how does UHC think about the use of value-based care providers and maybe some expectations on the movement of membership into fully cap arrangements in 2022. I think you said 250,000 lives this year. So curious how you're thinking about next year? And then maybe as part of that, what advantages you see of using OptumCare as a partner over some of the others and kind of how you evaluate partners in the markets?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, I appreciate the question. Brian Thompson here again. I would say we certainly are encouraged by continuing our advanced care penetration with partners. OptumCare certainly being one of several. When we partner with OptumCare, we see not only our hig",173,"Yes, I appreciate the question. Brian Thompson here again. I would say we certainly are encouraged by continuing our advanced care penetration with partners. OptumCare certainly being one of several. When we partner with OptumCare, we see not only our highest satisfaction, but our best benefits and overall performance, and you heard that in our star quality results as well. And we're encouraged not only by what we have done by what's -- but also by what's on the horizon. Historically, you've looked at our combinations largely in a traditional Medicare Advantage space, and you're seeing us expand in the complex populations and duals, and  we're also really encouraged with what we're doing in the commercial marketplace as well. We've got some new offerings coming in that space. 
So I would say the key takeaway here is breadth and impact. We continue to scale and expand in that space. And it's important. We really see this value-based aligned care as a way to drive good value for those that we support and serve."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, BT. And Josh, thanks for the question. This is Wyatt Decker. I would just add that at OptumHealth and Care, we are very pleased to be playing a role in reinventing the U.S. health care system focused around patients as consumers and value-based ca",121,"Thanks, BT. And Josh, thanks for the question. This is Wyatt Decker. I would just add that at OptumHealth and Care, we are very pleased to be playing a role in reinventing the U.S. health care system focused around patients as consumers and value-based care as a major pillar. As you mentioned, we've grown by 250,000 fully capitated lives this year, and we're excited through our partnership with UHC as well as collaboration partnership with over 90 payers in total to continue to grow our value-based care delivery construct. The other point I'd make is you'll see us increasingly weaving together all of our assets in a comprehensive care delivery paradigm that we feel is unique and differentiated in the marketplace."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Okay. Thank you for that, BT and Wyatt.",8,"Okay. Thank you for that, BT and Wyatt."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ralph Giacobbe with Citi.",8,"Next, we'll go to Ralph Giacobbe with Citi."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Great. Just wanted to go to the guidance commentary. And I guess just to clarify, John, is it inclusive or exclusive of the $1.80 headwind from this year. So when you talked about reasonable relative to consensus, maybe at the higher end. Do you factor in",62,"Great. Just wanted to go to the guidance commentary. And I guess just to clarify, John, is it inclusive or exclusive of the $1.80 headwind from this year. So when you talked about reasonable relative to consensus, maybe at the higher end. Do you factor in the $1.80? Or can you just provide some guardrails around how you're thinking about that $1.80?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Ralph, so yes, so as it relates to this year's $1.80, look, our expectation is that will clearly be lower than it was in 2021, as we think about it. We also don't think it will be nothing. I can't imagine we hit January 1 and everything ceases immediately",134,"Ralph, so yes, so as it relates to this year's $1.80, look, our expectation is that will clearly be lower than it was in 2021, as we think about it. We also don't think it will be nothing. I can't imagine we hit January 1 and everything ceases immediately. So we don't think that will be the case at all. So inclusive of that, when you think about going to that, I think inclusive and as we look at where the analyst consensus currently centers, it seems like kind of a reasonable starting point in terms of how we think about that and how we would anticipate and be respectful of the fact that we don't know exactly how this will progress as we move into the -- in the new year. Thanks, Ralph."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Dave Windley with Jefferies.",8,"Next, we'll go to Dave Windley with Jefferies."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Coming back to the topic that Josh touched on in value-based care, but perhaps more OptumCare-focused. I'm wondering if you could talk about, one, the providers within the 53,000 that are responsible for the 2.2 million fully capitalized? Like how does th",88,"Coming back to the topic that Josh touched on in value-based care, but perhaps more OptumCare-focused. I'm wondering if you could talk about, one, the providers within the 53,000 that are responsible for the 2.2 million fully capitalized? Like how does that interleave? And then secondly, if you could talk about the, call it, the margin on the global cap revenue. So how capable or how much impact are those providers having on consumption of downstream care such that OptumCare makes a margin on the capitated revenue."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, we'll go to Wyatt on that. But let me first start by saying, of course, all of the all of the providers within OptumCare, they are responsible for managing the downstream spend, whether it be it specialists, whether it be in hospitals, global cap is",111,"Yes, we'll go to Wyatt on that. But let me first start by saying, of course, all of the all of the providers within OptumCare, they are responsible for managing the downstream spend, whether it be it specialists, whether it be in hospitals, global cap is that. And one of the key things that we do within OptumCare is we made investments in our systems to absorb, take and manage risk, right? It's just not a paper transfer. It's actually a system where the providers are fully aware of the capitate arrangements and they're managing accordingly. So Wyatt, why don't you add on top of that, you're more in the details."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question. And as Dirk mentioned, we focus relentlessly on the quadruple aim, including lowering total cost of care, providing better outcomes and outstanding patient experiences, and we are relentless in monitoring specific data points",225,"Yes. Thanks for the question. And as Dirk mentioned, we focus relentlessly on the quadruple aim, including lowering total cost of care, providing better outcomes and outstanding patient experiences, and we are relentless in monitoring specific data points that help deliver that -- those outcomes. Specifically, what we see is the members that are in fully capitated arrangements overall have about a 30% lower hospitalization rate and about 40% lower skilled nursing facility occupation rate than their counterparts and fee-for-service Medicare, as an example. So we'll continue to drive that value proposition. 
And as I touched on in the previous question that I'll go a little deeper as you think about us with our home and community assets increasingly meeting people in their terms, in their homes to deliver components of of value-based and primary care, preventive care and wellness care and identify early conditions that otherwise might have led to an ER visit or hospitalization. 
You'll also see us continuing to bring on board very innovative behavioral health care delivery solutions that are integrated with the primary care providers that, again, identify and treat mental health and substance use disorders by identifying them early and treating them in lower acuity settings when that's appropriate. So those are just a couple of examples of how we're creating value for those that we serve. Thank you."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Perfect. That's great, Wyatt.",4,"Perfect. That's great, Wyatt."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Sure. Next, we'll go to Kevin Fischbeck with Bank of America.",11,"Sure. Next, we'll go to Kevin Fischbeck with Bank of America."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I was wondering if you could provide just a little bit more color about utilization trends in the quarter and maybe do that by product line, breaking it out by COVID and non-COVID utilization where you are versus pent baseline.",40,"I was wondering if you could provide just a little bit more color about utilization trends in the quarter and maybe do that by product line, breaking it out by COVID and non-COVID utilization where you are versus pent baseline."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, this is John. So yes, a few perspectives on that as we think about utilization trends in the quarter. And I gave some broad indication just in terms of where we were with COVID inpatient stays and such for our members. Maybe to give a little kind o",325,"Kevin, this is John. So yes, a few perspectives on that as we think about utilization trends in the quarter. And I gave some broad indication just in terms of where we were with COVID inpatient stays and such for our members. Maybe to give a little kind of further commentary. So as we sit here today, about 5,000 of our members are in an inpatient setting for a COVID-related condition right now. And I'd say versus the peak that we experienced during the quarter, that's probably just a little more than 50% of the peak in that zone, probably a little of that we experienced over the course of the period. 
That fell across categories, probably categories much like you would have observed in the reports coming out nationally in terms of the types of individuals who are in these settings, an average age that was considerably younger than we saw in prior to that -- in prior periods for COVID. So similar to what we have noticed across the board. In terms of broad utilization trends, similar to what we would have described in 2Q or what we did describe where  we continue to see commercial members be more active in elective care and public sector or government program members a little bit less active. And so kind of similar, just trending at different levels, given the prevalence of COVID. It's been interesting over the course of the 20 months, there has been a consistent, fairly rapid reaction when COVID cases go up nationally in terms of the preference of patients to whether or not to seek elective care, that again happened this quarter, where it comes in fairly quickly in terms of the hesitation in the system to access. So broadly, kind of similar along those ranges. Hopefully, that provides a little additional color for you in what we're seeing across the whole book of business. Thanks for your -- Kevin, question."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Justin Lake with Wolfe Research.",9,"Next, we'll go to Justin Lake with Wolfe Research."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","First, let me just follow up there. John, you've talked about, I think, on the previous calls, your guidance assumed about 101%, 102% of normal in the back half of this year. If you could run that it sounds like you're saying commercial might have been a",134,"First, let me just follow up there. John, you've talked about, I think, on the previous calls, your guidance assumed about 101%, 102% of normal in the back half of this year. If you could run that it sounds like you're saying commercial might have been a little higher and Medicare and Medicaid a little lower. But if you can give us those numbers specifically, just so we have kind of a re-through to the rest of the industry, that might be helpful. and what you saw in the quarter? And then what do you price -- would it be fair to -- for you to share what you price for, for next year in terms of trend? Did you price to 101%, 102% for next year kind of similar conservatism versus this year?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, so a few other elements on that. So similar broad trends to what we observed in 2Q. Just shifting because of the COVID prevalence. So down shifting a bit in terms of elective in terms of COVID prevalence, but then really fully offset by COVID. So",119,"Justin, so a few other elements on that. So similar broad trends to what we observed in 2Q. Just shifting because of the COVID prevalence. So down shifting a bit in terms of elective in terms of COVID prevalence, but then really fully offset by COVID. So that is elective downshifting because of COVID prevalence and then fully offset as we saw COVID care become a more important part of the business. So that really flowed across the businesses with those trends across the book, like I described in terms of the general outlook on that. And let me turn to Dirk here to talk about some implications of how we would have anticipated that in our forward pricing."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. I mean, Justin, I mean, we, of course, are going to always price to our best estimates of forward trend. And we're going to take into consideration all the variables that we talked about that toggle that John just talked about between COVID and what",87,"Yes. I mean, Justin, I mean, we, of course, are going to always price to our best estimates of forward trend. And we're going to take into consideration all the variables that we talked about that toggle that John just talked about between COVID and what we expect with abatement. I don't want to get into the specific details. Clearly, that's competitive. But at the end of the day, just be aware that we've considered all factors as we priced our forward business within our books. Thanks."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Lance Wilkes with Bernstein.",8,"Next, we'll go to Lance Wilkes with Bernstein."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Yes. I wanted to ask a little bit about employer growth and was interested in for the third quarter how much of that was new wins versus in accounts? And then as you're looking at '22 and you're getting visibility on national accounts and middle market, i",90,"Yes. I wanted to ask a little bit about employer growth and was interested in for the third quarter how much of that was new wins versus in accounts? And then as you're looking at '22 and you're getting visibility on national accounts and middle market, if you can just give a little color on those individual segments? And what's driving wins in 2022 in particular? Is it product features? Or is it the All Savers product? Maybe just a little more color on kind of why you're getting wins."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Okay. Why don't we send that question to Bill Golden, who will talk about all 3 of those quarter, but also why you think we could having some success.",29,"Okay. Why don't we send that question to Bill Golden, who will talk about all 3 of those quarter, but also why you think we could having some success."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So thank you for the question. So we're excited about the traction we're seeing in our third quarter enrollment Membership growth for the quarter was really attributed to what I would say are 3 main components. One is in group growth was net positive",167,"Yes. So thank you for the question. So we're excited about the traction we're seeing in our third quarter enrollment Membership growth for the quarter was really attributed to what I would say are 3 main components. One is in group growth was net positive for the quarter. Our wins versus losses was also positive for the third consecutive quarter, and obviously, the preferred 1 acquisition contributed to our overall growth. We're expecting continued commercial growth in 2022 across both our fully insured and self-funded segments. We're confident in the value story. It is resonating in the market. We're getting good traction with our broad product portfolio. And so products like Bind and Care Cash and Harmony and Motion and also areas are all contributing to that growth. 1/1/22 for Middle Market is obviously a little early to predict exactly how all those products will perform in the market, but we're very confident in our ability to continue to perform well in the commercial market for 2022."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. And I would just add on to what Bill said. I mean the new products are important. But one of the fundamental things within the commercial group is clearly affordability. And as we sit back, we have a good program where we manage utilization. We manag",80,"Yes. And I would just add on to what Bill said. I mean the new products are important. But one of the fundamental things within the commercial group is clearly affordability. And as we sit back, we have a good program where we manage utilization. We manage medical cost initiatives. We work hard on our network contracts. So a lot of things contribute to success in commercial and some product and a lot of affordability. So thanks for your question."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Scott Fidel with Stephens.",8,"Next, we'll go to Scott Fidel with Stephens."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Interested if you can maybe talk a bit about the labor and staffing environment right now in health care and one, how that's impacting the OptumCare provider businesses, whether you're seeing an impact as the vaccine mandates are going into effect as well",125,"Interested if you can maybe talk a bit about the labor and staffing environment right now in health care and one, how that's impacting the OptumCare provider businesses, whether you're seeing an impact as the vaccine mandates are going into effect as well. And then just more broadly, as we look at just some of the tightness around labor and staffing in the system. How is that influencing your thoughts in terms of where overall health system capacity is right now? I mean it feels like we're pretty much maxed out, right? And we sort of just shift between coin and non-COVID, but it seems like the system itself is running pretty much at full capacity right now in terms of just the staffing dynamics."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, this is Wyatt Decker, very key question. And as you point out, the U.S. health care market is very tight right now. For us, in our care delivery assets, we are seeing good, both the retention, engagement and recruitment of physicians and care provi",217,"Scott, this is Wyatt Decker, very key question. And as you point out, the U.S. health care market is very tight right now. For us, in our care delivery assets, we are seeing good, both the retention, engagement and recruitment of physicians and care providers. 
A couple of examples I'll give you. We mentioned at the start of the year our intent to bring onboard 10,000 additional physicians to our ranks, and we've already brought on board about 8,000 year-to-date. So just as a high-level indicator, why -- what do we attribute this to? And I would say in partnership with Patricia Lewis and our human capital team, we're relentlessly focused on supporting our frontline care provider teams throughout the pandemic and they know this and have been deeply appreciative of it. And we work very hard, and this precedes the pandemic but has yielded dividends during the pandemic to support them in an environment that decreases clerical burden and allows them to focus on the work they love, which is actually taking care of patients, which is what we all want. 
So overall, we're managing through this. I won't kid you, it's tight, and we're keeping a close eye on it throughout all of our operations in our 43 states where we provide care. Thank you."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. And I would just say, as Wade said, we're managing through this. From an environmental standpoint, it's not just clinicians. It's all workers. But one thing I would say is we had a fairly significant work at home presence before the pandemic even sta",142,"Yes. And I would just say, as Wade said, we're managing through this. From an environmental standpoint, it's not just clinicians. It's all workers. But one thing I would say is we had a fairly significant work at home presence before the pandemic even started. So sort of our employee value proposition sort of was -- we had a good value proposition before. It started and that sort of carried through. And I think like all employers, what we're trying to do is take care of our people, do the right things from a reasonableness standpoint. And continue to focus on our mission, and that's what we're continuing to do. So I'm optimistic that we're going to continue to be able to staff our operation and provide the services that we need to all of our patients and members across the country."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ricky Goldwasser with Morgan Stanley.",9,"Next, we'll go to Ricky Goldwasser with Morgan Stanley."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Yes. Just a quick follow-up question on the 2022 early comments. So a couple of variables there. One is we think about the change transaction, I think you said to close in the first half of the year. If you can give us an updated change accretion number,",139,"Yes. Just a quick follow-up question on the 2022 early comments. So a couple of variables there. One is we think about the change transaction, I think you said to close in the first half of the year. If you can give us an updated change accretion number, I think, it was $0.20 to $0.50 previously, at least for 2021. So how should we think about for 2022? 
And then I understand that there are a lot of uncertainties around COVID and that $1.80 in net COVID headwinds. But I think previously, you quantified about $0.70 is coming from risk adjustments. So should we think that these at least are going to reverse next year? And maybe how are you tracking with the annual wellness visits completion versus where you were last year or where you were in 2019?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks for the question, Ricky. I think a few components there, and we'll get it -- try to get at all of those. So just in terms of relates to change in impact, I'd just point out that we don't bring in acquisitions into our outlook until those close. So",263,"Thanks for the question, Ricky. I think a few components there, and we'll get it -- try to get at all of those. So just in terms of relates to change in impact, I'd just point out that we don't bring in acquisitions into our outlook until those close. So my commentary doesn't anticipate change in there, and we wouldn't look to bring that into closes. -- when that does complete, we have no reason to expect that we wouldn't be trending along the same levels that we talked about prior when that does come in. It's just a question when it comes in and year and how the how the benefits play. There's just timing impacts in terms of that when it would actually close during the year. But not incorporated in that outlook. 
As it relates to kind of the $1.80 that we articulated last year. Yes, we broke out a number of different components that were important in that element. And frankly, my hope would be we're not talking about a COVID number by the time we get into '22, that we move beyond that and we can move beyond to business as normal as we can while being always ready and to address the environment that's at hand. But that would be certainly our intent as we'd step out here that we'd be moving beyond that view. In terms of elements and such, in terms of elements such as annual wellness visits and things as BT to comment -- Brian Thompson to comment in a moment on that also."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure, John. As you laid out at the beginning, while both our Medicaid and Medicare businesses are running still below baseline on a net basis, we are encouraged by the encounters with the physicians, the primary care visits and annual wellness visits as w",74,"Sure, John. As you laid out at the beginning, while both our Medicaid and Medicare businesses are running still below baseline on a net basis, we are encouraged by the encounters with the physicians, the primary care visits and annual wellness visits as well as in-home clinical visits. So those have been encouraging. So I certainly expect less of a headwind in 2022 due to those encounters, certainly getting traction certainly compared to 2021."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Kevin Caliendo with you at UBS.",10,"Next, we'll go to Kevin Caliendo with you at UBS."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Can you talk a little bit about elective trends in September and as they moved into October, how that's changed at all if you've seen any uptick in -- also just on your commercial market growth, your membership growth in the quarter, can you break it out",53,"Can you talk a little bit about elective trends in September and as they moved into October, how that's changed at all if you've seen any uptick in -- also just on your commercial market growth, your membership growth in the quarter, can you break it out between small group versus large group?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So thanks, Kevin. Let's let Brian Thompson address a couple of those.",12,"So thanks, Kevin. Let's let Brian Thompson address a couple of those."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. Kevin, Brian here. As I think about elective care, what we've really seen is a pretty steady return to normal. We don't really see what I'll call as an unnatural suppression nor have we seen a significant bounce back suggesting a big catch up. In fa",184,"Sure. Kevin, Brian here. As I think about elective care, what we've really seen is a pretty steady return to normal. We don't really see what I'll call as an unnatural suppression nor have we seen a significant bounce back suggesting a big catch up. In fact, when you think about scheduled care, what we have found is that most of that cycles through in about 4 to 6 months. We look at things like colonoscopies and joint replacements as good leading indicators. And those are running pretty close to baseline. 
Obviously, with the spike that we saw in September, there's a little bit of that, that we would expect to flow through in the fourth quarter, but that's fully accounted for in our outlook. And I would just say from a commercial perspective, maybe echoing what Bill said, feeling really balanced really across our fully insured growth for the quarter. So just optimistic that, that was across not only our group business but we also saw a return of our nonexchange individual growth. So a really good quarter from a fully insured perspective."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to A.J. Rice with Credit Suisse.",9,"Next, we'll go to A.J. Rice with Credit Suisse."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Maybe just to drill down a little bit on the OptumRx and what's incorporated in outlook headwinds and tailwinds. I know we had the vaccine this year probably helped script trends a little bit. We had some specialty conversions maybe that helped? And obvio",64,"Maybe just to drill down a little bit on the OptumRx and what's incorporated in outlook headwinds and tailwinds. I know we had the vaccine this year probably helped script trends a little bit. We had some specialty conversions maybe that helped? And obviously, what was the dynamic around renewing contracts and so forth? What are you thinking about for '22 for OptumRx?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Hey, Heather Cianfrocco here. Thanks, A.J., for the question. So you mentioned -- we talked in the second quarter a bit about vaccine. We saw a little bit of that this quarter in growth, but it's proportionately down. The last quarter, I think it was abou",302,"Hey, Heather Cianfrocco here. Thanks, A.J., for the question. So you mentioned -- we talked in the second quarter a bit about vaccine. We saw a little bit of that this quarter in growth, but it's proportionately down. The last quarter, I think it was about 1/3 of the growth. This quarter, it's down to about, call it, between 20% and 25%. So you're seeing really our growth first of all, in this quarter as a result of modest PBM growth together with continued and membership growth together with continued pharmacy services growth. When we look at '22, we're going to see that to continue. So our pharmacy services growth, remember, that's our home delivery, specialty, infusion, the multidose as well as our direct-to-consumer community businesses. Those will continue to grow in '22. We see those sort of outpacing growth of the rest of OptumRx pharmacy. 
And I guess I'd call out a few things when I think about '22. First of all, we've made those investments. And so we're seeing that. We talked about Genoa and our community pharmacies and Dirk talked about this morning and how they're growing, not just in expanded sites, but our existing sites are continuing to show really strong growth as they expand services to existing members and expand in different types of health centers. We'll continue to see that in '22. And we think the solutions we're bringing in an integrated way together with our consumer experience and our real push to make therapeutics affordable and easy to access for our members will continue to see that. And I just point you back to our long-range growth where we'll continue to be, I think, stable with our revenue and earnings growth in '22 as we look towards our long-range plan. So thanks for the question."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, that was great. And I think, A.J., what that points out, clearly, a broad pharmacy portfolio with clearly, a laser focus on affordability and laser focus on serving people, getting the medications in people's hands where they need them and basically",58,"Yes, that was great. And I think, A.J., what that points out, clearly, a broad pharmacy portfolio with clearly, a laser focus on affordability and laser focus on serving people, getting the medications in people's hands where they need them and basically servicing the entire sort of what I'll call a pharmacy landscape with effective products and services."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll go to Lisa Gill with JPMorgan.",8,"We'll go to Lisa Gill with JPMorgan."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I just want to go back to your comments around virtual care and a digital first product in 2022. Can you talk about what that will entail of. And then secondly, when you talk about connecting multiple channels of care in 2022, I would assume that's primar",78,"I just want to go back to your comments around virtual care and a digital first product in 2022. Can you talk about what that will entail of. And then secondly, when you talk about connecting multiple channels of care in 2022, I would assume that's primarily keeping the patient in the home. But can you maybe just give a little more detail around what those programs would look like and what the potential cost savings could be?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So first of all, let me hit on the virtual products that we have. I've talked about it before, we're sort of getting into from version 1 to version 2. The second version is really not telehealth as a stand-alone service but really effectively integra",197,"Yes. So first of all, let me hit on the virtual products that we have. I've talked about it before, we're sort of getting into from version 1 to version 2. The second version is really not telehealth as a stand-alone service but really effectively integrated into physical delivery and total courses of care. And so as I think about how we might -- how we're organizing our products, what we would have is a virtual PCP available to some people and many people across the country don't have relationships with PCPs. So a product based on having virtual PCP having that PCP managed like a brick-and-mortar PCP, and then manage the downstream expenses being able to refer to digital properties to be able to, as I said, bring in a behavioral specialist where needed. And as we sit and we look at some of the products that we have and we're designing, we're expecting probably about a 15% price advantage to other sort of similar products in the market. So we're kind of excited about the efficiency of virtual in that context. Yes. So give me your second question again, Lisa, I was focused on virtual."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Just more around when you talk about connecting multiple channels of care in 2022, should I assume that, that's primarily connecting care in the home? Or is there something that I'm not thinking about?",34,"Just more around when you talk about connecting multiple channels of care in 2022, should I assume that, that's primarily connecting care in the home? Or is there something that I'm not thinking about?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","No. No, you're thinking of this multimodality right. It's home, it's digital. It's what we do in the office. And that's one of the things that we're trying to do, and I'm glad you hit on that. Our ability to serve people where they want to be served is so",90,"No. No, you're thinking of this multimodality right. It's home, it's digital. It's what we do in the office. And that's one of the things that we're trying to do, and I'm glad you hit on that. Our ability to serve people where they want to be served is something that we're really focused on across all 3 of our lines of business. It's very important. And clearly, people have different care needs, and they have different preferences for care, and we want to provide that access across the board."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. within OptumHealth or OptumCare, the build-out of the home and community platform is one of the more important areas that Wyatt and his team are focused on. There's been lots of development there. Wyatt, maybe you could add a little color?",42,"Yes. within OptumHealth or OptumCare, the build-out of the home and community platform is one of the more important areas that Wyatt and his team are focused on. There's been lots of development there. Wyatt, maybe you could add a little color?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Absolutely. So we're very excited about bringing virtual care, as Dirk said, in a differentiated way into people's homes so that they can access care. We can help triage them and onboard them. We can provide primary care. And when needed, we can provide c",106,"Absolutely. So we're very excited about bringing virtual care, as Dirk said, in a differentiated way into people's homes so that they can access care. We can help triage them and onboard them. We can provide primary care. And when needed, we can provide care delivery in appropriate in some instances in the home or we're leveraging particularly our urgent care platform to provide nearby physical care. And then we blended in our virtual and physical behavioral care  deliveries as well. So  we're now live in all 50 states. We're serving over 7 million members today, and we look forward to continuing to expand these offerings."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Operator, next question, please. And I think we have time for about 2 more questions here as we approach the bottom of the hour.",24,"Operator, next question, please. And I think we have time for about 2 more questions here as we approach the bottom of the hour."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Okay. Next, we'll go to Steven Valiquette with Barclays.",9,"Okay. Next, we'll go to Steven Valiquette with Barclays."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","So you touched on the topic of Medicare risk adjuster payments earlier. This was also a little bit more topical about a month ago with The Wall Street Journal putting a spotlight on it. So I guess I'm just curious if you have any updated high-level though",76,"So you touched on the topic of Medicare risk adjuster payments earlier. This was also a little bit more topical about a month ago with The Wall Street Journal putting a spotlight on it. So I guess I'm just curious if you have any updated high-level thoughts on MRA payments conceptually for the managed care industry overall. And do you see any potential reform of MRA near term? Or do you expect status quo going forward?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you very much for the question. First, let me point to the value proposition that Medicare Advantage provides. I think that's important context. So may serve 27 million Americans with very high-quality care. And compared to fee-for-service Medi",188,"Yes. Thank you very much for the question. First, let me point to the value proposition that Medicare Advantage provides. I think that's important context. So may serve 27 million Americans with very high-quality care. And compared to fee-for-service Medicare, MA costs less is more equitable, has better quality access and outcomes and greater coverage and benefits with nearly 100% consumer satisfaction. So very, very important to the care that seniors receive, and it's important that we preserve the stability of this program that so many people rely on. 
And when we think about the risk adjustment model in the payment system,  the model has been critical to providing broad and equitable access to MA. Risk adjustment levels of playing field and ensures that there's no disincentive to care for the most vulnerable. So we really feel that it's a central part of encouraging the right incentives in the program and think that it's something to build on and broadly support that we need to think about how to build on these positive elements and aspects of the program for which this is one of them. 
Thanks, Tim."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","All right. We'll take our last question from Stephen Baxter with Wells Fargo.",13,"All right. We'll take our last question from Stephen Baxter with Wells Fargo."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wanted to come back to the labor market and some of the things that we're reading about provider financials.  Was wondering what you're hearing from your network partners on this issue and how you think it will or will not influence rate negotiations ov",51,"I wanted to come back to the labor market and some of the things that we're reading about provider financials.  Was wondering what you're hearing from your network partners on this issue and how you think it will or will not influence rate negotiations over the next couple of years?"
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So thanks for the question. I think yes, what we're hearing from network partners is that their cost of labor is higher. So that comes up in the negotiations. And like anything else, it's part of what we negotiate and how we try to work with our netw",220,"Yes. So thanks for the question. I think yes, what we're hearing from network partners is that their cost of labor is higher. So that comes up in the negotiations. And like anything else, it's part of what we negotiate and how we try to work with our network partners on coming up with the right pricing and negotiating accordingly. Yes, we're hearing that there's -- obviously, there's staffing shortages, obviously, many of the hospitals and other providers have to pay more for their input, and that's going to be reflected in the economics as we go forward. And of course, all that is reflected in how we price going forward. 
So yes, that occurs. 
Thank you for the question. With that, what I would like to close with is as follows: thanks, everybody, for your time and your questions today. We hope you're taking away the impression of a company that's confident in its opportunities and ability to grow. And we're deeply aware of where and how we need to improve, and we're fully committed to our mission of helping people live healthier lives and helping make the health system work better for everyone. We look forward to sharing with you more at our November 30 investor conference, hopefully, in person in New York. Thanks for your time today."
104673,1682559831,2406258,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","That does conclude today's conference. We thank everyone again for their participation.",13,"That does conclude today's conference. We thank everyone again for their participation."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Good morning, everyone, and welcome to the UnitedHealth Group's Third Quarter 2021 earnings conference call. [Operator Instructions] As a reminder, this call is being recorded. Here is some important introductory information. This call contains forward-lo",190,"Good morning, everyone, and welcome to the UnitedHealth Group's Third Quarter 2021 earnings conference call. [Operator Instructions] As a reminder, this call is being recorded. Here is some important introductory information. This call contains forward-looking statements under U.S. federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations. A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the cautionary statements included in our current and periodic filings.  
This call will also reference non-GAAP amounts. A reconciliation of the non-GAAP to GAAP amounts is available on the financial and earnings reports section of the company's Investor Relations page at www.unitedhealthgroup.com. Information presented on this call is contained in the earnings release we issued this morning and in our Form 8-K dated October 14, 2021, which may be accessed from the Investor Relations page of the company's website. I will now turn the conference over to the President and Chief Operating Officer for UnitedHealth Group, Dirk McMahon. Please go ahead, sir."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Good morning, and thank you for joining us today. Unfortunately, our CEO and colleague, Andrew, is not with us this morning since he had an urgent but straightforward procedure last night for a kidney stone. All went very well, and we expect him fully bac",1177,"Good morning, and thank you for joining us today. Unfortunately, our CEO and colleague, Andrew, is not with us this morning since he had an urgent but straightforward procedure last night for a kidney stone. All went very well, and we expect him fully back in just a few days. I'm quite confident he is listening now, so I hope you're doing well, Boss.  
John Rex and I will be subbing for Andrew this morning, and we have our management team with us as usual to help with your questions.  
We're here today to discuss third quarter results and the expanding opportunities we see looking ahead. As a result of the progress at both Optum and UnitedHealthcare, we have increased our 2021 adjusted earnings outlook to a range of $18.65 to $18.90 per share. We continue to prioritize 3 themes Andrew has discussed before which our -- before which are foundational to the growth of our enterprise. First, unlocking the collaborative potential within Optum and UnitedHealthcare for the benefit of all; second, further developing our technology and data science platform to aid patient care and experience and to help the system run better; third, strengthening our consumer experience, capabilities and value. I'll briefly highlight a couple of items for you. 
You will likely have seen the CMS Medicare Advantage Star -- Medicare Advantage Star Quality rating showing 95% of our UnitedHealthcare members will be in 4-star-rated plans or better for 2023, up from 78% for 2022 and a new high for our company. Within Optum Care, on behalf of the many payers we serve, 99% of Medicare Advantage patients will be in 4-star plans or better for 2023. A second important highlight in the quarter. We were encouraged by the ongoing strength in our employer and individual business, which has now grown by over 330,000 people this year with revenue up 7% year-over-year. We continue to see active interest in our product innovations, such as our All Savers level-funded offering and are encouraged by our competitiveness in the market and momentum heading into '22. We also elevated consumer connectivity by incorporating fitness offerings from industry-leading partners.  
OptumHealth continues to build momentum as well. Entering the open enrollment period for Medicare Advantage, we have more than 2.2 million people served under physician-led, fully accountable arrangements and expect '22 to be another year of record expansion in this key part of our portfolio. Our broad home-based clinical care initiatives at Optum and UnitedHealthcare are central to improving near and longer-term health outcomes for people with medical, behavioral and social needs. These efforts include Optum at Home, which delivers high-quality primary care services in the convenience of the home setting and support recovery after hospitalizations. Seniors served by our home and community offering experienced a 14% lower rate of hospital admissions and about a 4% higher rate of physician encounters.  
In addition to caring for people in their homes, we continue to expand capabilities in other optimal sites of care, including via digital means. Optum is distinctively enabling virtual care for patients using their own primary care physicians and with behavioral clinicians. For example, a physician engaging in a virtual visit with a patient can easily bring in a behavioral health professional for a real-time consultation. UnitedHealthcare is using Optum's virtual capabilities to introduce a new suite of digital-first products, offering a near seamless experience between virtual and traditional primary, specialty and urgent care.  
We expect during 2022 and beyond to further build on these opportunities to connect and integrate multiple channels of care, simplify the experience for patients and providers and deliver quality care that is affordable and in the optimal setting. Let me now go a little deeper in a few areas to give you an assessment of how we're doing on the themes I mentioned at the outset. OptumInsight continues to drive better clinical and operational performance at the health system level. Last week, we reached a new multiyear partnership with a leading and innovative health system, SSM Health, whose 40,000 employees, 33 hospitals and post-acute facilities and 300 physician clinics serve the people of Missouri, Oklahoma, Wisconsin and Illinois. OptumInsight brings real value in helping systems strengthen and scale essential functions, such as care coordination, revenue cycle management and digital modernization, all to improve health outcomes and patient's care experiences.  
These and similar efforts to simplify processes, reduce administrative burdens and help our partners focus -- help our partners focus more attention on their care -- on their core missions of patient care. OptumRx continues to deliver to health system partners, such as its new multiyear agreement with Point32Health, which serves more than 2 million people in New England through its founding organizations, Harbor Pilgrim Health Care and Tufts Health Plan. OptumRx will provide integrated pharmacy benefit and specialty offerings that will enhance services and deliver improved affordability for their plan members. OptumRx is having a substantial impact through its community behavioral health pharmacies, which now serve nearly 700,000 people with mental health, addiction and other conditions through more than 600 dispensaries across 47 states. The pharmacies deliver a high-touch approach to care that contributes to a more than 90% medication adherence rate and lowers emergency room visits and hospitalizations by 18% and 40%, respectively, driving better outcomes and a lower total cost of care.  
Within our UnitedHealthcare government businesses, we have increased processing efficiency by 25% over the last year by using Optum technology to improve auto adjudication rates and intelligent work distribution to appropriately skilled channels. We have many such initiatives underway across the enterprise in affordability, provider experience and product development as we employ advanced technology and data analytics to drive even greater value for the people we serve and the health system.  
Before turning over the call to John, a quick word on our pending combination with Change Healthcare. We continue to work diligently to satisfy regulatory requests and now believe, based on our experience so far, the transaction should close in the first part of 2022.  
We are highly energized about the positive impact we can have working together with the exceptional change team, a team aligned with our mission and values and focused on delivering substantial benefits for the health care system. These benefits will include helping clinicians by simplifying access to real-time evidence-based guidance as they are serving patients, closing gaps in care more rapidly to improve health outcomes and lower cost, reducing unnecessary complexity by removing administrative waste and obstruction to make the care process simpler, more cost effective and more transparent. And bringing greater convenience and simplicity to managing consumer health finances, while ensuring care providers get paid more quickly and accurately. Optum and Change Healthcare's capabilities fundamentally are complementary and distinct because both companies already successfully serve health plans and state governments, care providers and consumers in a highly competitive market. We believe this combination will make the health care system work better for everyone and bring exceptional value to those we serve. With that, I'll turn it over to our Chief Financial Officer, John Rex."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thank you, Dirk. This morning, we reported third quarter and year-to-date revenues of $72 million and $214 million, respectively, growth of 11% and 12% over last year. This growth was led by OptumHealth, primarily our care businesses. In the third quart",760,"Thank you, Dirk. 
This morning, we reported third quarter and year-to-date revenues of $72 million and $214 million, respectively, growth of 11% and 12% over last year. This growth was led by OptumHealth, primarily our care businesses. In the third quarter, the Optum platform comprised 54% of enterprise operating earnings and continues to show strong growth momentum. Our performance reflects the diverse and complementary strengths of our business, setting the stage for growth in the years ahead. Our updated full year '21 outlook includes unfavorable COVID impacts, consistent with the expectations we have discussed throughout the year. 
During the third quarter, while direct COVID care and testing costs ran above the expectations we had nearly a year ago, we again saw elective care offsetting the impacts of higher case rates, much like previous cycles in the pandemic. This quarter, there were approximately 60,000 COVID hospitalizations meaningfully above the second quarter, with the month of August peaking at nearly 30,000 and then declining in September. 
Looking at specific business performance. OptumHealth's third quarter revenue and earnings increased 32% and 37%, respectively, year-over-year. Revenue per consumer grew by 30%. This reflects the increasing impact and number of value-based relationships within OptumCare. The expansion of our in-home and community health platform as well as the growing acuity of the needs we can serve. 
OptumInsight's revenue grew 13% in the quarter, and earnings grew 15% as the revenue backlog increased by 12% to $22.3 billion. We see overall business development sourcing and activity levels increasing, particularly with care provider customers, and for our software and analytics offerings. OptumRx revenue and scripts grew 6% year-over-year and earnings, 5%. OptumRx has seen both strong customer retention levels and sales success for the largely completed '22 selling season and early activity for '23. 
Turning to UnitedHealthcare. The third quarter showed increasing member growth in our commercial offerings, particularly in employer-sponsored benefits. Increased employment is a broad underlying contributor, but we are particularly encouraged by the growth we are achieving in our affordable consumer-centric offerings. Medicare Advantage membership has grown 745,000 this year, inclusive of plans which serve dual special needs members. We expect to add a total of over 900,000 Medicare Advantage members. 
The number of people served through managed Medicaid grew by more than 1 million members over last year as we began to serve people in new regions such as North Carolina, Kentucky and Indiana, and as state-based redetermination activities remained paused. We were honored to begin serving people in the Missouri Medicaid expansion this month. Our liquidity and capital positions remain strong with third quarter cash flows from operations at $7.6 billion or 1.8x net income, and we ended the quarter with a debt-to-capital ratio of 39%. As noted earlier, given the strength of our business performance,  this morning, we updated our 2021 adjusted earnings outlook to a range of $18.65 to $18.90 per share. 
Now with the close of the third quarter, your attention understandably turns to next year. As is our custom, we will offer a few early observations here while reserving the majority of this conversation for our November 30 investor conference, which we hope will be held in person in New York. 
Our businesses are both growing and operating well with strong momentum heading into next year. While the pandemic-related impacts remain difficult to predict, given the current trends, we would expect a lower unfavorable COVID impact than experienced in '21. Still, as the dramatic variation over the last 20 months has demonstrated to all, prudent management suggests we should offer an outlook respectful of the fact that the current situation is without precedent. 
Taking all elements together at this distance, we see current analyst consensus as reasonably beginning to calibrate a '22 outlook. Envisioning that consensus as being toward the upper end of our initial adjusted earnings per share outlook range, with the range being similar to that offered initially for '21.  The still untapped collaborative potential between UnitedHealthcare and Optum to benefit individuals in the system, the power of applied technology to advance care and service, improved opportunity in consumer health and experience and the passion of our people. These and so many other elements lead us to believe our performance expectations for the years ahead remain fully supportive of our long-term 13% to 16% earnings per share growth outlook. 
We look forward to going into more detail on both our view of '22 and the many years of growth beyond at our investor conference. With that, operator, let's open it up for questions. One per caller, please."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","[Operator Instructions]. So we'll go ahead and take our first caller, Matt Borsch with BMO Capital Markets.",17,"[Operator Instructions]. So we'll go ahead and take our first caller, Matt Borsch with BMO Capital Markets."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","All right. Squeaky clean quarter. I was hoping maybe you could just talk about how United and, to the extent you have visibility on others, are approaching commercial -- group commercial fully insured rate increases for 2022?",37,"All right. Squeaky clean quarter. I was hoping maybe you could just talk about how United and, to the extent you have visibility on others, are approaching commercial -- group commercial fully insured rate increases for 2022?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Why don't we let Brian Thompson take that question? Go ahead, BT.",13,"Yes. Why don't we let Brian Thompson take that question? Go ahead, BT."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question, Matt. Certainly, as we look forward to 2022, the picture is a lot more clear. Then as we look at the past 20 months, I would say that we feel optimistic not only about our pricing and the rationality of the market, but most i",64,"Yes. Thanks for the question, Matt. Certainly, as we look forward to 2022, the picture is a lot more clear. Then as we look at the past 20 months, I would say that we feel optimistic not only about our pricing and the rationality of the market, but most importantly, the value that we're bringing to customers. So we're optimistic as we look forward."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Yes, we'll go to Josh Raskin with Nephron Research.",9,"Yes, we'll go to Josh Raskin with Nephron Research."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","My question relates to the value-based care, but more from the UnitedHealthcare side. And so how does UHC think about the use of value-based care providers and maybe some expectations on the movement of membership into fully cap arrangements in 2022. I th",90,"My question relates to the value-based care, but more from the UnitedHealthcare side. And so how does UHC think about the use of value-based care providers and maybe some expectations on the movement of membership into fully cap arrangements in 2022. I think you said 250,000 lives this year. So curious how you're thinking about next year? And then maybe as part of that, what advantages you see of using OptumCare as a partner over some of the others and kind of how you evaluate partners in the markets?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, I appreciate the question. Brian Thompson here again. I would say we certainly are encouraged by continuing our advanced care penetration with partners, OptumCare, certainly being one of several. When we partner with OptumCare, we see not only our hi",173,"Yes, I appreciate the question. Brian Thompson here again. I would say we certainly are encouraged by continuing our advanced care penetration with partners, OptumCare, certainly being one of several. When we partner with OptumCare, we see not only our highest satisfaction, but our best benefits and overall performance, and you heard that in our star quality results as well. And we're encouraged not only by what we have done by what's -- but also by what's on the horizon. Historically, you've looked at our combinations largely in a traditional Medicare Advantage space, and you're seeing us expand in the complex populations and duals. And we're also really encouraged with what we're doing in the commercial marketplace as well. We've got some new offerings coming in that space. 
So I would say the key takeaway here is breadth and impact. We continue to scale and expand in that space. And it's important. We really see this value-based aligned care as a way to drive good value for those that we support and serve."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks, BT. And Josh, thanks for the question. This is Wyatt Decker. I would just add that at OptumHealth and Care, we are very pleased to be playing a role in reinventing the U.S. health care system focused around patients as consumers and value-based ca",121,"Thanks, BT. And Josh, thanks for the question. This is Wyatt Decker. I would just add that at OptumHealth and Care, we are very pleased to be playing a role in reinventing the U.S. health care system focused around patients as consumers and value-based care as a major pillar. As you mentioned, we've grown by 250,000 fully capitated lives this year, and we're excited through our partnership with UHC, as well as collaboration partnership with over 90 payers in total, to continue to grow our value-based care delivery construct. The other point I'd make is you'll see us increasingly weaving together all of our assets in a comprehensive care delivery paradigm that we feel is unique and differentiated in the marketplace."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Yes, next, we'll go to Ralph Giacobbe with Citi.",9,"Yes, next, we'll go to Ralph Giacobbe with Citi."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Great. Just wanted to go to the guidance commentary. And I guess just to clarify, John, is it inclusive or exclusive of the $1.80 headwind from this year? So when you talked about reasonable relative to consensus, maybe at the higher end. Do you factor in",62,"Great. Just wanted to go to the guidance commentary. And I guess just to clarify, John, is it inclusive or exclusive of the $1.80 headwind from this year? So when you talked about reasonable relative to consensus, maybe at the higher end. Do you factor in the $1.80? Or can you just provide some guardrails around how you're thinking about that $1.80?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, Ralph, so yes, so as it relates to this year's $1.80, look, our expectation is that will clearly be lower than it was in 2021, as we think about it. We also don't think it will be nothing. I can't imagine we hit January 1 and everything ceases immedi",135,"Yes, Ralph, so yes, so as it relates to this year's $1.80, look, our expectation is that will clearly be lower than it was in 2021, as we think about it. We also don't think it will be nothing. I can't imagine we hit January 1 and everything ceases immediately. So we don't think that will be the case at all. So inclusive of that, when you think about going to that, I think inclusive and as we look at where the analyst consensus currently centers, it seems like kind of a reasonable starting point in terms of how we think about that and how we would anticipate and be respectful of the fact that we don't know exactly how this will progress as we move into the -- in the new year. Thanks, Ralph."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Dave Windley with Jefferies.",8,"Next, we'll go to Dave Windley with Jefferies."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Coming back to the topic that Josh touched on in value-based care, but perhaps more OptumCare-focused. I'm wondering if you could talk about, one, the providers within the 53,000 that are responsible for the 2.2 million fully capitalized? Like how does th",87,"Coming back to the topic that Josh touched on in value-based care, but perhaps more OptumCare-focused. I'm wondering if you could talk about, one, the providers within the 53,000 that are responsible for the 2.2 million fully capitalized? Like how does that interweave? And then secondly, if you could talk about the, call it, the margin on the global cap revenue. So how capable or how much impact are those providers having on consumption of downstream care such that OptumCare makes a margin on decapitated revenue?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, we'll go to Wyatt on that. But let me first start by saying, of course, all of the providers within OptumCare, they are responsible for managing the downstream spend, whether it be it specialists, whether it be in hospitals,like [ global ] cap is tha",109,"Yes, we'll go to Wyatt on that. But let me first start by saying, of course, all of the providers within OptumCare, they are responsible for managing the downstream spend, whether it be it specialists, whether it be in hospitals,like [ global ] cap is that? And one of the key things that we do within OptumCare is we made investments in our systems to absorb, take and manage risk, right? It's just not a paper transfer. It's actually a system where the providers are fully aware of decapitated arrangements and they're managing accordingly. So Wyatt, why don't you add on top of that? You're more in the details."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thanks for the question. And as Dirk mentioned, we focus relentlessly on the quadruple aim, including lowering total cost of care, providing better outcomes and outstanding patient experiences, and we are relentless in monitoring specific data points",223,"Yes. Thanks for the question. And as Dirk mentioned, we focus relentlessly on the quadruple aim, including lowering total cost of care, providing better outcomes and outstanding patient experiences, and we are relentless in monitoring specific data points that help deliver that -- those outcomes. Specifically, what we see is the members that are in fully capitated arrangements overall have about a 30% lower hospitalization rate and about 40% lower skilled nursing facility occupation rate than their counterparts and fee-for-service Medicare, as an example. So we'll continue to drive that value proposition. 
And as I touched on the previous question that I'll go a little deeper. As you think about us with our home and community assets increasingly meeting people in their terms, in their homes to deliver components of value-based and primary care, preventive care and wellness care, and identify early conditions that otherwise might have led to an ER visit or hospitalization. 
You'll also see us continuing to bring on board very innovative behavioral health care delivery solutions that are integrated with the primary care providers that, again, identify and treat mental health and substance use disorders by identifying them early and treating them in lower acuity settings, when that's appropriate. So those are just a couple of examples of how we're creating value for those that we serve. Thank you."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Perfect. That's great, Wyatt.",4,"Perfect. That's great, Wyatt."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Sure. Next, we'll go to Kevin Fischbeck with Bank of America.",11,"Sure. Next, we'll go to Kevin Fischbeck with Bank of America."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I was wondering if you could provide just a little bit more color about utilization trends in the quarter and maybe do that by product line, breaking it out by COVID and non-COVID utilization where you are versus [ bench line ] -- baseline.",44,"I was wondering if you could provide just a little bit more color about utilization trends in the quarter and maybe do that by product line, breaking it out by COVID and non-COVID utilization where you are versus [ bench line ] -- baseline."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Kevin, this is John. So yes, a few perspectives on that as we think about utilization trends in the quarter. And I gave some broad indication just in terms of where we were with COVID inpatient stays and such for our members. Maybe to give a little kind o",325,"Kevin, this is John. So yes, a few perspectives on that as we think about utilization trends in the quarter. And I gave some broad indication just in terms of where we were with COVID inpatient stays and such for our members. Maybe to give a little kind of further commentary. So as we sit here today, about 5,000 of our members are in an inpatient setting for a COVID-related condition right now. And I'd say versus the peak that we experienced during the quarter, that's probably just a little more than 50% of the peak in that zone, probably a little of that we experienced over the course of the period. 
That fell across categories, probably categories much like you would have observed in the reports coming out nationally, in terms of the types of individuals who are in these settings. An average age that was considerably younger than we saw in prior to that -- in prior periods for COVID. So similar to what we have noticed across the board. In terms of broad utilization trends, similar to what we would have described in 2Q or what we did describe where  we continue to see commercial members be more active in elective care and public sector or government program members, a little bit less active. And so kind of similar, just trending at different levels, given the prevalence of COVID. It's been interesting over the course of the 20 months. There has been a consistent, fairly rapid reaction when COVID cases go up nationally in terms of the preference of patients to whether or not to seek elective care. That again happened this quarter, where it comes in fairly quickly in terms of the hesitation in the system to access. So broadly, kind of similar along those ranges. Hopefully, that provides a little additional color for you in what we're seeing across the whole book of business. Thanks for your -- Kevin, question."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Justin Lake with Wolfe Research.",9,"Next, we'll go to Justin Lake with Wolfe Research."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","First, let me just follow up there. John, you've talked about, I think, on the previous calls, your guidance assumed about 101%, 102% of normal in the back half of this year. If you could run that by -- it sounds like you're saying commercial might have b",136,"First, let me just follow up there. John, you've talked about, I think, on the previous calls, your guidance assumed about 101%, 102% of normal in the back half of this year. If you could run that by -- it sounds like you're saying commercial might have been a little higher and Medicare and Medicaid a little lower. But if you can give us those numbers specifically, just so we have kind of a read-through to the rest of the industry, that might be helpful, and what you saw in the quarter? And then what do you price -- would it be fair to -- for you to share what you price for, for next year in terms of trend? Did you price to 101%, 102% for next year kind of similar conservatism versus this year?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Justin, so a few other elements on that. So similar broad trends to what we observed in 2Q. Just shifting because of the COVID prevalence. So down shifting a bit in terms of elective, in terms of COVID prevalence, but then really fully offset by COVID. So",119,"Justin, so a few other elements on that. So similar broad trends to what we observed in 2Q. Just shifting because of the COVID prevalence. So down shifting a bit in terms of elective, in terms of COVID prevalence, but then really fully offset by COVID. So that is elective downshifting because of COVID prevalence and then fully offset as we saw COVID care become a more important part of the business. So that really flowed across the businesses with those trends across the book, like I described in terms of the general outlook on that. And let me turn to Dirk here to talk about some implications of how we would have anticipated that in our forward pricing."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. I mean, Justin, I mean, we, of course, are going to always price to our best estimates of forward trend. And we're going to take into consideration all the variables that we talked about. That toggle that John just talked about between COVID and what",87,"Yes. I mean, Justin, I mean, we, of course, are going to always price to our best estimates of forward trend. And we're going to take into consideration all the variables that we talked about. That toggle that John just talked about between COVID and what we expect with abatement. I don't want to get into the specific details. Clearly, that's competitive. But at the end of the day, just be aware that we've considered all factors as we priced our forward business within our books. Thanks."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Lance Wilkes with Bernstein.",8,"Next, we'll go to Lance Wilkes with Bernstein."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Yes. I wanted to ask a little bit about employer growth and was interested in for the third quarter, how much of that was new wins versus in accounts? And then as you're looking at '22 and you're getting visibility on national accounts and middle market.",90,"Yes. I wanted to ask a little bit about employer growth and was interested in for the third quarter, how much of that was new wins versus in accounts? And then as you're looking at '22 and you're getting visibility on national accounts and middle market. If you can just give a little color on those individual segments? And what's driving wins in 2022 in particular? Is it product features? Or is it the All Savers product? Maybe just a little more color on kind of why you're getting wins."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Okay. Why don't we send that question to Bill Golden, who will talk about all 3 of those quarter, not only this quarter but also why you think we've been having some success.",33,"Okay. Why don't we send that question to Bill Golden, who will talk about all 3 of those quarter, not only this quarter but also why you think we've been having some success."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So thank you for the question. So we're excited about the traction we're seeing in our third quarter enrollment. Our membership growth for the quarter was really attributed to what I would say, our 3 main components. One is in-group growth was net po",166,"Yes. So thank you for the question. So we're excited about the traction we're seeing in our third quarter enrollment. Our membership growth for the quarter was really attributed to what I would say, our 3 main components. One is in-group growth was net positive for the quarter. Our wins versus losses was also positive for the third consecutive quarter, and obviously, the PreferredOne acquisition contributed to our overall growth. We're expecting continued commercial growth in 2022 across both our fully insured and self-funded segments. We're confident in the value story. It is resonating in the market. We're getting good traction with our broad product portfolio. And so products like Bind and Care Cash and Harmony and Motion and also areas are all contributing to that growth. 1/1/22 for middle market is obviously a little early to predict exactly how all those products will perform in the market, but we're very confident in our ability to continue to perform well in the commercial market for 2022."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. And I would just add on to what Bill said. I mean the new products are important. But one of the fundamental things within the commercial group is clearly affordability. And as we sit back, we have a good program where we manage utilization. We manag",80,"Yes. And I would just add on to what Bill said. I mean the new products are important. But one of the fundamental things within the commercial group is clearly affordability. And as we sit back, we have a good program where we manage utilization. We manage medical cost initiatives. We work hard on our network contracts. So a lot of things contribute to success in commercial and some product and a lot of affordability. So thanks for your question."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Scott Fidel with Stephens.",8,"Next, we'll go to Scott Fidel with Stephens."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Interested if you can maybe talk a bit about the labor and staffing environment right now in health care. And one, how that's impacting the OptumCare provider businesses, whether you're seeing an impact as the vaccine mandates are going into effect as wel",125,"Interested if you can maybe talk a bit about the labor and staffing environment right now in health care. And one, how that's impacting the OptumCare provider businesses, whether you're seeing an impact as the vaccine mandates are going into effect as well. And then just more broadly, as we look at just some of the tightness around labor and staffing in the system. How is that influencing your thoughts in terms of where overall health system capacity is right now? I mean it feels like we're pretty much maxed out, right? And we sort of just shift between COVID and non-COVID, but it seems like the system itself is running pretty much at full capacity right now in terms of just the staffing dynamics."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Scott, this is Wyatt Decker, very key question. And as you point out, the U.S. health care market is very tight right now. For us, in our care delivery assets, we are seeing good, both the retention, engagement and recruitment of physicians and care provi",217,"Scott, this is Wyatt Decker, very key question. And as you point out, the U.S. health care market is very tight right now. For us, in our care delivery assets, we are seeing good, both the retention, engagement and recruitment of physicians and care providers. 
A couple of examples I'll give you. We mentioned at the start of the year, our intent to bring onboard 10,000 additional physicians to our ranks, and we've already brought on board about 8,000 year-to-date. So just as a high-level indicator, why -- what do we attribute this to? And I would say in partnership with Patricia Lewis and our human capital team, we're relentlessly focused on supporting our frontline care provider teams throughout the pandemic and they know this and have been deeply appreciative of it. 
And we work very hard, and this precedes the pandemic but has yielded dividends during the pandemic to support them in an environment that decreases clerical burden and allows them to focus on the work they love, which is actually taking care of patients, which is what we all want. So overall, we're managing through this. I won't kid you, it's tight, and we're keeping a close eye on it throughout all of our operations in our 43 states where we provide care. Thank you."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. And I would just say, as Wyatt said, we're managing through this. From an environmental standpoint, it's not just clinicians. It's all workers. But one thing I would say is we had a fairly significant work at home presence before the pandemic even st",142,"Yes. And I would just say, as Wyatt said, we're managing through this. From an environmental standpoint, it's not just clinicians. It's all workers. But one thing I would say is we had a fairly significant work at home presence before the pandemic even started. So sort of our employee value proposition sort of was -- we had a good value proposition before. It started and that sort of carried through. And I think like all employers, what we're trying to do is take care of our people, do the right things from a reasonableness standpoint. And continue to focus on our mission, and that's what we're continuing to do. So I'm optimistic that we're going to continue to be able to staff our operation and provide the services that we need to all of our patients and members across the country."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Ricky Goldwasser with Morgan Stanley.",9,"Next, we'll go to Ricky Goldwasser with Morgan Stanley."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Yes. Just a quick follow-up question on the 2022 early comments. So a couple of variables there. One is we think about the change transaction, I think you said you expect it to close in the first half of the year. If you can give us an updated change accr",142,"Yes. Just a quick follow-up question on the 2022 early comments. So a couple of variables there. One is we think about the change transaction, I think you said you expect it to close in the first half of the year. If you can give us an updated change accretion number, I think, it was $0.20 to $0.50 previously, at least for 2021. So how should we think about for 2022? 
And then I understand that there are a lot of uncertainties around COVID and that $1.80 in net COVID headwinds. But I think previously, you quantified about $0.70 is coming from risk adjustments. So should we think that these at least are going to reverse next year? And maybe how are you tracking with the annual wellness visits completion versus where you were last year or where you were in 2019?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Thanks for the question, Ricky. I think a few components there, and we'll get it -- try to get at all of those. So just in terms of the -- relates to change in impact, I'd just point out that we don't bring in acquisitions into our outlook until those clo",264,"Thanks for the question, Ricky. I think a few components there, and we'll get it -- try to get at all of those. So just in terms of the -- relates to change in impact, I'd just point out that we don't bring in acquisitions into our outlook until those close. So my commentary doesn't anticipate change in there. And we wouldn't look to bring that in until it closes.  When that does complete, we've have no reason to expect that we wouldn't be trending along the same levels that we talked about prior when that does come in. It's just a question when it comes in and year and how the benefits play. There's just timing impacts in terms of that, when it would actually close during the year. But not incorporated in that outlook. 
As it relates to kind of the $1.80 that we articulated last year. Yes, we broke out a number of different components that were important in that element. And frankly, my hope would be -- we're not talking about a COVID number by the time we get into '22. That we move beyond that and we can move beyond to business as normal as we can while being always ready and to address the environment that's at hand. But that would be certainly our intent as we'd step out here that we'd be moving beyond that view. In terms of elements and such, in terms of elements such as annual wellness visits and things, ask BT to comment -- Brian Thompson to comment a moment on that also."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure, John. As you laid out at the beginning, while both our Medicaid and Medicare businesses are running still below baseline on a net basis, we are encouraged by the encounters with the physicians, the primary care visits and annual wellness visits as w",74,"Sure, John. As you laid out at the beginning, while both our Medicaid and Medicare businesses are running still below baseline on a net basis, we are encouraged by the encounters with the physicians, the primary care visits and annual wellness visits as well as in-home clinical visits. So those have been encouraging. So I certainly expect less of a headwind in 2022 due to those encounters, certainly getting traction certainly compared to 2021."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to Kevin Caliendo with UBS.",8,"Next, we'll go to Kevin Caliendo with UBS."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Can you talk a little bit about elective trends in September and as they moved into October, how that's changed at all? If you've seen any uptick. And also just on your commercial market growth, your membership growth in the quarter. Can you break it out",52,"Can you talk a little bit about elective trends in September and as they moved into October, how that's changed at all? If you've seen any uptick. And also just on your commercial market growth, your membership growth in the quarter. Can you break it out between small group versus large group?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","So thanks, Kevin. Let's let Brian Thompson address a couple of those.",12,"So thanks, Kevin. Let's let Brian Thompson address a couple of those."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Sure. Kevin, Brian here. As I think about elective care, what we've really seen is a pretty steady return to normal. We don't really see, what I'll call as, an unnatural suppression nor have we seen a significant bounce back suggesting a big catch up. In",184,"Sure. Kevin, Brian here. As I think about elective care, what we've really seen is a pretty steady return to normal. We don't really see, what I'll call as, an unnatural suppression nor have we seen a significant bounce back suggesting a big catch up. In fact, when you think about scheduled care, what we have found is that most of that cycles through in about 4 to 6 months. We look at things like colonoscopies and joint replacements as good leading indicators. And those are running pretty close to baseline. 
Obviously, with the spike that we saw in September, there's a little bit of that, that we would expect to flow through in the fourth quarter, but that's fully accounted for in our outlook. And I would just say from a commercial perspective, maybe echoing what Bill said, feeling really balanced really across our fully insured growth for the quarter. So just optimistic that, that was across not only our group business but we also saw a return of our nonexchange individual growth. So a really good quarter from a fully insured perspective."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Next, we'll go to A.J. Rice with Credit Suisse.",9,"Next, we'll go to A.J. Rice with Credit Suisse."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Maybe just to drill down a little bit on the OptumRx and what's incorporated in '22 outlook, headwinds and tailwinds. I know we had the vaccine this year probably helped script trends a little bit. We had some specialty conversions maybe that helped. And",65,"Maybe just to drill down a little bit on the OptumRx and what's incorporated in '22 outlook, headwinds and tailwinds. I know we had the vaccine this year probably helped script trends a little bit. We had some specialty conversions maybe that helped. And obviously, what was the dynamic around renewing contracts and so forth? What are you thinking about for '22 for OptumRx?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Hey, Heather Cianfrocco here. Thanks, A.J., for the question. So you mentioned -- we talked in the second quarter a bit about vaccine. We saw a little bit of that this quarter in growth, but it's proportionately down. The last quarter, I think it was abou",302,"Hey, Heather Cianfrocco here. Thanks, A.J., for the question. So you mentioned -- we talked in the second quarter a bit about vaccine. We saw a little bit of that this quarter in growth, but it's proportionately down. The last quarter, I think it was about 1/3 of the growth. This quarter, it's down to about, call it, between 20% and 25%. So you're seeing really our growth first of all, in this quarter as a result of modest PBM growth, together with continued and membership growth, together with continued pharmacy services growth. 
When we look at '22, we're going to see that to continue. So our pharmacy services growth, remember, that's our home delivery, specialty, infusion, the multidose as well as our direct-to-consumer community businesses. Those will continue to grow in '22. We see those sort of outpacing growth of the rest of OptumRx pharmacy. 
And I guess I'd call out a few things when I think about '22. First of all, we've made those investments. And so we're seeing that. We talked about Genoa and our community pharmacies and Dirk talked about this morning and how they're growing, not just in expanded sites, but our existing sites are continuing to show really strong growth as they expand services to existing members and expand in different types of health centers. 
We'll continue to see that in '22. And we think the solutions we're bringing in an integrated way, together with our consumer experience and our real push to make therapeutics affordable and easy to access for our members will continue to see that. And I just point you back to our long-range growth where we'll continue to be, I think, stable with our revenue and earnings growth in '22 as we look towards our long-range plan. So thanks for the question."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes, that was great. And I think, A.J., what that points out, clearly, a broad pharmacy portfolio with clearly, a laser focus on affordability and laser focus on serving people, getting the medications in people's hands where they need them and basically",58,"Yes, that was great. And I think, A.J., what that points out, clearly, a broad pharmacy portfolio with clearly, a laser focus on affordability and laser focus on serving people, getting the medications in people's hands where they need them and basically servicing the entire sort of what I'll call a pharmacy landscape with effective products and services."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","We'll go to Lisa Gill with JPMorgan.",8,"We'll go to Lisa Gill with JPMorgan."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I just want to go back to your comments around virtual care and a digital first product in 2022. Can you talk about what that will entail, first up? And then secondly, when you talk about connecting multiple channels of care in 2022, I would assume that's",79,"I just want to go back to your comments around virtual care and a digital first product in 2022. Can you talk about what that will entail, first up? And then secondly, when you talk about connecting multiple channels of care in 2022, I would assume that's primarily keeping the patient in the home. But can you maybe just give a little more detail around what those programs would look like and what the potential cost savings could be?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So first of all, let me hit on the virtual products that we have. I've talked about it before, we're sort of getting into from version 1 to version 2. The second version is really not telehealth as a stand-alone service but really effectively integra",196,"Yes. So first of all, let me hit on the virtual products that we have. I've talked about it before, we're sort of getting into from version 1 to version 2. The second version is really not telehealth as a stand-alone service but really effectively integrated into physical delivery and total courses of care. And so as I think about how we might -- how we're organizing our products, what we would have is a virtual PCP available to some people and many people across the country don't have relationships with PCPs. So a product based on having virtual PCP, having that PCP managed like a brick-and-mortar PCP, and then manage the downstream expenses. Being able to refer to digital properties, be able to, as I said, bring in a behavioral specialist where needed. And as we sit and we look at some of the products that we have and we're designing, we're expecting probably about a 15% price advantage to other sort of similar products in the market. So we're kind of excited about the efficiency of virtual in that context. Yes. So give me your second question again, Lisa, I was focused on virtual."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","Just more around when you talk about connecting multiple channels of care in 2022. Should I assume that, that's primarily connecting care in the home? Or is there something that I'm not thinking about?",34,"Just more around when you talk about connecting multiple channels of care in 2022. Should I assume that, that's primarily connecting care in the home? Or is there something that I'm not thinking about?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","No. No, you're thinking of this multimodality right. It's home, it's digital. It's what we do in the office. And that's one of the things that we're trying to do, and I'm glad you hit on that. Our ability to serve people where they want to be served is so",90,"No. No, you're thinking of this multimodality right. It's home, it's digital. It's what we do in the office. And that's one of the things that we're trying to do, and I'm glad you hit on that. Our ability to serve people where they want to be served is something that we're really focused on across all 3 of our lines of business. It's very important. And clearly, people have different care needs, and they have different preferences for care, and we want to provide that access across the board."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. within OptumHealth or OptumCare, the build-out of the home and community platform is one of the more important areas that Wyatt and his team are focused on. There's been lots of development there. Wyatt, maybe you could add a little color?",42,"Yes. within OptumHealth or OptumCare, the build-out of the home and community platform is one of the more important areas that Wyatt and his team are focused on. There's been lots of development there. Wyatt, maybe you could add a little color?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Absolutely. So we're very excited about bringing virtual care, as Dirk said, in a differentiated way into people's homes so that they can access care. We can help triage them and onboard them. We can provide primary care. And when needed, we can provide c",106,"Absolutely. So we're very excited about bringing virtual care, as Dirk said, in a differentiated way into people's homes so that they can access care. We can help triage them and onboard them. We can provide primary care. And when needed, we can provide care delivery, in appropriate, in some instances in the home, or we're leveraging particularly our urgent care platform to provide nearby physical care. And then we blended in our virtual and physical behavioral care deliveries as well. So we're now live in all 50 states. We're serving over 7 million members today, and we look forward to continuing to expand these offerings."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","Okay. Next, we'll go to Steven Valiquette with Barclays.",9,"Okay. Next, we'll go to Steven Valiquette with Barclays."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","So you touched on the topic of Medicare risk adjuster payments earlier. This was also a little bit more topical about a month ago with The Wall Street Journal putting a spotlight on it. So I guess I'm just curious if you have any updated high-level though",76,"So you touched on the topic of Medicare risk adjuster payments earlier. This was also a little bit more topical about a month ago with The Wall Street Journal putting a spotlight on it. So I guess I'm just curious if you have any updated high-level thoughts on MRA payments conceptually for the managed care industry overall. And do you see any potential reform of MRA near term? Or do you expect status quo going forward?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. Thank you very much for the question. First, let me point to the value proposition that Medicare Advantage provides. I think that's important context. So I may serve 27 million Americans with very high-quality care. And compared to fee-for-service Me",187,"Yes. Thank you very much for the question. First, let me point to the value proposition that Medicare Advantage provides. I think that's important context. So I may serve 27 million Americans with very high-quality care. And compared to fee-for-service Medicare MA costs less, is more equitable, has better quality access and outcomes and greater coverage and benefits with nearly 100% consumer satisfaction. So very, very important to the care that seniors receive, and it's important that we preserve the stability of this program that so many people rely on. 
And when we think about the risk adjustment model in the payment system. The model has been critical to providing broad and equitable access to MA. Risk adjustment levels of playing field and ensures that there's no disincentive to care for the most vulnerable. So we really feel that it's an essential part of encouraging the right incentives in the program, and think that it's something to build on and broadly support that we need to think about how to build on these positive elements and aspects of the program for which this is one of them."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","All right. We'll take our last question from Stephen Baxter with Wells Fargo.",13,"All right. We'll take our last question from Stephen Baxter with Wells Fargo."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Analysts","I wanted to come back to the labor market and some of the things that we're reading about provider financials.  Was wondering what you're hearing from your network partners on this issue and how you think it will or will not influence rate negotiations ov",51,"I wanted to come back to the labor market and some of the things that we're reading about provider financials.  Was wondering what you're hearing from your network partners on this issue and how you think it will or will not influence rate negotiations over the next couple of years?"
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Executives","Yes. So thanks for the question. I think yes, what we're hearing from network partners is that their cost of labor is higher. So that comes up in the negotiations. And like anything else, it's part of what we negotiate and how we try to work with our netw",220,"Yes. So thanks for the question. I think yes, what we're hearing from network partners is that their cost of labor is higher. So that comes up in the negotiations. And like anything else, it's part of what we negotiate and how we try to work with our network partners on coming up with the right pricing and negotiating accordingly. Yes, we're hearing that there's -- obviously, there's staffing shortages. Obviously, many of the hospitals and other providers have to pay more for their input, and that's going to be reflected in the economics as we go forward. And of course, all that is reflected in how we price going forward. So yes, that occurs. 
Thank you for the question. With that, what I would like to close with is as follows. Thanks, everybody, for your time and your questions today. We hope you're taking away the impression of a company that's confident in its opportunities and ability to grow. And we're deeply aware of where and how we need to improve, and we're fully committed to our mission of helping people live healthier lives and helping make the health system work better for everyone. We look forward to sharing with you more at our November 30 Investor Conference, hopefully, in person in New York. Thanks for your time today."
104673,1682559831,2406328,"UnitedHealth Group Incorporated, Q3 2021 Earnings Call, Oct 14, 2021",2021-10-14,"Earnings Calls","UnitedHealth Group Incorporated","Operator","That does conclude today's conference. We thank everyone again for their participation.",13,"That does conclude today's conference. We thank everyone again for their participation."
